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Endocrine disrupting chemicals (EDCs) are a class of environmental toxicants, of 
both natural and synthetic origin, that interfere with normal endocrine function. Exposure 
to EDCs during susceptible periods of development, particularly embryogenesis, can 
result in profound neurological and reproductive deficits. While the impact of 
developmental exposure to EDCs on reproductive function and behavior has been much 
studied, the underlying mechanisms responsible for these observed effects are not well 
understood. The goal of the research detailed in this dissertation is to elucidate the 
cellular and molecular targets by which a representative class of EDCs, polychlorinated 
biphenyls (PCBs), disrupts normal reproductive neuroendocrine function. My specific 
hypothesis is that PCBs cause changes in sexually dimorphic brain regions underlying 
sex-specific reproductive physiology and behavior through the perturbation of normal 
developmental apoptosis, with long-term consequences for reproductive success. 
 vii 
The studies detailed herein focus on three areas which contribute to an 
understanding of the effects of PCBs on neuroendocrine reproductive function: (1) the in 
vitro effects of PCBs on a neuroendocrine cell line, (2) developmental effects of PCBs on 
the gestationally exposed F1 generation, and (3) the physiological consequences of these 
developmental alterations for adult reproductive function. In the first section of this 
dissertation, the neurotoxic and endocrine disrupting effects of PCBs on a representative 
developing neuroendocrine cell model, the GT1-7 GnRH cell line, are investigated in 
time- and dose-response experiments. Treatment and dose-dependent effects are observed 
for GnRH peptide concentrations, cell viability, apoptotic and necrotic cell death, and 
caspase activation. In general, GnRH peptide levels are suppressed by high doses and 
longer durations of PCBs, and elevated at low doses and shorter time points. The 
suppression of GnRH peptide levels was partially reversed in cultures co-treated with the 
estrogen receptor antagonist ICI 182,780. All PCBs tested reduced viability and increased 
both apoptotic and necrotic cell death. The second section of this dissertation examines 
whether prenatal PCB exposure alters normal neuroendocrine development in the F1 
generation, including sexual differentiation of the brain. Disruption of hypothalamic 
development is detectable as early as the day after birth (postnatal day (P) 1), as indicated 
by abnormal programmed cell death, and alterations in neuroendocrine gene and protein 
expression.  The third section discusses the physiological impact of developmental PCB 
exposure on reproductive maturation and adult neuroendocrine function. Pubertal onset is 
advanced and estrous cyclicity irregular in PCB endocrine-disrupted females. 
Furthermore, sexual differentiation of female neuroendocrine systems is 
 viii 
masculinized/defeminized.  Collectively, these results suggest that the disrupted sexual 
differentiation of the POA can be detected as early as the day after birth, effects that may 
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CHAPTER 1: GENERAL INTRODUCTION 
The text in this section is modified from the book chapter “Reproductive 
Neuroendocrine Targets of Developmental Exposure to Endocrine Disruptors,” 
Dickerson SM, Cunningham SL, and Gore AC, in Endocrine Disruptors and Puberty 
(2010), with permission from the publisher. 
 
HYPOTHALAMIC CONTROL OF REPRODUCTION 
Endocrine disruptors (EDCs) are chemicals in our environment that interfere with 
the normal functioning of an organism’s endocrine systems, including those involved in 
reproduction. In vertebrate species, reproductive function is regulated by the 
hypothalamic-pituitary-gonadal (HPG) axis, which includes the gonadotropin-releasing 
hormone (GnRH), pituitary gonadotropins [luteinizing hormone (LH) and follicle-
stimulating hormone (FSH)], and gonadal steroid hormones. The hypothalamus, located 
at the base of the brain, maintains homeostasis of a variety of physiologic functions by 
acting as a central processor, integrating converging inputs from sensory and autonomic 
systems. Importantly, the hypothalamus coordinates cues related to the organism’s 
internal and external environment with the timing of reproductive capacity, in order to 
ensure that the energetically costly process of reproduction occurs only during the most 
favorable conditions. Although the hypothalamic GnRH neurons provide the primary 
driving force onto other HPG levels, all three levels must function properly for the 
appropriate control of reproduction. 
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The GnRH neuroendocrine cells controlling reproduction have their neural 
somata (cell bodies) in the hypothalamus, and extend an axon to the base of the 
hypothalamus, the median eminence. For the control of HPG processes, GnRH-releasing 
cells respond to changing environmental conditions by rapidly adjusting their release of 
the GnRH peptide into the portal capillary vasculature that transports the peptide to the 
anterior pituitary gland. From the pituitary, LH and FSH are released into the general 
circulatory system, and target the gonads to drive steroidogenesis and gametogenesis. 
Gonadal steroids then act upon steroid hormone receptors, primarily estrogen receptors 
(ERs), androgen receptors (ARs) and progesterone receptors (PRs) that are widely and 
heterogeneously expressed in target tissues, both reproductive and non-reproductive, 
including the reproductive tract and genitalia, breast, fat, bone, muscle, kidney, liver, and 
many other organ systems. Of relevance to the regulation of HPG function, steroid 
hormone receptors are also expressed in the central nervous system (CNS) and pituitary 
gland. These receptors enable steroid feedback to be exerted on the hypothalamic-
pituitary levels of the HPG axis. 
While GnRH neurons in the hypothalamus control pituitary and gonadal hormone 
release through feedforward regulatory mechanisms, and in turn are regulated by gonadal 
steroid hormones through feedback regulatory mechanisms, it is important to note that 
GnRH neurons themselves do not express most of the nuclear sex steroid hormone 
receptors. This raises the question: how are GnRH neurons regulated by steroid 
feedback? The answer is provided by observations that the CNS, and particularly the 
hypothalamus is abundant in ERs, ARs and PRs (Chakraborty and Gore, 2004). A 
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network of these steroid-sensitive neurons in the hypothalamus converges upon the 
GnRH cells. This neural circuitry is quite heterogeneous, as the neurons can arise from a 
variety of locations, and they can release a diversity of neurotransmitters. This circuit 
may seem unduly complex, but it makes sense in considering that reproduction must be 
properly coordinated with the internal and external environment. Many CNS pathways 
are needed to convey all of the specific types of information to the GnRH system, which 
is the final common pathway to the pituitary gland.  
 
Sex differences in HPG function 
There are important sex differences in the control of reproductive physiology and 
behavior. Although both male and female mammals release GnRH in a pulsatile manner, 
at intervals of about 30-120 minutes depending upon species, the GnRH neurosecretory 
system differs between males and females in a fundamental way. In females, the 
amplitude and frequency of GnRH release varies profoundly across the reproductive 
cycle, whereas in males, GnRH is fairly consistently released in pulses. Moreover, 
feedback of gonadal steroid hormones onto GnRH cells is always negative in males, 
whereas it shifts from negative to positive during the preovulatory surge in females. CNS 
inputs to GnRH neurons are also sexually dimorphic in their regulation of GnRH release 
and in their neuroanatomical properties. For example, important inputs to GnRH cells 
arise from the anteroventral periventricular nucleus (AVPV), which regulates GnRH 
release via expression of ERs (Petersen and Barraclough, 1989; Wintermantel et al., 
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2006), and is approximately two times larger in volume and cell number/density in adult 
females than in males (Bleier et al., 1982; Sumida et al., 1993). The preovulatory 
GnRH/gonadotropin surge in females is regulated by inputs from the AVPV to GnRH 
neurons, a process that does not occur in males. Conversely, the sexually dimorphic 
nucleus of the preoptic area (SDN-POA), the size of which is correlated with regulation 
of sexual behavior and levels of gonadotropins, has a volume roughly two to four times 
higher in male rats than in females (Gorski et al., 1978; Gorski et al., 1980). Normal 
reproductive function depends on proper development of these and other sexually 
dimorphic neural circuits that take shape during the process of brain sexual 
differentiation, which in rodents occurs during late embryonic/early postnatal 
development (Barraclough, 1961).  
The concept of a critical period of brain sexual differentiation has been proposed 
and studied by neuroendocrinologists for decades. However, its importance to 
environmental endocrine disruption is only just recently becoming clear. A growing body 
of scientific evidence has illuminated the vulnerability of the developing neonate to 
exposure to environmental EDCs that may disrupt sexual differentiation, but effects of 
which may not be manifested until much later in life. The importance of developmental 
exposures is a focus of the current article, and will be elaborated upon below. 
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Sexual differentiation of the hypothalamus: Hormones and apoptosis 
In vertebrate species, sex differences in reproductive physiology and behavior are 
attributed to phenotypic differences in the neuroanatomy and neurochemistry of specific 
brain regions. These differences become organized during critical developmental 
windows, particularly the late embryonic and early postnatal periods, and are permanent. 
At these times, sex differences in levels of gonadal hormones are large, and contribute to 
morphological and functional differences in the size, cell number, phenotype, and 
neurochemistry of hypothalamic brain regions (Gorski et al., 1980; Simerly et al., 1984; 
Simerly et al., 1985; De Vries and al-Shamma, 1990; Sumida et al., 1993). A key 
component in the shaping of the brain into a male or female typical pattern is the 
presence of the testicular hormone testosterone, and its aromatization to estradiol. 
Neonatal female rodents have relatively low levels of gonadal hormones because the 
perinatal ovary is quiescent, and the steroid binding protein alpha (α)-fetoprotein forms a 
complex with any circulating endogenous estrogen, which prevents it from entering the 
brain. Conversely, around the time of birth the testis releases a surge of testosterone in 
neonatal males, which is not bound by α-fetoprotein (Bakker and Baum, 2008). Once it 
enters the brain, testosterone may act directly upon androgen receptors (ARs), or may it 
may be converted to estradiol, the endogenous ligand for estrogen receptors (ERs), by the 
enzyme aromatase. Consequently, while the female brain develops under relatively low 
levels of steroid hormones, the male brain is exposed to high levels of both testosterone 
and estradiol. Thus, testosterone and estradiol act directly upon their cognate receptors in 
a sexually dimorphic manner to organize the brain into a sex-appropriate pattern. Not 
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surprisingly, alterations in the normal hormonal milieu during this phase of development 
can have deleterious effects, which may manifest as deficits in reproductive function and 
behavior during adulthood.  
Apoptosis, an essential component of normal neuronal development, is one of the 
mechanisms through which hormones sculpt the brain during sexual differentiation 
(Forger et al., 2004). Depending upon the hypothalamic nucleus, estradiol may stimulate 
or inhibit apoptosis through the interaction of ligand bound ER dimers with nuclear 
response elements that promote cell survival or death. For instance, the number of 
apoptotic cells in the medial preoptic nucleus, spinal nucleus of the bulbocavernosis 
(SNB) (Nordeen et al., 1985), bed nucleus of the stria terminalis (BNST) (Chung et al., 
2000), and SDN-POA (Davis et al., 1996a) is higher in female rodents than in males 
during early postnatal development. In males, these regions are involved in penile 
erection, and in masculine sexual physiology and behavior. On the other hand, the 
number of apoptotic cells in the anteroventral periventricular nucleus (AVPV) is greater 
in male rodents compared to females during a similar time period (Sumida et al., 1993; 
Yoshida et al., 2000), and this region is accordingly larger in females than in males. 
There are discrete hormone-sensitive time periods during which the volumes of 
these particular regions are vulnerable to substances that act on steroid hormone receptors 
(Rhees et al., 1990a; Rhees et al., 1990b). For example, exposure of developing female 
rats to testosterone or excessive levels of estradiol (more than can be bound by circulating 
α-fetoprotein) results in a larger, masculinized SDN-POA in adulthood, while castration 
of neonatal males results in a smaller, feminized SDN-POA (Rhees et al., 1990a). 
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Similarly, the rat AVPV is sensitive to hormone influence during a period spanning late 
prenatal and early postnatal development (Patisaul et al., 2007). Orchidectomy of 
neonatal males and treatment of neonatal females with testosterone or estradiol abolishes 
the sex difference in AVPV volume and cell number (Simerly et al., 1985; Simerly, 
1989; Sumida et al., 1993; Davis et al., 1996b). As will be discussed in greater detail 
below, perinatal exposure to environmental EDCs, which do not bind to the protective α-
fetoprotein, also causes similar changes in the volume of sexually dimorphic nuclei 
(Masutomi et al., 2003; Ikeda et al., 2005; Yamamoto et al., 2005b).  
Sexual dimorphism is not limited solely to anatomical differences or number of 
cells in these brain nuclei; there are also marked differences in the phenotype of cells in 
sexually dimorphic brain regions. For instance, the AVPV of female rodents expresses a 
greater number of cells that are immunopositive for tyrosine hydroxylase (Simerly et al., 
1997; Forger et al., 2004), kisspeptin (Simerly, 2002; Clarkson and Herbison, 2006; 
Kauffman et al., 2007a; Bateman and Patisaul, 2008; Gonzalez-Martinez et al., 2008), 
and estrogen receptor (ER) (Simerly et al., 1997; Orikasa et al., 2002). In the end, adult 
sex-specific reproductive behaviors are the manifestation of proper organization of the 
brain by sex steroid hormones during perinatal development. Thus, late prenatal and early 
postnatal development comprises a critical window during which the functional 
morphology and neurochemistry of these sexually dimorphic regions are established. 
Exposure to endocrine active exogenous substances or even to maternal or endogenous 
hormones at the inappropriate time could cause permanent alterations in adult 
reproductive function. To follow is a summary of the literature investigating the effects of 
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endocrine disrupting chemicals on neonatal development of reproductive neuroendocrine 
function. For more detailed information regarding compounds, age and duration of 
treatment, dosage, exposure route, and species, refer to Tables 1-3.  
 
ENDOCRINE DISRUPTION OF NEUROENDOCRINE SYSTEMS 
Environmental EDCs were originally defined by the United States Environmental 
Protection Agency (EPA) as “exogenous agents that interfere with the synthesis, 
secretion, transport, binding action, or elimination of natural hormones in the body that 
are responsible for the maintenance of homeostasis, reproduction, development, and/or, 
behavior” (Kavlock et al., 1996). The EPA has gone on to expand its definition to: “An 
exogenous substance that changes endocrine function and causes effects at the level of 
the organism, its progeny, and/or (sub)populations of organisms.” Regardless of which 
definition one uses, it is clear that EDCs have a diversity of targets and act through a 
number of pathways related to endocrine control of homeostasis. In addition to their 
effects on the HPG axis, EDCs may also have actions on other neuroendocrine hormonal 
systems, including the thyroid (hypothalamic-pituitary-thyroid axis), stress 
(hypothalamic-pituitary-adrenal axis), growth (somatotropic axis), lactotrophic axis, 
neuropeptides, and other metabolic hormones. The current chapter will primarily focus 
on the effects of developmental EDC exposure on reproductive neuroendocrine targets in 
the perinatal and pubertal mammal. Regarding the effects of developmental EDC 
exposure on other hormonal systems, refer to the following reviews on the thyroid axis 
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(Zoeller, 2005; Zoeller, 2007; Anderson, 2010); glucocorticoids (Schantz and Widholm, 
2001; Desvergne et al., 2009); growth (Scarth, 2006); and general metabolism 
(Swedenborg et al., 2009). Endocrine disruption is also a significant concern for non-
mammalian species. Invertebrates and aquatic species may be particularly vulnerable, as 
they have a large surface-to-volume ratio and lack a barrier such as skin to protect against 
environmental toxicants, and they are swimming in the very substance (water) in which 
many EDCs are dissolved or in solution. Egg-laying animals also have vulnerability 
through exposure of the eggshell to the environment. Although this chapter focuses on 
effects of EDCs on the HPG axis of mammals, we refer readers to the following articles 
and reviews on other species/classes: nematodes (Hoss and Weltje, 2007); Drosophila 
(Hirsch et al., 2010); aquatic invertebrates (McLachlan et al., 2001; Hotchkiss et al., 
2008; Kloas et al., 2009); fish (Rempel and Schlenk, 2008); reptiles (Sheehan et al., 
1999; Guillette and Gunderson, 2001); and birds (Panzica et al., 2007).  
As will be discussed in greater detail, the mediation of the endocrine disrupting 
effects of EDCs on neuroendocrine reproductive function often occurs through (but is not 
limited to) steroid hormone receptors, particularly ERs and ARs, which are expressed 
abundantly in the hypothalamus, but are differentially affected by EDCs. Some effects 
may also occur directly upon GnRH neurons, as illustrated by the section on GnRH cell 
lines. Later in this chapter, we will highlight the evidence for neuroendocrine effects of 
one of the most extensively studied classes of EDCs: the polychlorinated biphenyls 
(PCBs). Although they will not be discussed herein, several other classes of EDCs are 
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also known to disrupt the HPG axis, including phytoestrogens, industrial organohalogen 
compounds, pesticides, bisphenol A, and phthalates (Figure 1.1).  
  
A PROTOTYPICAL EDC: POLYCHLORINATED BIPHENYLS 
Regardless of whether they are naturally occurring or man-made, EDCs are 
chemicals in our environment that act through numerous mechanisms to block, imitate or 
otherwise modify normal hormonal function. These alterations to endogenous endocrine 
activity may involve the direct or indirect interaction of EDCs with steroid hormone or 
neurotransmitter receptors, alterations in levels of bioavailable endogenous hormones or 
their receptors by EDCs, or actions on enzymes involved in the biosynthesis or 
degradation of endogenous hormones, among other potential mechanisms. From a 
historical perspective, the first endocrine disruptors to be identified were estrogenic in 
nature, although it is now known that EDCs may also be anti-estrogenic or anti-
androgenic in nature. Hundreds of chemicals have already been identified as known 
EDCs, and systematic screening by the Endocrine Disruptor Screening Program (EDSP) 
by the EPA of pesticides and other environmental contaminants is currently underway. 
This section will highlight one class of EDCs known to target reproductive 
neuroendocrine systems: polychlorinated biphenyls (PCBs), structures of which are 
shown in Figure 1.1. In this section, we provide background information about this class 
of EDC, and in subsequent sections, we review evidence for their actions on 
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neuroendocrine systems, particularly when exposure occurs during critical developmental 
windows such as the prenatal, early postnatal, and pubertal periods. 
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Figure 1.1: Chemical Structure of Representative EDCs 
 
Figure 1.1. Structures of representative endocrine disruptors. 
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Chemical Properties of PCBs: 
Industrial organohalogens encompass an array of compounds used for or 
produced as a byproduct of industrial applications. They include a diverse group of 
chemicals such as polychlorinated biphenyls (PCBs), polybrominated biphenyls (PBBs), 
polybrominated diphenyl ether flame-retardants (PBDEs), chlorinated paraffins, furans, 
and dioxins. As a whole, members of this family of persistent organic pollutants (POPs) 
are generally structurally stable and resistant to environmental or biodegradation, and are 
routinely detected in the tissues of humans and wildlife. 
Much of the information regarding the effects of industrial organohalogens on the 
reproductive axis comes from studies involving PCBs (Figure 1.1). PCBs are a group of 
related compounds that consist of chlorine atoms arranged around a biphenyl core, a 
feature that contributes to their ability to interact with various hormone and 
neurotransmitter receptors as agonists, antagonists, or with mixed activity. Endogenous 
estradiol has a phenolic moiety in its A ring, and the interaction of this moiety with ERs 
in particular is mimicked by environmental EDCs such as PCBs. Although widely used 
between the 1930s and 1970’s, manufacture of PCBs was prohibited in 1977 due to their 
toxicity. Ironically, the same qualities that made use of PCBs desirable for such industrial 
applications as capacitors, transformer oil, sealants, paints, etc., contributed to their 
persistence in the environment and their toxicity. For instance, PCBs resist degradation, 
and because they bioaccumulate and biomagnify, they are still prevalent as complex 
mixtures throughout the food chain and in environmental samples. Remarkably, they 
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contaminate even remote areas, such as the Arctic and Antarctic regions (Jenssen, 2006; 
Letcher et al., 2009), due to movement of marine biota associated with fluctuating 
climate, as well as through air and water currents. Exposure of humans and wildlife to 
PCBs occurs mainly through consumption of contaminated food, and has been linked to 
reproductive deficits. For example, farmed salmon has relatively high concentrations of 
PCBs (among other EDCs) (Hites et al., 2004) and pregnant women have been advised to 
limit consumption of this otherwise healthy food choice to once monthly. 
Based on their chemical structure, PCBs are grouped into one of the following 
three categories: coplanar, dioxin-like coplanar, or non-coplanar. In addition, the 
structural properties of each PCB class determine whether and how (i.e. agonist, 
antagonist) they interact with hormone and neurotransmitter receptors. Along with 
actions on ERs, PCBs target a broad range of hormone receptors (thyroid hormone 
receptor, androgen receptor), neurotransmitter receptors (e.g. acetylcholine, dopamine, 
GABA, and serotonin), hormone-binding proteins (e.g. thyroid hormone binding protein), 
as well as orphan receptors (e.g. aryl hydrocarbon receptor) and intracellular signaling 
receptors (e.g. ryanodine receptor). In addition, in vitro studies have shown that the 
hydroxylated metabolites of PCBs inhibit estradiol sulfotransferase, which may prolong 
the bioavailability of endogenous estradiol (Kester et al., 2000). Furthermore, depending 
on their structure, individual PCBs may be estrogenic, anti-estrogenic, or anti-androgenic. 
To complicate matters, because PCBs are present in human and wildlife samples as 
mixtures of the most persistent congeners and their hydroxylated metabolites, additive, 
synergistic, or antagonistic effects between PCBs may occur (Bergeron et al., 1994).  
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EDC EFFECTS ON THE GNRH SYSTEM AND DEVELOPING 
HYPOTHALAMUS 
EDC Effects on GnRH Cell Lines 
GnRH neurons in the hypothalamus are notoriously difficult to study. Their 
location at the base of the brain makes them inaccessible to traditional 
electrophysiological measures, as does the fact that they are scattered across a continuum 
in the preoptic area of the hypothalamus. These have been significant obstacles to 
research in the hypothalamic control of HPG function. The GnRH GT1 cell lines, created 
in the late 1980’s (Mellon et al., 1990) have proven to be valuable resources for 
understanding GnRH properties. They have many neural properties, and they synthesize 
and release the GnRH peptide in a pulsatile manner (Martinez de la Escalera and Clapp, 
2001). To date, this cell line has been used to study effects of the EDCs, PCBs, dioxin 
(TCDD) and organochlorine (methoxychlor, chlorpyrifos) and pyrethroid (tefluthrin) 
pesticides, and the phytoestrogen coumestrol. A brief summary of those results is 
provided, with evidence that most of these compounds directly affect these immortalized 
GnRH cells (Table 1).
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The first studies to investigate actions of EDCs on GT1-7 cells were those from 
our laboratory, investigating effects of PCBs and organochlorine pesticides. Dose-
response analysis of the PCB mixtures, Aroclor 1221 and Aroclor 1254, for 24 hours 
demonstrated differential effects on cell morphology, GnRH release, and GnRH gene 
expression (Gore, 2002). Specifically, GnRH peptide release was stimulated by Aroclor 
1221 (but not Aroclor 1254), an effect that was blocked by the estrogen receptor 
antagonist, ICI 182780. GnRH mRNA levels were elevated at the intermediate 
concentration of 1 µM but were unchanged at higher/lower concentrations. By contrast, 
Aroclor 1254 stimulated GnRH mRNA levels only at the lowest concentration (0.01 
µM). Finally, GT1-7 cell morphology was altered by PCB treatment, with Aroclor 1221 
increasing cell confluence and promoting neurite outgrowth. Aroclor 1254 tended to 
cause some cell death and for GT1-7 cells to retract their neural processes. As a whole, 
these data support the effects of PCB mixtures on this immortalized cell line. 
Effects of the pesticides, chlorpyros and methoxychlor, have been studied on 
GnRH peptide and mRNA levels in GT1-7 cells (Gore, 2002). Neither pesticide affected 
GnRH peptide concentrations. Chlorpyrifos increased confluency of the cells and 
stimulated neurite extension, whereas methoxychlor was mildly neurotoxic. Effects of the 
pesticides on GnRH gene expression were similar: both stimulated GnRH mRNA levels 
at lower concentrations, and inhibited levels at the highest concentrations. 
Other laboratories have investigated actions of other EDCs on more limited 
endpoints in GT1 cells. Petroff et al. (2003; Table 1) showed that the dioxin TCDD had 
no effect on GnRH secretion, on promoter-reporter expression in transfected GT1-7 cells, 
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or on GT1-7 cell number (Petroff et al., 2003). They also demonstrated that their GT1-7 
cells did not express the aryl hydrocarbon receptor, possibly explaining the lack of effect 
of dioxin on this orphan receptor. 
The effects of the pyrethroid insecticide tefluthrin were tested on ion currents in 
GT1-7 cells (Wu et al., 2009b). Cells were treated with this compound at 10 µM, and 
currents were measured. Current amplitude and firing frequency were both increased by 
tefluthrin application. It will be interesting to examine other effects of this pyrethroid, 
including GnRH peptide release and gene expression. 
Finally, coumestrol has been studied for its effects on GnRH gene expression in 
GT1-7 cells, with a focus on the mediation of these actions by the ERβ (Bowe et al., 
2003). In general, coumestrol had inhibitory effects on GnRH mRNA levels, with the 
greatest effect seen at the 6-hour time point and the 1 µM concentration (Table 1). A role 
for ERβ was established through use of the specific antagonist, R,R-diethyl 
tetrahydrochrysene (R,R-THC), which blocked the inhibitory effect of coumestrol on 
GnRH mRNA levels (Bowe et al., 2003). These data support the actions of this 
phytoestrogen directly on GnRH immortalized neurons through this ER subtype. 
As a whole, these studies on the GT1-7 cell line support the likelihood that 
environmental EDCs can directly target GnRH neurons. Although it is critical to extend 
these studies to in vivo models, they provide a potential mechanism for effects of these 
compounds on HPG systems. 
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PCB Effects on the Developing Hypothalamus 
Brain development is a highly complex and coordinated sequence of events that 
begins early on during embryogenesis and continues through puberty and into early 
adulthood. The perinatal brain is particularly vulnerable to disruption by EDCs, as it is 
during this time that proper development of the central nervous system and 
neuroendocrine reproductive axis is fine-tuned by factors that are influenced by 
endocrine hormones, including genes, neurotransmitters, and growth/survival factors 
(Dickerson and Gore, 2007; Gore, 2008b). Importantly, through the developmental 
process of brain sexual differentiation, the organism acquires sex-appropriate brain 
morphology and function. As will be discussed in greater detail below, disruption of any 
of these development processes may permanently alter brain morphology and function, 
causing disruptions in adult reproductive physiology and behavior later in life. This 
section will highlight evidence that early exposures to PCBs may disrupt this crucial 
process. 
 
BRAIN SEXUAL DIFFERENTIATION  
As mentioned earlier, neonatal exposure of developing humans and animals to 
organohalogen compounds is a global public health and environmental concern, as 
humans and wildlife even from remote areas have appreciable levels of this class of ED 
in their body burden. Early studies with pregnant laboratory animals showed that PCBs 
readily cross the placenta, and are also passed to the suckling young (Masuda et al., 
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1978a; Masuda et al., 1978b; Ando et al., 1985). Trans-placental transfer of PCBs has 
been confirmed in humans, as levels in the serum of newborns corresponds with maternal 
levels (Lackmann et al., 1999; Covaci et al., 2002; Park et al., 2008). Moreover, since 
they are small, lipophilic compounds, PCBs also cross the blood-brain-barrier, and have 
been detected in human fetal brain tissue at an average concentration of 50 ppb (Lanting 
et al., 1998). Age at parity may be an important consideration, as presumably the body 
burden of organohalogens increases with age, and many women are delaying childbirth in 
industrialized nations. Indeed, epidemiological evidence suggests that children born to 
older mothers may have increased exposure to compounds such as PCBs (Lackmann et 
al., 1999). This type of exposure may have relevance for human health, as a growing 
body of evidence shows that developmental exposure to organohalogens such as PCBs 
have effects on the developing neuroendocrine system of laboratory animals (Table 2). 
The effects of neonatal exposure to PCBs on brain sexual differentiation has been 
studied in several animal models, and collectively these data suggest that this endpoint is 
sensitive to disruption by these environmental pollutants. Several studies have reported 
that such exposure to PCBs alters expression of nuclear hormone receptors and aromatase 
activity, an effect that seems to be dependent upon the specific PCB molecule(s). For 
instance, Hany et al. (1999) found that newborn male pups gestationally exposed to a 
reconstituted mixture of PCBs formulated after the congener pattern found in human milk 
exhibited significantly reduced aromatase activity in the hypothalamus/preoptic area, 
while no effect was observed in pups similarly exposed to Aroclor 1254 (Hany et al., 
1999). A study by Colciago et al. (2006) found that prenatal Aroclor 1254 (A1254) 
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exposure during late gestation had no effect on hypothalamic aromatase expression or 
activity (Colciago et al., 2006). Hypothalamic androgen receptor protein expression is 
sensitive to even short-term prenatal PCB exposure, as acute A1254 exposure during 
embryonic development reduced hypothalamic AR protein expression in embryonic 
female rats at embryonic day 20 in rats, which is late in gestation. In a follow-up study by 
the same group, Colciago et al. (2009) found that perinatal exposure to a reconstituted 
PCB mixture caused an increase in hypothalamic aromatase expression in male rats at 
weaning, while females were unaffected (Colciago et al., 2009). In contrast, only female 
rats had decreased levels of hypothalamic 5-alpha-reductase, the enzyme that converts 
testosterone into the more potent androgen dihydrotestosterone, at the time of weaning. 
Whether these reductions in aromatase and 5-alpha reductase activities result in reduced 
androgen action in the developing female brain or impairments on adult female sexual 
behavior are not clear. In a related study using the same experimental design, Pravettoni 
et al. (2005) evaluated the effect of PCBs on the developmental profile of aryl 
hydrocarbon receptors (AhR), a nuclear orphan receptor that mediates effects of dioxins 
and dioxin-like PCBs, in the male and female rat hypothalamus. The group found that 
AhR gene expression progressively increases in the male hypothalamus during 
embryonic development, and that A1254 further stimulated gene expression of AhR in 
males. No effect was observed in females (Pravettoni et al., 2005).   
Estrogen receptor, and estrogen-dependent gene expression is also affected by 
developmental exposure to PCBs. For instance, Lichtensteiger et al. (2003) found that 
gestational exposure to A1254 increased ERα gene expression in the ventromedial 
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nucleus of the hypothalamus (VMN), a region important for feminine sexual behavior, in 
female rat embryos (Lichtensteiger, 2003). In contrast, progesterone receptor gene 
expression in the female VMN was decreased by treatment in the same study. Together, 
the studies highlighted above suggest that gestational exposure to PCBs affects 
expression of nuclear receptors in sexually dimorphic brain regions. However, the impact 
of these alterations in gene and protein expression on the volume of these sexually 
dimorphic nuclei is not yet clear. 
In a recent study by Shimada et al. (2009) investigating the toxicogenomics of 
prenatal exposure to A1254 in male mice at birth, the gene expression of α-fetoprotein in 
whole brain extracts was increased several-fold (~6.8-fold change) compared to control 
(Shimada et al., 2009). Since PCBs do not bind α-fetoprotein, this could have 
implications for the bioavailability of endogenous estradiol aromatized from fetal testis. 
As a whole, these studies suggest acute disruption of hormone receptors and 
metabolism/biosynthesis of hormones by organohalogen EDCs.  
 
SERUM HORMONES AND ANOGENITAL DISTANCE  
In addition to disruptions in the normal pattern of gene and protein expression in 
the developing brain, early exposure to PCBs also alters serum hormone levels and 
anogenital distance (AGD) in exposed offspring. For example, Kaya et al. (2002) 
reported decreased serum estradiol and testosterone in female rats exposed to a 
reconstituted mixture of PCBs throughout the period of gestation and lactation, while 
only serum testosterone was reduced in exposed males (Kaya et al., 2002). The effect of 
PCBs on serum hormones may be dependent upon the composition of the congeners and 
the dose used. For instance, gestational exposure to low doses (3–30 µg/kg/day) of the 
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individual PCB congeners PCB126 or PCB169 resulted in reduced levels of serum 
testosterone in weanling males (Yamamoto et al., 2005a). In contrast, another group 
showed that when rats were exposed to a higher doses (4 mg/kg/day) throughout the 
period of late gestation until weaning, PCB126 combined with PCB138, PCB153, and 
PCB180 had no effect on testosterone in exposed males (Cocchi et al., 2009). Finally, 
Lilienthal et al. (2006) found that gestational exposure to A1254 caused reductions in 
serum estradiol in weanling male rats, while female estradiol levels were not affected. As 
a whole, these data support effects of PCBs on hormone levels in early life (Lilienthal et 
al., 2006). 
PCB effects on neonatal AGD are dependent upon compound and sex. For 
instance, a study investigating the effects of gestational and lactational exposure to the 
dioxin-like coplanar congener PCB118 found that male rats had hypermasculinized AGD 
throughout early postnatal development, although the effects on female AGD were not 
reported (Kuriyama and Chahoud, 2004).  Interestingly, A1254 exposure hyperfeminized 
(shortened) the AGD in female pups, while male AGDs were unchanged compared to 
control (Lilienthal et al., 2006). The effect of A1254 on female AGD seems to be dose-
dependent, as gestational exposure to A1254 over the same time period with a lower dose 
caused an increase in the AGD of treated females, compared to control females 
(Ceccatelli et al., 2006). However, the same study found that similar doses of PBDE-99, 
a major congener found in human breast milk samples, had no effect on AGD in treated 
females. Similarly, exposure to the non-coplanar congener PCB47 and the dioxin-like 
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congener PCB77 during gestation defeminized AGD in female neonates, while males 
were unaffected (Wang et al., 2002).   
Collectively, the studies mentioned herein demonstrate the sensitivity of sex 
steroid hormone-dependent gene expression in the brain, anogenital distance, and serum 
steroid hormone levels in the neonate to developmental PCB exposure. More studies need 
to be conducted, in order to understand the impact of developmental PCB exposure on 
sexually dimorphic brain regions in exposed neonates.   
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Table 2: Effects of PCB Exposure on Neonatal Neuroendocrine Development 
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↑: increased; ↓: decreased; A1221: Aroclor 1221; A1254: Aroclor 1254; AGD: 
anogenital distance; AVPV: anteroventral periventricular nucleus of the hypothalamus; 
bw: Body weight; E: embryonic day; ERα: estrogen receptor alpha; ERβ: estrogen 
receptor beta; F: female; GnRH: gonadotropin hormone releasing hormone; Inj: injection; 
IP: Intraperitoneal; M: male; MPOA: medial preoptic area; MPN: medial preoptic 
nucleus; mRNA: messenger RNA; No Δ: unchanged; P: postnatal day; P4: progesterone; 
PCB: polychlorinated biphenyl; PR: progesterone receptor; RM: reconstituted mixture; 
SC: subcutaneous; SDN-POA: sexually dimorphic nucleus of the preoptic area; VMN: 
ventromedial nucleus of the hypothalamus. 
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PCB EFFECTS ON THE PUBERTAL TRANSITION 
Puberty is the developmental process whereby the juvenile organism reaches 
adulthood, and is initiated by the activation of the HPG axis. This protracted transitional 
period is marked by acceleration of growth, development of secondary sexual 
characteristics, and culminates with the attainment of adult reproductive function. 
Following organization of the brain throughout early postnatal development, during 
which the HPG axis is active, a quiescent phase characterized by low levels of 
gonadotropins and circulating steroid hormones maintains inhibitory control over HPG 
activity. During the pubertal transition to adult reproductive capacity, reactivation of the 
GnRH neurosecretory system is manifested as increased pulse frequency and amplitude 
of hypothalamic GnRH release. This in turn, promotes pulsatile release of the 
gonadotropins LH and FSH from the anterior pituitary and subsequent activation of the 
gonads. The increase in levels of circulating gonadal sex steroid hormones results in 
development of secondary sex characteristics. Furthermore, the sex-specific brain 
morphology and neurochemical circuits organized during early postnatal development 
become activated to coordinate reproductive capacity with sexual behaviors.  
Recent studies have provided much insight into the central mechanisms governing 
pubertal initiation in mammals. The use of laboratory animal models as sentinels for the 
potential impact of EDCs on human puberty should be considered with the caveat that 
inhibitory control over GnRH secretion during the quiescent phase differs in some ways 
between rodents and primates. While steroid inhibitory control represses GnRH 
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neurosecretory activity in rodents, this is much less potent in primates. Central 
mechanisms that operate independently of gonadal hormones operate to suppress GnRH 
in primates, as well as in rodents. Because the bulk of research on endocrine disruption is 
performed in rodents, most of this discussion will focus on those species. In rodents, the 
onset of puberty is traditionally reflected by the external markers of vaginal opening (an 
estrogen-mediated event) in females, and preputial separation (an androgen-mediated 
event) in males. In addition, in female rodents the final endpoint for pubertal onset is the 
age at first estrus, as it follows the first preovulatory gonadotropin surge.  
A large body of evidence supports the idea that developmental exposure to 
environmental EDCs influences the onset and progression of puberty. Indeed, precocious 
(early) puberty, delayed puberty, or no change in timing of puberty, can occur in response 
to developmental ED exposure, depending upon the nature of the endocrine disruptor, the 
dose, the sex, and the timing of exposure. These studies on laboratory rodents are likely 
to reflect processes in humans, as epidemiological and clinical studies have shown a 
correlation between environmental chemical exposures and pubertal timing (Buck Louis 
et al., 2008; Wolff et al., 2008; Chou et al., 2009).  
Developmental exposure to PCBs has been shown to affect the timing of puberty, 
as well as serum gonadotropins and hormones, with effects varying by compound and sex 
(summarized in Table 3). In contrast to the sex difference in susceptibility to other 
classes of EDCs, both males and females seem to be vulnerable to pubertal disruption 
caused by PCBs.  
 As mentioned earlier, PCBs are categorized into three classes based upon 
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arrangement of chlorine atoms around the biphenyl core. The available literature suggests 
that their three-dimensional structure greatly impacts their potential for disruption of 
pubertal onset, which is presumably related to their ability to impact interactions of 
hormones with their cognate steroid hormone receptors. In addition, the effects of 
individual PCBs may be sex-specific. Studies with the dioxin-like coplanar congener 
PCB126 have consistently indicated a delay in female puberty following gestational 
exposure over a range of doses in rats (Faqi et al., 1998; Muto et al., 2003; Shirota et al., 
2006), while male pubertal onset is unaffected. The effects of PCB126 may be species-
specific though, as pubertal onset in female goats was unaffected by gestational and 
lactational exposure (Lyche et al., 2004). Although the onset of male puberty is not 
affected by PCB126, a demasculinization of the AGD was observed in male rats (Faqi et 
al., 1998), and an increase in the prepubertal testosterone peak in male goats was reported 
(Oskam et al., 2005). 
The effects of PCB mixtures on puberty have also been reported, including for the 
once commercially available Aroclors, which are named according to the average 
percentage chlorine of the congeners that comprise the mixture. The effects of mixtures 
also seem to be sex-dependent. For instance, the PCB mixture A1254 (54% chlorine 
content) delays the onset of puberty in gestationally- but not early postnatally-exposed 
male rats, while in female rats a delay in pubertal onset was noted regardless of whether 
exposure is restricted to gestation (Lilienthal et al., 2006) or early postnatal development 
(Sager and Girard, 1994). Delayed female puberty in response to A1254 exposure is 
consistently observed, even at high doses (Lee et al., 2007). Conversely, the more lightly 
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chlorinated commercial PCB mixture, A1221 (21% chlorine content), has been shown to 
advanced onset of puberty in female rats whether exposure occurs throughout gestation 
and lactation, or acutely exposed after birth (Gellert, 1978). One potential explanation for 
the opposite effects of A1221 and A1254 on pubertal timing in females is the difference 
in percentage chlorine composition of each technical Aroclor mixture. For instance, 
because A1254 has a greater proportion of more highly chlorinated biphenyls than 
A1221, these structural disparities may manifest as differences in binding affinity to 
hormone and neurotransmitter receptors, and their ability to act as an estrogen agonist or 
antagonist. While studies investigating the effects of Aroclors on puberty are informative, 
the effects of environmentally relevant mixtures of individual PCB congeners have also 
been studied. For example, our laboratory and others have observed a sex-dependent 
effect of puberty in rats exposed throughout the period of gestation and lactation to a 
reconstituted mixture of PCBs comprised of the most prevalent congeners measured in 
human samples. An advancement of vaginal opening and first estrus was seen in females, 
while a delay of preputial separation was observed in males (Colciago et al., 2009). 
In addition to their effects on pubertal timing, PCBs have also been reported to 
affect serum gonadotropin and hormone levels during the peri-pubertal transition. For 
example, in goats gestationally exposed to PCB153, a delay in pubertal onset, reduced 
prepubertal serum LH and reduced serum progesterone during ovulation was observed in 
females (Lyche et al., 2004), while a decrease in serum LH was noted in males. Similar 
results were obtained with male goats by a separate lab. Oskam et al. (2005) found that 
PCB126 and PCB153 exposure during embryonic development caused a reduction in 
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prepubertal LH, an effect that persisted into the post-pubertal period (Oskam et al., 
2005). Furthermore, that group also observed an increase in the prepubertal testosterone 
peak followed by a lasting reduction in testosterone for the five weeks following puberty. 
Effects of PCBs on serum hormones are not limited to goats; both serum estradiol and 
progesterone were decreased at late puberty/early adulthood (P50) in female rats 
gestationally exposed to PCB126 (Muto et al., 2003).   
 The question of whether early exposure to PCBs causes disruptions in human 
puberty remains largely unanswered (Den Hond and Schoeters, 2006).  For example, 
epidemiologic studies have reported no association between maternal exposure to PCBs 
and breast development (Blanck et al., 2000; Gladen et al., 2000; Den Hond et al., 2002) 










Table 3: PCB Effects on Peri-pubertal Neuroendocrine Endpoints 
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Abbreviations:  
↑: increased; ↓: decreased; A1221: Aroclor 1221; A1254: Aroclor 1254; AGD: 
anogenital distance; AVPV: anteroventral periventricular nucleus of the hypothalamus; 
bw: Body weight; E: embryonic day; ERβ: estrogen receptor beta; F: female; FSH: 
follicle-stimulating hormone; GnRH: gonadotropin hormone releasing hormone; Inj: 
injection; IP: Intraperitoneal; M: male; mRNA: messenger RNA; No Δ: unchanged; P: 
postnatal day; P4: progesterone; PCB: polychlorinated biphenyl; ppm: parts per million; 
PR: progesterone receptor; RM: reconstituted mixture; SC: subcutaneous 
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SUMMARY 
Taken together, the data summarized in this chapter support a role for these five 
classes of EDCs on development of the reproductive neuroendocrine axis. The effects of 
EDCs on the developing HPG axis range from disruptions of sexual differentiation of 
dimorphic brain regions, to alterations in gene and protein expression, enzymatic activity, 
serum gonadotropin and hormone levels, to interference with feedback responses 
between the different levels of the HPG axis. While there is limited human data, and 
there are inconsistencies in the available animal data, it can be concluded that the 
developing reproductive neuroendocrine system constitutes a sensitive target of 
developmental ED exposure. There appears to be increased interest in research on 
neuroendocrine endpoints, and we expect that the future will bring novel information, and 
potentially insights into mechanisms by which environmental EDCs cause 
neuroendocrine dysfunctions. 
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CHAPTER 2: EXPERIMENTAL OVERVIEW 
AIMS OF THIS RESEARCH 
As described in Chapter 1, PCBs are persistent environmental toxicants known to 
cause neurological and reproductive deficits in mammals (Morse et al., 1996; Schantz et 
al., 1996; Tilson and Kodavanti, 1997; Hany et al., 1999; Guo et al., 2000; Gore, 2001a). 
The developing offspring of exposed pregnant females are particularly vulnerable to 
endocrine-disrupting effects of PCBs and other toxicants, because the critical period of 
brain sexual differentiation occurs in late fetal/early postnatal life, and disruption of 
normal development during this period can be devastating to adult sexual functions. The 
overarching goal of this dissertation research project is to characterize the mechanisms 
through which perinatal PCB exposure disrupts sexual differentiation of the 
hypothalamus. My focus is a sexually dimorphic nucleus whose morphology, 
neurochemistry, and expression of nuclear hormone receptors correlate with the control 
of adult reproductive physiology and behavior: the anteroventral periventricular nucleus 
(AVPV). Sex differences in this region occur due in part to developmental apoptosis, and 
are organized by perinatal gonadal steroid hormones. Embryonic levels of sex steroid 
hormones contribute not only to the observed sex differences in volume and cell number 
in this region during adulthood (Rhees et al., 1990b; Sumida et al., 1993), but also to the 
development of appropriate sex-specific neuroendocrine physiology and behavior. The 
specific hypothesis behind the research is that perinatal PCB exposure disrupts 
sexual differentiation of the developing AVPV via alterations in developmental 
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apoptosis, gene and protein expression, ultimately resulting in reproductive 
dysfunction during adulthood. This hypothesis is based on the following observations: 
1) prenatal PCB exposure causes endocrine disrupting effects at the hypothalamic level of 
the reproductive axis in vertebrate species, including mammals (Khan et al., 2001; 
Lichtensteiger, 2003; Salama et al., 2003; Colciago et al., 2006); 2) PCBs induce 
apoptosis in neuronal cultures (Hwang et al., 2001; Mariussen et al., 2002; Howard et al., 
2003; Sanchez-Alonso et al., 2003; Sanchez-Alonso et al., 2004); 3) perinatal exposures 
to substances that act on steroid hormone receptors change apoptosis in a sex-specific 
manner (Ito et al., 1986; Murakami and Arai, 1989; Nishizuka et al., 1993; Sumida et al., 
1993; Arai et al., 1994), although this latter question has not yet been addressed 
specifically for PCBs. The specific aims are designed to provide a comprehensive 
assessment of the PCB-induced alterations in normal development of the sexually 
dimorphic neuroendocrine system.   
 
Specific Aim I: Test the hypothesis that environmentally persistent PCB congeners have 
neurotoxic effects on the hypothalamic GT1-7 cell line in vitro. Selection of congeners 
and doses for in vivo experiments in Aims II and III are informed by these data.  
a) Evaluate whether treatment with representative PCBs affect GnRH peptide 
levels in GT1-7 cells.  
b) Assess whether PCBs induce cell death in the GT1-7 cell line as indicated by 
loss of cell viability and abnormal cell and nuclear morphology. If cell death is 
induced, establish whether death is due to apoptosis or necrotic cell death. 
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Specific Aim II: Test the hypothesis that prenatal exposure to PCBs has sexually 
dimorphic effects on the developing hypothalamus of male and female Sprague-Dawley 
rats, and ascertain the mechanisms for these effects.   
a) Determine whether prenatal exposure to PCBs changes developmental apoptosis 
in a sexually dimorphic manner in the AVPV, and, if so, determine whether 
those changes manifest as altered adult volume of the AVPV at P60.   
b) Investigate whether PCB exposure alters gene expression of GnRH and nuclear 
hormone receptors in the preoptic area at P1 and P60. 
c) Establish whether PCBs affect protein expression of the nuclear hormone 
receptor ERα in the developing and adult hypothalamus. To this end, the 
numbers of cells in the AVPV and MPN that express estrogen receptor alpha 
(ERα) will be counted in males and females at P1 and P60.  
 
Specific Aim III: Test the hypothesis that prenatal PCB exposure has long-term 
physiological consequences on reproductive development and physiology. 
a) Determine whether pubertal endpoints in rats (body weight, anogenital distance, 
age at vaginal opening and onset of estrous cycles for females, and preputial 
separation for males) are significantly different between PCB- and vehicle-
treated animals. 
b) Determine whether PCB exposure alters normal estrous cyclicity in females. 
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c) Determine whether serum hormone levels (estradiol, testosterone, progesterone, 
luteinizing hormone) are altered during adulthood. 
 
GENERAL RESEARCH METHODS 
There are three major experiments in my dissertation. Detailed methods for each 
experiment are described in each chapter. 
Aim I:  
PCB congeners are classified into three categories, coplanar, dioxin-like coplanar, 
and non-coplanar, based upon arrangement of chlorine substituents around the biphenyl 
core. Congeners with no more than one chlorine atom in an ortho position may assume a 
coplanar configuration. Congeners that have no more than one chlorine atom in the ortho 
positions, a total of four or more chlorine substituents, both para positions (4 and and 4') 
chlorinated, and two or more chlorinated meta positions (3, 3', 5, and 5'), are classified as 
dioxin-like coplanar. Because these congeners bind to the aryl hydrocarbon (Ah) 
receptor, they are associated with toxicities similar to dioxins (Safe, 1994). More than 
one chlorine substituent in the ortho position results in steric hindrance of ring rotation; 
these congeners are classified as noncoplanar. While all three classes persist in the 
environment, the non-coplanar class is found in the highest concentrations in both human 
and wildlife samples (Gladen et al., 2003). As our model, we use the hypothalamic GT1-
7 cells, which synthesize and secrete GnRH, to establish the mechanisms of neurotoxicity 
exerted by individual PCBs of the three classes. GT1-7 cells (generously provided by Dr. 
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Pamela Mellon, UCSD (Mellon, 1990) will be treated with PCB74 (coplanar), PCB118 
(dioxin-like coplanar), or PCB138 (noncoplanar), in a dose-response and time-course 
design. Cells are assessed for GnRH peptide, morphology, viability, and DNA 
fragmentation. See detailed methods for in vitro experiments in Chapter 3. 
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Figure 2.1: Experimental overview of in vitro studies 
 
Figure 2.1: GT1-7 cells grown in culture are treated in time- and dose-response 
experiments with representative PCBs from each classification (coplanar, dioxin-like 
coplanar, non-coplanar) alone or in combination, with or without estrogen receptor 
antagonist. At each timepoint, cells are either qualitatively evaluated for morphology, or 
harvested for viability, apoptosis, or necrosis assays. Cell culture media is harvested at 
each timepoint to assay GnRH peptide. 
 41 
Aim II: 
Gender differences in gonadal steroid hormones during perinatal development 
influence developmental neuronal apoptosis, and contribute to the morphological 
differences between male and female AVPV. The volume, cell number, and functional 
neurochemistry of this brain region are particularly sensitive to small changes in hormone 
status. Perinatal exposures to substances that act on steroid hormone receptors change 
apoptosis in a sex-specific manner (Ito et al., 1986; Murakami and Arai, 1989; Nishizuka 
et al., 1993; Sumida et al., 1993; Arai et al., 1994), although this has not yet been 
addressed specifically for PCBs. Because PCBs can exert anti-estrogenic activity via 
competitive binding of the estrogen receptor (Bonefeld-Jorgensen et al., 2001; Salama et 
al., 2003), and are known to alter sex steroid hormone levels in gestationally exposed 
neonatal rodents (Kaya et al., 2002; Yamamoto et al., 2005a), they may interfere with 
processes that are regulated by sex hormones, such as sexual differentiation of the brain. 
The choice of age for investigation of apoptosis, P1, was based on previous 
evidence showing sex differences in the extent of apoptosis in the AVPV at this age 
(Sumida et al., 1993; Davis et al., 1996a; Yoshida et al., 2000). P60 was selected as an 
age for investigation of the impact of altered developmental apoptosis on the adult 
volume of the AVPV because by this age, the sex differences in the size, cell number and 
expression of nuclear hormone receptors are established. The selection of the POA for 
investigation of gene expression is based on the location of the AVPV within the POA, 
and the relative ease of performing the POA microdissection compared to the technical 
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difficulty of isolating the AVPV. Thus, whether prenatal exposure to PCBs alters the 
extent of developmental apoptosis, gene expression, and expression of ERα in a gender-
dependent manner in the AVPV of the postnatal rat hypothalamus, leading to permanent 
alterations in the adult brain will be assessed.   
Timed-pregnant Sprague-Dawley rats will be injected intraperitoneally on E16 
and E18 with either vehicle (sesame oil), 50 µg estradiol benzoate, or 1 mg/kg A1221, or 
1 mg/kg of a reconstituted mixture of PCB138, PCB153, and PCB180. This treatment 
timing falls after the differentiation of cells in the AVPV and MPN, and before 
developmental apoptosis begins. Based on the maternal dose, each pup will be exposed to 
an estimated 2 µg/kg PCB, which falls within the range of human neonatal exposures 
(Lackmann, 2002). For each experiment, gonadally-intact male and female rats 
gestationally and lactationally exposed to PCBs will be used at P1 and P60. Animals 
from Aim II will be allowed to mature to puberty for Aim III, and will be euthanized at 
P60 (Figure 2.2). 
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In addition to cellular and molecular effects, PCBs may cause permanent changes 
that are manifested during the pubertal process, during which endogenous steroid 
hormone production increases and activates the sex-specific brain morphology and 
neurochemistry organized during early postnatal life. Thus, precocious (early) puberty, 
delayed puberty, or no change in timing of puberty, can occur in response to 
developmental PCB exposure. Preputial separation (PPS) in males and vaginal opening 
(VO) in females are reflections of the increase in gonadal steroid hormone secretion 
associated with puberty. These endpoints have been historically used as a general 
indicator of the progression from adolescence to adult reproductive capacity (Korenbrot 
et al., 1977; Safranski et al., 1993), although neither is a definitive marker that adult 
reproductive capacity has been attained. Reproductive maturity occurs shortly after VO 
and PPS in rats, and these endpoints are useful markers that rats are within the 
peripubertal stage of development. In addition, the anogenital distance (AGD) is a useful 
marker of masculinization/defeminization (Marois, 1968), and can be an indicator of 
endocrine disruption. Therefore, the goal of Aim III is to ascertain the repercussions of 
prenatal PCB treatment on the attainment and manifestation of adult reproductive 
functions. Thus, whether pubertal endpoints in rats (body weight, anogenital distance, age 
at vaginal opening and onset of estrous cycles for females, preputial separation for males, 
and serum hormones) are significantly different between PCB- and vehicle-treated 




Exposure to EDCs during the vulnerable developmental period can result in 
profound neurological and reproductive deficits. As PCBs are pleiotropic compounds that 
exert estrogenic or anti-estrogenic activity via competitive binding of the estrogen 
receptor, they may interfere with processes that are regulated by sex hormones, such as 
sexual differentiation of the brain. The studies outlined above are designed to provide 
new insight into the mechanisms responsible for the neuroendocrine toxicity of PCBs, 
and may form the basis for therapeutic strategies to prevent or ameliorate reproductive 
deficits resulting from perinatal PCB exposure.
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CHAPTER 3: CELL DEATH MECHANISMS IN GT1-7 GNRH CELLS 
EXPOSED TO POLYCHLORINATED BIPHENYLS PCB74, PCB118, 
AND PCB153 
The text in this section is excerpted from the article “Cell death mechanisms in 
GT1-7 GnRH cells exposed to polychlorinated biphenyls PCB74, PCB118, and 
PCB153,” Dickerson SM, Cunningham SL, and Gore AC, in Toxicology & Applied 
Pharmacology (2009), with permission from the journal. 
 
ABSTRACT 
Exposure to endocrine-disrupting chemicals (EDCs) such as polychlorinated 
biphenyls (PCBs) causes functional deficits in neuroendocrine systems. We used an 
immortalized hypothalamic GT1-7 cell line, which synthesizes the neuroendocrine 
peptide gonadotropin-releasing hormone (GnRH), to examine the neurotoxic and 
endocrine disrupting effects of PCBs and their mechanisms of action. Cells were treated 
for 1, 4, 8, or 24 h with a range of doses of a representative PCB from each of three 
classes: coplanar (2,4,4',5-tetrachlorobiphenyl: PCB74), dioxin-like coplanar (2',3,4,4',5' 
pentachlorobiphenyl: PCB118), non-coplanar (2,2',4,4',5,5'-hexachlorobiphenyl: 
PCB153), or their combination. GnRH peptide concentrations, cell viability, apoptotic 
and necrotic cell death, and caspase activation were quantified. In general, GnRH peptide 
levels were suppressed by high doses and longer durations of PCBs, and elevated at low 
doses and shorter time points. The suppression of GnRH peptide levels was partially 
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reversed in cultures co-treated with the estrogen receptor antagonist ICI 182,780. All 
PCBs reduced viability and increased both apoptotic and necrotic cell death. Although 
the effects for the three classes of PCBs were often similar, subtle differences in 
responses, together with evidence that the combination of PCBs acted slightly differently 
from individual PCBs, suggest that the three tested PCB compounds may act via slightly 
different or more than one mechanism. These results provide evidence that PCB 
congeners have endocrine disrupting and/or neurotoxic effects on the hypothalamic 
GnRH cell line, a finding that has implications for environmental endocrine disruption in 
animals.   
  
INTRODUCTION 
Polychlorinated biphenyls (PCBs) are a family of synthetic organic pollutants that 
contaminate both urban and rural environments. These compounds were widely used for 
industrial applications between the 1930s and 1970s, due to their stability, non-
flammability and high dielectric constant. The same properties that made PCBs desirable 
for industrial use contribute to their resistance to degradation and to their toxicity. 
Despite the banning of PCB manufacture in the United States in 1977, humans are still 
exposed via food, and have appreciable body burdens (Stellman et al., 1998).  
PCBs can act as endocrine disrupting chemicals (EDCs) via their interactions with 
sex steroid hormone receptors, steroidogenic enzymes, and other mechanisms [reviewed 
in (Dickerson and Gore, 2007)]. Indeed, PCBs have been shown to perturb endocrine and 
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reproductive systems in a variety of species (Khan and Thomas, 2001; Salama et al., 
2003; Khan and Thomas, 2004). Further, PCBs have been proposed to disrupt 
neuroendocrine cells in the hypothalamus, including cells that synthesize and release the 
neurohormone, gonadotropin-releasing hormone (GnRH) [reviewed in (Dickerson and 
Gore, 2007; Gore, 2008a)]. The decapeptide GnRH is released from neuroterminals in the 
hypothalamus into the portal capillary system leading to the anterior pituitary gland, 
where GnRH acts to stimulate synthesis and release of gonadotropins into the general 
circulation. These two hormones, follicle-stimulating hormone (FSH) and luteinizing 
hormone (LH) act at the gonads to stimulate gonadal maturation, steroidogenesis and 
gametogenesis. Although all three levels of the hypothalamic-pituitary-gonadal axis must 
function properly in order for reproductive function to occur, the hypothalamic GnRH 
neurons provide the driving force upon this system.  
PCBs have other actions on the nervous system beside neuroendocrine GnRH 
cells. They target neurotransmitter receptors and biosynthetic enzymes (Seegal et al., 
1991b; Seegal et al., 1991a; Juarez de Ku et al., 1994; Altmann et al., 2001; Mariussen et 
al., 2002; Gafni et al., 2004; Coccini et al., 2006), and they act upon steroid hormone 
receptors in the brain (Dickerson and Gore, 2007). Importantly, GnRH neuroendocrine 
cells are regulated by a complex interplay of neurotransmitters and steroid hormones. 
Thus, PCBs may exert both direct and indirect actions upon GnRH neurons, thereby 
disrupting hypothalamic-pituitary-gonadal function. 
The mechanisms of action and the degree of toxicity of PCBs are dependent upon 
degree of chlorination, three-dimensional structure, timing and duration of exposure, 
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dosage, and cell type (Kodavanti, 2005; Ruiz et al., 2008). PCBs are grouped into three 
general categories: coplanar, dioxin-like coplanar, and non-coplanar, with differential 
effects on cell death, including apoptosis and necrosis as shown in neuronal hippocampal 
or cortical cell cultures or immortalized neuronal cell lines (Hwang et al., 2001; 
Inglefield et al., 2001; Kang et al., 2001; Howard et al., 2003; Sanchez-Alonso et al., 
2003; Lee et al., 2004; Sanchez-Alonso et al., 2004; Costa et al., 2007). However, the 
neurotoxicity of PCBs has not been addressed for neuroendocrine cells. Although 
previous work (Gore et al., 2002) has shown that PCBs can alter release of GnRH and 
change GnRH gene expression in the GT1-7 immortalized hypothalamic cell line (Mellon 
et al., 1990), the mechanisms of neurotoxicity have never been studied or quantified. 
Here, we hypothesized that the three different classes of PCBs (coplanar, dioxin-like 
coplanar, non-coplanar) would cause a differential endocrine disruption of GnRH release, 
and induce differing levels of apoptosis or necrosis in GT1-7 hypothalamic cells. We also 
evaluated effects of a mixture of the three PCBs in order to assess whether there were 
additive or synergistic effects on these endpoints. Finally, we examined the role of the 
nuclear estrogen receptor in mediating effects of PCBs on GnRH release by co-





We purchased 2,4,4',5-tetrachlorobiphenyl (CAS RN: 32690-93-0; PCB74- 99.9% 
purity; lot no. 102293), 2',3,4,4',5' pentachlorobiphenyl (CAS RN: 31508-00-6; PCB118- 
99.9% purity; lot no. 961002LB-AC), and 2,2',4,4',5,5'-Hexachlorobiphenyl (CAS RN: 
35065-27-1; PCB153- 99.9% purity; lot no. 062703JR-AC), from Accustandard (New 
Haven, CT, USA).  Dimethylsulfoxide (DMSO), and staurosporine (positive control for 
apoptotic cell death) were purchased from Sigma (St. Louis, MO, USA) and 4’,6-
diamidino-2-phenylindole (DAPI) was purchased from Calbiochem (La Jolla, CA, USA). 
ICI 182,780 was purchased from Tocris Bioscience (Ellisville, MO, USA). We purchased 
phenol red-free Dulbecco's Modification of Eagle's Medium (DMEM), fetal calf serum, 
L-glutamine, penicillin, and streptomycin from CellGro (MediaTech, Inc., Herndon, VA, 
USA). The CellTiter-Blue™ Cell Viability and APO-One Homogeneous Caspase-3/7 
Activation assay was purchased from Promega Corporation (Madison, WI, USA). Anti- 
mouse cleaved caspase-3 and anti-mouse cleaved caspase-9 antibodies were from Cell 
Signaling Technology, Inc. (catalog no. 9664 and 9509, respectively; Beverly, MA, 
USA), while anti-mouse cleaved caspase-8 antibody was obtained from R&D Systems, 
Inc. (catalog no. AF1650; Minneapolis, MN, USA). 
GT1-7 cell culture and maintenance 
GT1-7 cells (kindly provided by Dr. Pamela Mellon; (Mellon et al., 1990) were 
maintained in phenol red-free DMEM supplemented with 10% heat-inactivated fetal calf 
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serum (FCS) and antibiotics (100 U/ml, penicillin, 100 mg/ml streptomycin). Cells were 
grown at 37°C with 5% CO2 as described previously (Gore, 2002; Gore et al., 2002), and 
used between passages 15 – 20. Cells were sub-cultured into six-well or 96-well tissue 
culture dishes 2–3 days before experiments in Dulbecco’s minimum essential medium 
(DMEM) plus FCS and antibiotics, and grown to approximately 60–70% confluency. To 
avoid growth hormone or steroid effects of FCS, we switched to serum-free medium four 
hours before experiments. All experiments were performed on triplicate monolayers of 
either approximately 1X106 cells for six-well plates or 50,000 cells for 96-well plates, 
and were repeated three to four times on separate culture dishes. 
PCB congener treatments 
GT1-7 cells were treated with either vehicle (DMSO), individual PCBs [PCB74, 
PCB118 or PCB153 (each at 0.1, 1, 10, 100 µM)] or a PCB Mix [1:1:1 mixture of 
PCB74, PCB118, and PCB153 (0.1, 1, 10, 100 µM final additive molar equivalent of 
individual PCBs)]. For some experiments, staurosporine (200 nM; Sigma) was used as a 
control for apoptotic cell death (Koh et al., 1995). We diluted all drugs in DMSO and 
used them at a final dilution of 1:1000 in medium. The vehicle was applied at a 1:1000 
dilution. In separate experiments, cells were co-administered 1000 nM ICI 182,780. We 
maintained cultures at 37°C with 5% CO2 after application of drugs.  Following 1, 4, 8, or 
24 h of treatment, cells were viewed on an inverted phase contrast microscope at a 
magnification of X250. Photomicrographs were imaged using a Nikon digital camera 
mounted on the microscope.    
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GnRH Peptide Assay 
GnRH peptide levels in the medium were measured in two double-antibody 
radioimmunoassays with duplicate samples of 100 µl. For each experiment, media from 
triplicate cultures were pooled into a single sample. Three pooled samples per experiment 
were analyzed, and the experiment was repeated four times. The antibody to GnRH was 
provided by Dr T. Nett (R1245). Synthetic GnRH used as trace and standard was 
purchased from Richelieu Laboratories (Montreal, Canada). Assay sensitivity was 
0.1 pg/tube at 95% binding. The intra-assay coefficients of variation were 3.4% and 
3.9%, and the inter-assay coefficient of variation was 3.1%. 
Determination of Cell Viability 
We used the CellTiter-Blue® Cell Viability Assay (Promega Corporation) to 
measure the viability of cells after PCB treatment. This fluorometric assay is based on the 
metabolic capacity of viable cells to reduce resazurin into resorufin, which is highly 
fluorescent at 590 nm.  Nonviable cells lose metabolic capacity to reduce the indicator 
dye, and therefore do not generate a fluorescent signal. Briefly, the assay was carried out 
according to the manufacturer’s recommendations (Promega). Cells were treated with 
PCB or vehicle for durations between 0 and 24 hours. CellTiter-Blue® Reagent was 
added at a volume of 20 µL to each well one hour before fluorescence was recorded.  The 
fluorescence of the samples was measured at 590 nm on a DTX 880 Multimode Plate 
Reader (Beckman-Coulter, Inc., Fullerton, CA). The presence of PCBs in the culture 
media did not interfere with the viability assay procedures.   
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Detection of cell death 
To detect the presence of necrotic cell death, treated cell populations were 
trypsinized and resuspended in a 1:1 mixture of 1X PBS and 0.4% Trypan Blue solution 
(Sigma) and counted under an inverse phase contrast microscope with a Neubauer 
improved hemacytometer (Hausser Scientific, Horsham, PA). Cells with an intact 
membrane (viable or apoptotic cells) are not permeable to Trypan Blue and remained 
unstained, while cells with a damaged membrane (necrotic cells) stain blue. Necrotic cell 
death is expressed as the percentage stained cells per total cell number counted. Three 
replicates per experiment were analyzed, and the experiment was repeated four times. 
DAPI STAINING OF APOPTOTIC NUCLEI 
Following fixation with 4% paraformaldehyde, GT1-7 cells grown on 22 mm 
glass cover slips were rinsed for 5 minutes with PBS, and stained with 1 µg/ml DAPI in 
water for 20 min at room temperature. We then removed excess DAPI by a rinse with 
water, and mounted cover slips onto slides with VectaShield (Vector Laboratories, 
Burlingame, CA, USA). We characterized nuclear morphology and quantified chromatin 
condensation using an Olympus BX61 System fluorescence microscope at a 
magnification of 400X. Normal cells have a smooth, round nucleus characterized by faint 
staining. Apoptotic cells were identified by the presence of brightly labeled pyknotic 
nuclei.  The number of neurons with condensed nuclei vs. the number of neurons with 
intact nuclei was scored in five randomly chosen microscopic fields (each field typically 
contained 25 – 50 cells). We counted a total of at least 200 cells per slide, and then 
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reported the number of apoptotic cells as a percentage. Three cultures were analyzed per 
experimental condition for each experiment, and experiments were repeated three times. 
DETERMINATION OF CASPASE ACTIVATION 
The Apo-ONE Homogeneous Caspase-3/7 Detection system (Promega 
Coropration, Madison, WI) was used to determine whether caspase-3/7 was activated 
following treatment with the toxicants, using the protocol provided by the manufacture. 
Following incubation at room temperature for three hours, caspase-3/7 activation were 
estimated from the fluorescence of each sample at the excitation wavelength at 485 nm 
and the emission wavelength at 535 nm using a fluorescence reader DTX 880 Multimode 
Detector (Beckman-Coulter, Inc., Fullerton, CA). 
To visualize activated (cleaved) caspases -8 or -9, GT1-7 cells grown on top of 22 
mm glass coverslips in 6-well tissue culture were fixed in 4% paraformaldehyde for 10 
minutes at 4°C and then rinsed in PBS.  Non-specific binding of endogenous proteins to 
primary antibody was blocked by incubating coverslips in 5% normal goat serum and 5% 
bovine serum albumin in PBS for 1 hour at room temperature.  Cells were incubated for 1 
hour at room temperature with rabbit polyclonal antibodies against mouse active caspase-
8 or caspase-9.  Following a rinse in PBS and incubation in an anti-rabbit secondary 
antibody conjugated to fluorescein (Vector Labs, Burlingame, CA, USA), slides were 
mounted with VectaShield mounting media (Vector Labs, Burlingame, CA, USA) and 
visualized on an Olympus BX61 System fluorescence microscope. Observations of the 
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presence or absence of activated caspase staining were made for each treatment and time 
point.   
Statistical analysis of results 
The effects of each PCB were analyzed by two-way ANOVA. Variables for most 
studies were dose and duration. For the ICI 182,780 experiment, variables were treatment 
(PCB alone or PCB plus ICI 182,780) and dose. Experiments were performed identically 
for each collection on the triplicate cultures.  Results of triplicate cultures for each 
experiment were considered to be one independent variable; and thus for statistical 
purposes, final N’s were 3 – 4 per group. When a significant effect was observed, post-
hoc comparisons were performed using Fishers PLSD/Tukey-b analysis. In all cases, P < 
0.05 was considered statistically significant. 
 
RESULTS 
GnRH peptide levels: 
The GT1-7 cell media were collected 1, 4, 8 or 24 hours following treatment with 
PCBs 74, 118, 153, or their combination (referred to hereafter as PCB Mix). For each 
individual PCB and the PCB Mix, two-way ANOVA showed significant main effects of 
both dose (p < 0.005) and duration (p < 0.005), as well as an interaction of dose and 
duration (p < 0.005). In general, GnRH peptide levels were higher in the PCB treatment 
groups when compared to corresponding vehicle treatment at early timepoints (1 and 4 
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hours; Figure 3.1) and lower in PCB-treated cultures at later time points (8 and 24 hours; 
Figure 3.2).  
 
Figure 3.1: PCB Effects on GnRH Peptide Release in GT1-7 Cells 
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Figure 3.1. The effects of (A) PCB74, (B) PCB118, (C) PCB153, or (D) PCB Mix on 
GT1-7 GnRH peptide levels. The cells, seeded on 96-well plates, were treated for 1, 4, 8, 
and 24 hrs with 0.1% DMSO alone (vehicle) or with 0.1, 1, 10, or 100 mM PCB. By 4 hr 
post-treatment, a stimulation of peptide was observed in PCB-treated cells in a dose-
dependent manner that varied by compound. At late time points (8 hr, 24 hr) PCBs 
suppressed GnRH peptide. Results are expressed as average GnRH peptide levels ± 
S.E.M for each experimental average of pooled triplicate cultures (N = 4) per treatment. 
*p < 0.05, **p < 0.005 vs. vehicle (DMSO). 
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The nuclear estrogen receptor antagonist ICI 182,780 (1000 nM) was co-administered 
with PCB74, PCB118, PCB153, or PCB Mix (1 µM dose, 24 hour timepoint) to ascertain 
whether endocrine-disrupting effects of PCBs are manifested upon GnRH release. 
Significant differences between groups were detected by ANOVA (p < 0.001). Post-hoc 
analysis demonstrated that ICI alone reduced (p < 0.05) GnRH peptide levels in control 
cultures (Figure 3.1). PCB treatment was associated with suppressed GnRH peptide 
levels (p < 0.01), which was partially reversed by co-treatment with ICI 182,780 (p < 
0.001 compared to PCB with no ICI 182,780; Figure 3.2). 
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Figure 3.2. Estrogen receptor antagonism modulates PCB-suppression of GnRH 
peptide release. Cells were treated for 24 hrs with 0.1% DMSO alone (vehicle), 1000 
nM ICI alone, 1 µM PCBs, or 1 µM PCBs coadministered with ICI. Coadministration of 
PCB with ICI partially reversed PCB-induced suppression of GnRH peptide. Results are 
expressed as average GnRH peptide levels ± S.E.M for each experimental average of 
pooled triplicate cultures (N = 4) per treatment. *p < 0.05, **p < 0.005 vs. vehicle 
(DMSO). 
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GT1-7 cell viability: 
GT1-7 cell viability was measured by the CellTiter-Blue® Cell Viability Assay. 
We noted no significant differences in cellular viability from 0 to 24 h of exposure 
between untreated cultures and cultures treated with DMSO, the vehicle for PCBs (data 
not shown). For each PCB, two-way ANOVA showed significant main effects of both 
dose (p < 0.005) and duration (p < 0.005), as well as an interaction of dose and duration 
(p < 0.005). Effects varied for the individual congeners, but in general, PCB74 and 
PCB118 had inhibitory effects on relative cell viability at the intermediate doses and at 
all doses by the 24-hour timepoint (Figure 3.3A and 3.3B). PCB153 affected cell 
viability at varying doses depending upon timepoint (Figure 3.3C). The PCB Mix had 
the least effect on viability (Figure 3.3D). 
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Figure 3.3. The effects of (A) PCB74, (B) PCB118, (C) PCB153, and (D) PCB Mix on 
GT1-7 cell viability. Fluorescence measured at 560Ex/590Em is proportional to the number 
of metabolically active cells. Samples at each timepoint were normalized to vehicle 
control fluorescence at 1 hr timepoint, and are expressed as percentage control. Individual 
congeners had inhibitory effects upon cell metabolism/viability vs. vehicle at 1 hr, 
whereas their combination only differed from control at the lowest dose at 4 hr. Each 
value, expressed as percentage control, is the mean ± S.E.M of four experiments run in 
triplicate. After 24 hrs treatment, all PCBs decreased viability. *p < 0.05, **p < 0.005 vs. 
vehicle (DMSO) at 1 hr baseline. 
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Necrotic and apoptotic cell death: 
To differentiate between effects of PCBs on necrotic of apoptotic cell death, 
Trypan blue staining (Figure 3.4A) or DAPI labeling (Figure 3.4B) were used. 
Quantification of necrotic cell death (Figure 3.5) showed that PCBs caused little necrosis 
until the 8 hour timepoint, at which the highest concentration of PCB118 or PCB153 
caused a significant increase. After 24 h treatment, all of the PCBs caused a significant 
increase in necrotic cell death. 
We also examined the effects of PCBs on apoptotic cell death (Figure 3.4B, 
Figure 3.6). Staurosporine, a protein kinase inhibitor that induces apoptosis in neuronal 
cells (Krohn et al., 1998), served as a positive control. Staurosporine consistently induced 
cell death in GT1-7 cells (data not shown). For the PCBs, by 4 hours of exposure, all of 
the PCBs induced an increase in the percentage of apoptotic nuclei, and PCB118 and the 
PCB Mix had effects at the 1-hour timepoint. Notably, the low and intermediate 
concentrations of PCBs were most likely to induce apoptosis for all of the PCBs, with the 
highest concentrations having the least effect (Figure 3.6). 
Caspase activation was assessed at the 4-hour timepoint. For the caspase-3/7 
assay, PCB74, PCB118, and the PCB Mix had similar effects, with the low and 
intermediate concentrations of PCBs causing about a 2-fold increase in caspase-3/7 
activity (Figure 3.7). PCB153 did not significantly affect caspase-3/7 activity (Figure 
3.7).  
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Immunofluorescence for cleaved (activated) caspases -8, and -9 were visualized 
by fluorescence microscopy. Treatment with PCBs resulted in detection of activated 
caspase-9 in all PCB treatments but not the vehicle (Figure 3.4C, 3.4D). No 
immunolabeling was observed for caspase-8 for any of the treatments (Figure 3.4E, 
3.4F).  
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Figure 3.4: PCBs Activate Markers of Apoptosis 
 
Figure 3.4. Fluorescence assays of markers of cell death are shown. (A) Trypan Blue 
staining of GT1-7 cells is shown for a representative PCB118 treated culture. Normal 
cells appear unstained and necrotic cells (arrow) appear blue. (B) DAPI staining of GT1-
7 nuclei is shown in a representative PCB74 treated culture. The arrow shows a 
condensed apoptotic nucleus, and the arrowhead shows a mitotic (non-apoptotic) nucleus. 
Scale bar = 10 mm (panels A and B). (C and D) Cleaved caspase-9 immunofluorescence 
is shown for the 4 hour timepoint for a representative control (C) or PCB Mix (D) 
culture. Results for individual PCBs and the PCB Mix were similar, and all PCBs 
activated cleaved caspase-9 immunofluorescence. (E and F) Cleaved caspase-8 
immunofluorescence is shown for the 4 hour timepoint for a representative control (C) or 
PCB Mix (D) culture. Results for individual PCBs were indistinguishable from the PCB 
Mix (not shown). Caspase-8 immunofluorescence was not detectable in any of the PCB- 
or vehicle-treated cultures. Scale bar = 10 mm (panels C – F). 
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Figure 3.5: PCBs Induce Necrotic Cell Death 
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Figure 3.5. The effects of (A) PCB74, (B) PCB118, (C) PCB153, and (D) PCB Mix 
treatment upon GT1-7 trypan blue staining (necrotic cell death). Cells were incubated in 
absence (DMSO) or presence of PCB concentrations (0.1, 1, 10, or 100 µM) for different 
durations (1, 4, 8, 24 hr). Results are expressed as a percentage of blue stained cells 
characteristic of necrotic cells ± S.E.M for 4 triplicates of each experimental condition. 
We observed a slight but significant increase in necrotic cell death after 8 h treatment 
with the highest dose PCB118 or PCB153. After 24 h treatment, the highest dose PCB74 
and two highest doses of PCB118 and PCB153 caused an extensive increase in necrotic 
cell death. 
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Figure 3.6. The effects of (A) PCB74, (B) PCB118, (C) PCB153, and (D) PCB Mix on 
GT1-7 apoptotic cell death. Cells were incubated in absence (DMSO) or presence of PCB 
concentrations (0.1, 1, 10, or 100 µM) for different durations (1, 4, 8, 24 hr). Results are 
expressed as a percentage pyknotic DAPI stained cells characteristic of apoptotic cells ± 
S.E.M for 4 triplicates of each experimental condition. We observed a significant 
increase in apoptotic cell death as early as 1 hr treatment with lower doses (0.1 or 1 µM) 
PCB74, PCB118, or PCB Mix. After 24 h treatment, all PCBs caused a significant 
increase in apoptotic cell death. 
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Figure 3.7. The effects of (A) PCB74, (B) PCB118, (C) PCB153, or (D) PCB Mix on 
caspase-3/7 activation. Cells were incubated in absence (DMSO) or presence of PCB 
concentrations (0.1, 1, 10, or 100 µM) for four hours. Results are expressed as fold 
increase of caspase-3/7 activation compared to control cells ± S.E.M for 4 triplicates of 
each experimental condition. Treatment with PCB74, PCB118 or the PCB Mix resulted 
in activation of caspase-3/7, while PCB153 did not significantly affect caspase-3/7 




The current study investigated effects of three PCBs, each representing a member 
of different PCB classes, on GnRH release from the GT1-7 cell line, and on 
neuroendocrine toxicity due to apoptotic and necrotic cell death. Our results show that 
PCB74 (coplanar), PCB118 (dioxin-like coplanar), and PCB153 (non-coplanar), 
significantly affected both GnRH peptide levels and cell survival in the hypothalamic 
GT1-7 cell line. In general, individual PCBs had an overall stimulatory effect on GnRH 
peptide levels at early time points and lower concentrations, and inhibitory effects on 
GnRH peptide at the later time points and higher concentrations. Treatment with PCBs 
also affected cell survival, resulting in a decrease in viability of up to 60% in GT1-7 cells 
treated with PCBs for 24 hours. Moreover, the three congeners induced both necrotic and 
apoptotic cell death, as indicated by cell morphology and DNA fragmentation. Although 
there were some small differences, for the most part, lower concentrations of PCBs 
induced apoptosis, while higher concentrations caused necrotic cell death. Thus, PCBs 
caused both endocrine disrupting and neurotoxic effects in the GT1-7 cell line. Further, 
effects of a mixture of the three PCBs were not substantially different from those of the 
individual congeners. Therefore, at the dosages used in the current study, little additivity 
or synergism could be ascertained. 
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PCB effects on GnRH peptide concentrations 
The three classes of PCB congeners altered GnRH peptide levels in GT1-7 cell 
media. Effects of PCB74, PCB118, and the PCB Mix were similar: in general, GnRH 
peptide concentrations were elevated at intermediate to high dosages at the 4 hour 
timepoint, and lower at the 8- and 24-hour timepoints compared to DMSO controls. 
PCB153 was slightly different in its effects, as it was the only PCB to be associated with 
a change at the 1-hour timepoint (increased GnRH peptide at the lowest and highest 
concentration). By 24 hours, GnRH peptide levels were lower in PCB153 treated cells at 
the three highest concentrations.  
Overall, these studies on GnRH peptide suggest that PCBs may initially stimulate 
but then inhibit GnRH synthesis and/or secretion. The mechanisms by which GnRH 
peptide levels are altered by PCBs across time are likely attributable to changes in: (i) 
GnRH decapeptide biosynthesis; (ii) the release of GnRH from GT1-7 cells, 
independently of changes in biosynthesis; (iii) GnRH peptide degradation; and/or (iv) 
number of viable GT1-7 cells. The GnRH measured in culture media may have been 
secreted from live GT1-7 cells, but it is also possible that cellular stores of the 
decapeptide were released upon membrane disintegration from dying cells. Here, the 
initial increase in GnRH does not coincide with a loss in cell viability, making it unlikely 
that the GnRH levels measured can be attributed to dying cells dumping their stores of 
the decapeptide. At the earlier time points, the elevated GnRH levels are more likely to 
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be due to a stimulatory action of PCBs on release of peptide stores. Because PCBs have 
been shown to act through several neurotransmitter receptor systems, some of which can 
affect GnRH release and whose receptors are expressed on GT1 cells (e.g., serotonin, 
dopamine, norepinephrine – (Khan and Thomas, 1997; Mariussen et al., 1999; Mariussen 
and Fonnum, 2001), the activation of these neurotransmitter receptors may have the 
transient action of causing a release of GnRH. However, the number of viable GT1-7 
cells probably plays a role in the longer timepoints, as GT1-7 cell viability was 
decreased, and apoptosis and necrosis increased, over time (see below). 
At the molecular level, the actions of PCBs on endocrine systems are thought to 
be mediated, at least in part, by nuclear estrogen receptors. Therefore, we tested PCBs 
together with ICI 182,780, a nuclear estrogen receptor antagonist that can act at both 
estrogen receptors α and β (Wijayaratne et al., 1999), and which has previously been 
shown to block some effects of estradiol in GT1-7 cells (Gore et al., 2002) and other 
experimental models (Lee et al., 1999). In the current study, ICI 182,780 caused a partial 
reversal of the effects of the individual PCBs or their mixture on GnRH peptide secretion, 
suggesting potential involvement of an estrogen receptor-dependent mechanism, but also 
indicating that other mechanisms must be involved. We were surprised by the 
consistency of this result across the three classes of PCBs, as the three dimensional 
structure, degree of chlorination, and dose of a PCB congener contributes not only to its 
toxicity, but also to its interaction with steroid hormone receptors. Congeners that are 
lightly chlorinated tend to be more estrogenic, whereas the heavily chlorinated congeners 
may act as a weak estrogen receptor agonist or antagonist in a dose-dependent manner 
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(Safe, 1994; Bonefeld-Jorgensen et al., 2001). It is possible that a wider range of 
concentrations and duration of treatment may be necessary to better differentiate the role 
of the estrogen receptor in mediating these processes, since current experiments were 
performed at the 24 hour timepoint at a single concentration (1 mM) of PCBs.  
In addition, it should be stressed that these PCBs may also act through other non-
nuclear estrogen receptors, or through non-estrogenic pathways altogether. In primate 
GnRH neurons, ICI 182,780 does not block the estradiol-stimulated release of GnRH that 
is mediated through GPR30, the membrane G-protein coupled estrogen receptor (Noel et 
al., 2009). In fact, ICI 182,780 has been described as an agonist at the orphan receptor 
GPR30 (Thomas et al., 2005). However, because PCBs have a relatively low binding 
affinity for GPR30 in vitro (Thomas and Dong, 2006), PCB action on other non-estrogen 
membrane receptors, e.g. neurotransmitter receptors (Seegal et al., 1991a; Khan and 
Thomas, 1997; Mariussen and Fonnum, 2001) may also account for some of the observed 
effects. Future experiments investigating the potential role of GPR30 or other membrane 
receptors will provide a more complete understanding of the mechanisms underlying the 
observed effects of PCBs on GnRH release. 
 
PCB effects on apoptotic and necrotic cell death 
Previous studies have shown that PCBs can be neurotoxic, and that the 
mechanism can involve either or both apoptotic and necrotic cell death. Using primary 
fetal cortical neuron cultures, Sanchez-Alonso and colleagues (2003) found that neuronal 
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apoptosis reached 30 – 50% within 4 hours of incubation with 100 µM PCB77 (a dioxin-
like, coplanar PCB), which was also more cytotoxic than the non-coplanar congener 
PCB153. These effects may be tissue-specific. Howard et al. (2003) found that the non-
coplanar PCB47 (1 µM) induces apoptosis in primary cultured hippocampal neurons, but 
not cortical neurons. In the same study, the dioxin-like coplanar PCB77 (1 µM) had no 
effect on apoptosis in either cell type (Howard et al., 2003), a discrepancy which may be 
attributable to the lower dose used. A recent study by Ndountse and Chan (2008) found 
that the non-coplanar congener PCB99 had greater potency for apoptotic cell death in 
human neuroblastoma cells compared to a dioxin-like coplanar PCB126 and or the PCB 
mixture, Aroclor 1254 (Ndountse and Chan, 2009). In the same study, necrotic cell death 
was also observed, and was attributed to the secondary necrosis that follows apoptotic 
cell death. Necrosis may also be the primary form of cell death caused by PCBs. For 
instance, a study by Johansson and colleagues (2006) found that both PCB126 and 
PCB153 induce necrotic cell death in AtT20 pituitary cells, although PCB126 was more 
potent in this regard (Johansson et al., 2006). Merritt and Foran (2007) found that 
PCB153 caused necrotic cell death in two human glioblastoma cell lines at doses as low 
as 5000 nM (Merritt and Foran, 2007). Similarly, Mariussen et al. (2002) found that 
Aroclors 1242 and 1254 and PCB153, but not PCB126, caused extensive cell death in 
cultured rat cerebellar granule cells after 24 h treatment duration with doses as low as 
12.5 µM (Mariussen et al., 2002). Together, this literature suggests neurotoxic effects of 
PCBs, particularly due to a combination of apoptotic and necrotic mechanism. However, 
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prior to the current study, to our knowledge this question of whether and how PCBs may 
exert such effects in a neuroendocrine cell system has not been addressed. 
To this end, in the present study, we quantified cellular viability in response to 
individual PCBs or a mix, and determined whether this was due to apoptosis or necrosis. 
First, we found that the individual PCBs diminished cell viability, with PCB74 and 
PCB118 having such actions by the first hour of treatment. PCB153 was associated with 
a diminution of viability beginning at the fourth hour of treatment. The PCB Mix was, 
surprisingly, the least likely to cause diminished GT1-7 cell viability. Second, we 
ascertained effects of PCBs on necrosis. This mechanism for cell death was not observed 
until 8 hours (PCB118, PCB153, both at the highest concentrations) to 24 hours (all 
PCBs, particularly at the higher concentrations). Third, effects of PCBs on apoptosis 
were evaluated, with PCB74 and PCB118 having the greater potencies for induction of 
apoptotic cell death, especially at low to intermediate concentrations. This latter result 
with PCB74 and PCB118 is consistent with the decreased viability detected in cells 
treated with these two congeners. Differences in results among the PCBs suggest that the 
relative neurotoxic potency of individual PCB congeners for induction of neuronal cell 
death is dependent upon PCB structure.     
As a whole, our observations also show that lower doses of PCBs induce 
apoptosis, and higher doses induce necrosis (c.f. Figures 6 and 7). This result is consistent 
with other studies establishing a dose-dependent relationship between apoptosis and 
necrosis in neuronal cells exposed to toxicants (Bonfoco et al., 1995).   However, the 
level of apoptotic cell death induced by PCBs in the present study is not as extensive as 
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that observed in previous studies, a discrepancy likely due to differences in cell lines and 
methodology. In the dose range used in the current study, the loss of cell viability after 4 
hours of treatment can be attributed to the induction of apoptosis. In contrast to previous 
studies, here we found that the three classes of PCBs had similar potencies for induction 
of apoptosis at the dose range studied. At later timepoints, the loss of cell viability is due 
primarily to the induction of necrotic cell death. It is possible that some of the necrotic 
cells observed were due to the secondary necrosis that follows apoptosis. We also 
observed some apoptotic and necrotic cells after 24 h in the vehicle treatments alone. 
Serum starvation alone induces apoptosis over time, including in the GT1-7 cell line 
(Srinivasan et al., 1996). However, differences between vehicle and PCB treatments 
indicate that the PCBs themselves are inducing these responses.  
Apoptosis proceeds via the activation of caspases, a family of cysteine aspartate 
specific proteases (Nunez et al., 1998). Stimulation of membrane death receptors 
activates caspase-8 and initiates the extrinsic apoptotic pathway, while release of 
mitochondrial signaling factors and subsequent cleavage of caspase-9 activates the 
instrinsic apoptotic pathway. Regardless of the pathway initially activated, caspase-3 is 
widely regarded as the effector caspase, and is activated by both death receptor- and 
mitochondrial-mediated apoptosis. Once caspase-3 is activated by cleavage, the cell 
reaches a “point of no return” in the development of apoptosis. Thus, caspase-3 activation 
(assayed in concert with caspase-7) provides a useful marker of early apoptosis.  
The present study demonstrates that coplanar and dioxin-like coplanar PCB 
congeners (PCB74, PCB118) and their mixture activate caspase-3, consistent with 
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induction of apoptotic cell death. Moreover, we observed the activation of caspase-9 by 
all of the PCB treatments, which is associated with the mitochondrial-mediated intrinsic 
pathway of apoptosis. Our results are consistent with other studies that have 
demonstrated activation of caspase-9 following exposure to a non-coplanar (Ghosh et al., 
2007) and dioxin-like coplanar (Hsu et al., 2007) PCB. By contrast, caspase-8 was not 
activated by any PCB treatment, suggesting that this mechanism is not in play in the 
GT1-7 cell neurotoxicity. 
 
Environmental endocrine disruption by PCBs 
Developmental apoptosis, a process that is regulated by activation of estrogen 
receptors (McCarthy, 2008), plays a critical role in sexual differentiation of the 
hypothalamus and is necessary for normal maturational processes involved in the 
attainment and maintenance of reproductive function. PCBs may disrupt developmental 
apoptosis through actions on estrogen receptors as well as by other mechanisms of action 
in the nervous system. GT1-7 cells were originally isolated from developing GnRH 
neurons that have both mature neuronal properties but are not post-mitotic due to 
transformation with the SV-40 large T antigen (Mellon et al., 1990). Other exogenous 
compounds have effects on the developing brain in vivo at a range of micromolar 
concentrations similar to the one used in this study. For instance, a recent study found 
that the phytoestrogen genistein affects developmental apoptosis in the brain of zebrafish 
embryos at micromolar levels (Sassi-Messai et al., 2009). It is reasonable to postulate that 
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PCB-induced apoptosis or necrosis may be related to the neurotoxic effect of these EDCs 
on the reproductive axis, and that different molecular mechanisms may operate in the 
induction of cell death, depending on the structure of the PCB congeners, the neuronal 
population studied, and the developmental stage. Therefore, our results have considerable 
relevance to exposures of wildlife, humans and laboratory animals to PCBs, particularly 
when exposure occurs during key developmental life stages such as the period of sexual 
differentiation. 
Given that PCB74, PCB118, and PCB153 are congeners frequently found in 
environmental (Lake et al., 1995), wildlife (Kunisue et al., 2003), and human lipid and 
serum samples (Larsen et al., 1994; Lanting et al., 1998; Freels et al., 2007; Park et al., 
2007), results from this study are relevant for ecological exposures. As the human body 
burden of the three PCB congeners used in this study varies considerably by individual 
and tissue, and it is difficult to extrapolate from in vitro to in vivo, the doses in our study 
were chosen to approximate human levels. Because PCBs differentially accumulate into 
microenvironments in living tissues, with levels reaching approximately 50 ppb in 
neonatal human brains (Lanting et al., 1998), developing neurons may be exposed to 
micromolar concentrations of these toxicants. This study establishes the role of PCBs in 
the induction of apoptosis in GnRH GT1-7 cells as a model for developing hypothalamic 
neurons. Future experiments in animal models will apply the present observations in 
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CHAPTER 4: EFFECTS OF PRENATAL PCB EXPOSURE ON 
NEUROENDOCRINE DEVELOPMENT IN THE NEONATAL RAT 
The text in this section is modified from the article “Prenatal PCBs Disrupt Early 
Neuroendocrine Development of the Rat Hypothalamus,” Dickerson SM, Cunningham 
SL, and Gore AC, (Toxicology and Applied Pharmacology, submitted; 2010). 
 
ABSTRACT 
Neonatal exposure to endocrine disrupting chemicals (EDCs) such as 
polychlorinated biphenyls (PCBs) can interfere with hormone sensitive developmental 
processes, including brain sexual differentiation, and permanently alter reproductive 
physiology in adulthood. We tested the hypothesis that the disruption of these processes 
by gestational PCB exposure would be detectable as early as the day after birth (postnatal 
day (P) 1). Fetuses were exposed through injection of pregnant Sprague-Dawley rats on 
gestational days 16 and 18 with DMSO (vehicle), Aroclor 1221 (A1221, an estrogenic 
PCB mix), a reconstituted PCB mixture of PCB138, PCB153 and PCB180 (the three 
most prevalent congeners found in human samples), or estradiol benzoate (EB), an 
estrogenic control. On P1, litters were assessed for number of pups and sex ratio, and 
each pup was measured for anogenital distance (AGD) and body weight. Then, pups were 
euthanized to enable immunohistochemistry of estrogen receptor α (ERα) and TUNEL 
labeling, or gene expression measurements of 48 selected genes on a Taqman PCR array 
platform. AGD in P1 females was reduced (hyperfeminized), whereas male AGD was 
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increased (hypermasculinized), by prenatal EDC treatments. Treatment with EB or 
A1221 had a sex-specific effect on developmental apoptosis in the neonatal anteroventral 
periventricular nucleus (AVPV): exposed females had increased numbers of apoptotic 
nuclei, with no effect in males. ERα immunoreactive cell number was increased by EB 
treatment in both males and females, while PCBs had no effect. PCR analysis identified 
brain-derived neurotrophic factor, GABAB receptors-1 and -2, IGF-1, Kisspeptin 
receptor, NMDA receptor subunits NR2b and NR2c, prodynorphin, and TGFα mRNAs 
as significantly affected in P1 males or females.  Collectively, these results suggest that 
the disrupted sexual differentiation of the POA can be detected as early as the day after 
birth, effects that may underlie the adult reproductive phenotype. 
 
INTRODUCTION 
Exposure to environmental endocrine disrupting chemicals (EDCs) during critical 
developmental periods, particularly late gestation and infancy, are consistently linked to 
impairments in homeostatic, endocrine, and neurobiological processes in adulthood 
(Dickerson and Gore, 2007). Amid concerns that chronic low-dose exposures to EDCs 
may be contributing to a decline in fertility in humans (Diamanti-Kandarakis et al., 
2009), recent interest has turned to elucidating how reproductive neuroendocrine systems 
may be perturbed by EDC exposures during early critical life stages. As the hypothalamic 
control of reproduction develops in a sexually dimorphic manner due to sex differences 
in gonadal steroid hormone actions in the brain, it is plausible to hypothesize that some of 
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the links between perinatal EDCs and the diminution in reproductive competency may be 
due at least in part to reprogramming of the neonatal hypothalamus by these compounds. 
Sexual differentiation of the hypothalamus of rodents occurs during the third 
trimester of gestation through the early postnatal period. During these life stages, the 
number and phenotype of neurons that arise in the sexually dimorphic nuclei of the 
hypothalamus are sculpted by a number of neurodevelopmental processes, including 
programmed cell death, called apoptosis (Davis et al., 1996a; Yoshida et al., 2000). 
Whereas the female rodent brain develops in relatively low levels of gonadal hormones, 
the male brain is awash in estradiol locally aromatized from the testicular hormone 
testosterone, and differences in these neural exposures (Bakker and Brock, 2010) have 
profound effects on the numbers of cells that ultimately survive in a region-specific 
manner.  
  Importantly, there are links between steroid hormone exposures and apoptosis. 
Depending upon the brain region, ligand-bound estrogen receptors (primarily ERα) may 
bind nuclear response elements that promote transcription of factors that either stimulate 
or inhibit developmental apoptosis (McCarthy, 2008). This point is exemplified by 
developmental differences in apoptosis in the neonatal anteroventral periventricular 
nucleus (AVPV), a region that differs in size and cellular phenotype between males and 
females (Clarkson and Herbison, 2006) and is postulated to mediate estradiol positive 
feedback onto the GnRH/LH surge in females (but not males, which do not have this 
surge). In the developing AVPV, estradiol stimulates apoptosis during the early postnatal 
period (Murakami and Arai, 1989; Sumida et al., 1993; Waters and Simerly, 2009), 
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contributing to the development of a smaller AVPV in adult males (Davis et al., 1996b), 
and presumably, differences in reproductive physiology and behavior. Another brain 
region under investigation in this study is the medial preoptic area (MPN), a region 
important for adult reproductive behaviors (Wu et al., 2009a; Wu and Gore, 2010), 
sexually dimorphic in size (Madeira et al., 1999), and abundant in ERs (Chakraborty et 
al., 2003). Evidence that EDCs can act upon ERα and other steroid hormone receptors in 
the nervous system suggests that they may perturb developmental apoptosis in the AVPV 
and MPN, a hypothesis tested in this current study. 
Our laboratory has been using a class of compounds known as polychlorinated 
biphenyls (PCBs), a family of persistent chemicals once used widely for industrial 
applications, as a model for neuroendocrine disruptors (Salama et al., 2003; Steinberg et 
al., 2007; Steinberg et al., 2008; Dickerson et al., 2009). Although banned for decades, 
PCBs are still detectable in the body burden of most humans (Gladen et al., 2003). EDCs 
rarely exert their effects by a single mechanism, and PCBs have been shown to be weakly 
estrogenic (Mortensen and Arukwe, 2008; Nomiyama et al., 2010), as well as anti-
estrogenic and anti-androgenic, among other mechanisms (Bonefeld-Jorgensen et al., 
2001). We utilized two PCB mixtures that differ in their half-life, degree of chlorination, 
and chemical properties. Aroclor 1221 (A1221; an estrogenic PCB) is a technical mixture 
once used commercially, and is comprised of lightly chlorinated congeners with a half-
life on the order of days (Matthews and Anderson, 1975). We also used a reconstituted 
mixture of the three most prevalent congeners detected in human and wildlife samples: 
PCB138, PCB153, and PCB180, which are more heavily chlorinated and have a half-life 
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on the order of years (Milbrath et al., 2009; Seegal et al., 2010). In vitro studies have 
shown that these compounds interact with steroid hormone receptors including ERα at 
low doses (Bonefeld-Jorgensen et al., 2001). Therefore, we tested the hypotheses that 
prenatal EDCs would affect developmental apoptosis and expression of ERα in a 
sexually dimorphic manner, an effect that could be detectable as early as postnatal day 
(P) 1. We also used a 48-gene PCR-based array to identify novel gene expression targets 
of developmental PCB exposure on the P1 hypothalamus.  
 
METHODS 
Animals and perinatal treatment 
All protocols on rats were carried out following guidelines from the National 
Institute of Health Guide for Care and Use of Laboratory Animals, and performed 
following protocols approved by the Institutional Animal Care and Use Committee at the 
University of Texas at Austin. Dams for this study (Harlan Sprague–Dawley Inc.; 
Houston, Texas; Stock/Strain: Hsd:Sprague–Dawley®™ SD®™) were those described 
in a sister study on effects of prenatal PCBs on the adult hypothalamus (Dickerson et al., 
2011).  Rats were housed individually under standard husbandry [12:12 partially reversed 
light cycled (lights on 2300 h, lights off 1100 h)] and fed low-phytoestrogen Harlan-
Teklad 2019 Global Diet ad libitum for at least 3 weeks prior to mating. Rats were 
handled daily to minimize stress. 
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Dams were mated with sexually experienced male rats (males randomly rotated 
with females), and the day of sperm positive vaginal smears was termed embryonic day 
(E) 1. The pregnant rats (n=10-12 per treatment group) were randomly assigned to one of 
four treatment groups and injected i.p. on E16 and E18 with one of the following: 0.1 ml 
of vehicle (DMSO 99.5%, Sigma, #D4540, Lot# 037K07663); 50 µg/kg estradiol 
benzoate (Sigma, #E8515, Lot# 125K1029, serving as an estrogenic positive control); 1 
mg/kg Aroclor 1221 (AccuStandard, #C-221N, Lot# 083-166; dose based on our 
published work showing effects on reproductive function in female rats (Steinberg et al., 
2007; Steinberg et al., 2008); or 1 mg/kg reconstituted PCB mixture (referred to as PCB 
Mix). Rationale for the PCB Mix that these are the three most prevalent PCB congeners 
found in mammalian tissue samples (Gladen et al., 2003; Bentzen et al., 2008): PCB138 
(2,2',3,4,4',5'-Hexachlorobiphenyl; AccuStandard, #C138N, Lot# 082704MS-AC), 
PCB153 (2,2',4,4',5,5'-Hexachlorobiphenyl; AccuStandard, #C153N, Lot# 111804AG-
AC), and PCB180 (2,2',3,4,4',5,5'- Heptachlorobiphenyl; AccuStandard, #C180N, Lot# 
013004MT-AC) at equimolar concentration. It should be noted that they are non-coplanar 
and do not bind the aryl hydrocarbon receptor (Van den Berg et al., 1998). The dose, age 
and route of exposure were based on the literature on detectable levels of PCBs in 
humans (Lanting et al., 1998; Lackmann, 2002), the timing of brain sexual differentiation 
in rats (Murakami and Arai, 1989; Rhees et al., 1990a), and for consistency with other 
neuroendocrine studies including our own (Chung and Clemens, 1999; Chung et al., 
2001; Gore et al., 2002; Salama et al., 2003; Woodhouse and Cooke, 2004; Steinberg et 
al., 2008). Although we have not measured PCB content in the offspring, we have 
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previously predicted that pups were exposed to approximately 2 µg/kg total PCBs for 
both the A1221 treatment group and the PCB Mix treatment group (Takagi et al., 1986; 
Steinberg et al., 2007; Steinberg et al., 2008).  The day after birth, P1, the numbers of 
live and dead offspring were counted, and sex ratio was determined. Anogenital distance 
(AGD) was measured using a digital microcaliper (Marois, 1968; Steinberg et al., 2008), 
and the ratio of AGD to the cube root of body weight (AGD index) was calculated to 
evaluate AGD (Marois, 1968; Gallavan et al., 1999).  
Tissue collection 
The offspring were divided into two groups and either sacrificed at P1 between 
0900 – 1000 h to evaluate experimental endpoints reported herein, or allowed to mature 
for a study reported elsewhere (Dickerson et al., 2011). One male and female F1 rat per 
litter was euthanized for protein and apoptosis studies (N=8 per sex, each from different 
litters), and 1 male and female per litter was utilized for gene expression studies (N=6 per 
sex, each from different litters). For immunohistochemistry studies, pups were deeply 
anesthetized with 0.05 ml ketamine (100 mg/ml) and 0.05 ml of xylazine (20 mg/ml), and 
trans-cardially perfused with 0.9% saline (5 ml) at a rate of 5 ml/min, followed by 4% 
paraformaldehyde (50 ml). The brains were removed and postfixed overnight in 4% 
paraformaldehyde, and then transferred into PBS with 0.2% sodium azide. A vibrating 
microtome (Leica VT 1000S, Leica Microsystems, Nussloch, Germany) was used to cut 
50 µm-thick sections that were stored in PBS with 0.2% sodium azide at 4 °C until use.  
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For gene expression analyses, animals were rapidly euthanized by decapitation. 
Brains were quickly removed and the preoptic area-anterior hypothalamus (POA), which 
contains the AVPV and medial preoptic nucleus (MPN), was dissected on ice, snap 
frozen (Dickerson et al., 2008) and stored at -80 C until RNA extraction. Terminal trunk 
blood samples were collected and centrifuged at 5000 x g for five minutes to separate 
serum, and serum was stored at -80°C until steroid hormone analysis. Because EDC 
treatment can drastically affect AGD of treated animals, the sex of each animal was 
confirmed via visualization of the uteri or testes at the time of euthanasia. 
Immunohistochemistry for ER alpha 
Hypothalamic tissues were recoded for tissue processing and analyses so that the 
experimenter was blind to treatment group and sex. For each neonatal F1 animal, two 
AVPV tissues and four MPN tissues per rat were immunolabeled for ERα. Although the 
number of sections was too great to process in a single run, animals from each sex and 
treatment group were equally represented in every run. Sections were rinsed in PBS 
(Phosphate-buffered saline, pH = 7.4) at room temperature on a shaker, followed by 
treatment with 3:1 methanol: 3% H2O2 for 20 minutes at room temperature to eliminate 
endogenous peroxide activity. Sections were then washed, and incubated in the rabbit 
polyclonal anti-ERα antibody C1355 (1:10,000; Upstate Biotechnology, Waltham, MA) 
with 10% normal goat serum (NGS) and 0.1% Triton-X for 72 hours at 4°C on a shaker. 
This antibody was generated against the last 15 amino acids of ERα, which has no 
homology to the corresponding region of ERβ. The sections were then washed and 
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incubated in 5% normal goat serum and secondary antibody (biotinylated goat anti-rabbit 
immunoglobulin (Ig)G, 1:600; BA-1000; Vector Laboratories) for one hour, then 
subjected to peroxidase reaction with nickel-enhanced DAB. Sections were mounted on 
gelatin-subbed slides, dried, dehydrated in a graded alcohol series, counterstained with 
methyl green, and coverslipped with DPX (44581; Fluka, Steinheim, Germany). Controls 
were also run with the primary antibody omitted, and no specific binding was observed.  
Because ERα labeling was sparse and highly variable in the AVPV, stereological 
analysis for this region was not possible. Quantification of ERα in the MPN was 
performed using unbiased stereological analysis according to methods described in detail 
previously (Chakraborty et al., 2003; Chakraborty et al., 2005). A wet-mount of fresh 
tissue showed that average tissue thickness was 50.6 μm. The MPN region was identified 
in Nissl-stained sections by comparing anatomical landmarks to an atlas of the 
developing rat brain (Ashwell, 2008). Contours were drawn around the MPN at low 
magnification (10× objective) using an Olympus BX-61 microscope. A buffer zone at the 
top and bottom of sections was set at 3 μm for all experimental stereology. For each rat, 
the regional volume was extrapolated based on the contours and tissue thickness 
(Volume = regional area × thickness). The Stereo Investigator® software 
(MicroBrightField, Williston, VT) randomly placed 75 μm × 120 μm grids (“dissector 
frames”) within the MPN contour. Within these dissector frames, the DAB-stained ERα-
labeled nuclei were counted within a 45 μm × 45 μm counting frame for the MPN 
(“optical dissectors”). Based on these parameters, the number and density (# 
immunoreactive cells/volume of each nucleus) of ERα-immunoreactive (ERα-ir) nuclei 
 86 
falling within the region was quantified. The coefficients of error (Cruz-Orive/Geiser) 
and variation of the estimates were calculated as described previously (Schmitz and Hof, 
2000). Photomicrographs were taken to produce the figures, and images subjected to only 
minor adjustments of contrast using Adobe Photoshop CS4 (Adobe, San Jose, CA), with 
any adjustments were applied equally to tissues from rats of different treatment groups.   
Detection of apoptosis 
To stain the nucleosomal DNA fragments in apoptotic cells, we used a 
modification of the TUNEL method described by Bessert and Skoff (Bessert and Skoff, 
1999). All reagents were supplied by the Fluorescein-FragEL DNA Fragmentation 
Detection Kit (EMD Chemicals Inc., Gibbstown, NJ) and applied according to the kit 
protocol at room temperature (RT) unless otherwise noted. In brief, tissues were 
pretreated with sodium citrate buffer (10mM Sodium Citrate, 0.05% Tween 20, pH 6.0) 
at 60°C for 15 min, then washed in 0.1 M PBS, pH 7.4, incubated in 0.1% Triton X-100 
(Sigma-Aldrich, St. Louis, MO) in PBS for 15 min, and washed in 0.1 M PBS. The 
sections were then treated with 20 µg/ml proteinase K in 10 mM Tris pH 8 for 15 min 
and washed in PBS. The sections were incubated in equilibration buffer for 30 min, 
followed by incubation in labeling reaction mixture in a humidified chamber at 37°C for 
1.5 hr. Sections were washed in PBS and mounted onto gelatin subbed slides, and 
coverslipped with Fluorescein-FragEL™Mounting Media. Positive controls for the 
TUNEL assay were generated by pretreatment of sections with DNAse I (Applied 
Biosystems Inc., Foster City, CA). Negative controls for the TUNEL procedure were 
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treated in the same manner as the test samples except that the TdT enzyme was omitted 
from the reaction mixture and was replaced with dH2O. No labeling was found in the 
negative controls. Mounted sections were stored in the dark at 4°C until analysis. 
A 1:2 series from the AVPV (2 sections total) and 1:2 series from the MPN (4 
sections total) were selected from each animal. For apoptosis studies, numbers of labeled 
cells were counted unilaterally throughout the rostrocaudal extent of the region. Using 
StereoInvestigator software (MicroBrightField Inc.), contours were drawn for each region 
at low magnification (10× objective) using anatomical landmarks and a developing rat 
brain atlas (Ashwell, 2008). Ten counting grids measuring 25 µm X 25 µm per were 
randomly placed within the left hemisphere for the AVPV and ten counting grids 
measuring 45 µm X 45 µm were placed on the left side of the third ventricle for the 
MPN. Total numbers of apoptotic cells were counted for each region at high 
magnification (100× objective). 
Serum Hormone Assays 
Because of the small amount of serum obtainable from a P1 rat, serum samples 
from 2-3 same-sex siblings were pooled for littermates (N=8 pooled samples per sex per 
assay), and samples run in single testosterone, progesterone, or estradiol RIAs as 
described previously (Dickerson et al., 2011). Briefly, total serum testosterone was 
determined using the Active® Testosterone coated well EIA kit (Catalog # DSL-10-4000, 
Lot # 08035-B, Diagnostic Systems Laboratories, Inc., Webster, TX, USA) on duplicate 
volumes of 50 µl serum. The assay limit of detection was 0.04 ng/ml, and the intra-assay 
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CV based on duplicate samples for the assay was 2.97%. Progesterone concentrations 
were determined using the ACTIVE®¨ Progesterone Coated-Tube Radioimmunoassay Kit 
(Catalog # DSL-3900, Lot # 07076, Diagnostic Systems Laboratories, Inc., Webster, TX, 
USA), on duplicate volumes of 25 µl. The sensitivity of the assay was 0.12 ng/ml, and 
the intra-assay CV was 3.26%. Estradiol concentrations were determined using an 
ultrasensitive double-antibody RIA kit (Catalog # DSL-4800, Lot # 07076, Diagnostic 
Systems Laboratories, Inc., Webster, TX, USA), on duplicate volumes of 200µL. The 
assay limit of detection was 2.2 pg/mL, and the intra-assay coefficient of variability 
based on duplicate samples was 7.97%.  For all assays, a few samples for which the CV 
between duplicates was 10% or greater were excluded from analysis. 
RNA extraction 
Messenger RNA from frozen POA dissections was extracted using an in-house 
double detergent lysis buffer system as described previously (Dickerson et al., 2008; 
Walker et al., 2009). In brief, samples were homogenized and the cytoplasmic RNA was 
treated with proteinase K, followed by extraction with phenol chloroform and 
precipitation in isopropanol. Genomic DNA contamination was removed using the 
TURBO DNA-free kit (Applied Biosystems Inc., Cat. No. AM1907, Foster City, CA) 
according to the manufacturer’s protocol. The concentration of resulting cytoplasmic 
RNA was determined using a Nanodrop (ND-1000, Nanodrop Technologies, Inc., 
Wilmington, DE).  
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Taqman low-density arrays (TLDA) 
Samples were run as described by our laboratory (Walker et al., 2009) on a 
custom rat neuroendocrine TLDA (Applied Biosystems Inc., Foster City, CA), a panel of 
48 candidate neuroendocrine genes. Cytoplasmic RNA (2 µg) was converted to cDNA 
using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) 
according to the manufacturer’s instructions. The resulting cDNA was diluted 1:5 before 
PCR reactions were performed using Applied Biosystems’ Taqman reagents on an ABI 
7900 real-time PCR machine using the following parameters: 50 C for 2 min, 94.5 C for 
10 min, 45 cycles of 97 C for 30 sec, and 59.7 C for 1 min. Relative expression for each 
gene was determined using the comparative Ct method (Pfaffl, 2001). Each sample was 
normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression (Walker 
et al., 2009), and the data were calibrated to the average change in Ct for the treatment 
group with the lowest expression.  
Statistical Analysis 
SPSS statistical software (17.0 for Macintosh, SPSS Inc., Chicago, IL) was used 
to evaluate the effects of treatment on litter composition, body weight, AGD, serum 
hormones, AVPV and MPN volume, AVPV and MPN ERα immunoreactivity and 
apoptosis endpoints. We had independent a priori hypotheses for each sex; thus, statistics 
were performed separately for males and females. Datasets were examined for 
homogeneity of variance and normality. For datasets that met these criteria, comparisons 
were made by one-way ANOVA (factor: treatment) followed by Fisher’s LSD post-hoc 
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analysis when indicated by a significant main effect. When variance between treatment 
groups was unequal, datasets were compared using the nonparametric Kruskal-Wallis 
test. In all these cases p-values < 0.05 were considered statistically significant. For the 
gene expression data, statistics were conducted using the normalized Ct (δ-Ct) for each 
sample (before transformation to fold change). Because the TLDA measures expression 
of 48 genes, a Bonferroni correction was used to set the cut off for significance at p < 
0.001.   
 
RESULTS 
Litter composition, birth weight and anogenital distance  
On postnatal P1, litter composition, and birth weight and anogenital distance 
(AGD) were recorded for all pups in each litter. There was no effect of treatment upon 
total (DMSO: 13 ± 0.43; EB: 12.3 ± 0.85; A1221: 12.4 ± 1.0; PCB: 10.8 ± 1.3) or live 
(DMSO: 10.9 ± 0.81; EB: 10.9 ± 0.97; A1221: 11.8 ± 1.0; PCB: 10.2 ± 1.5) pup number 
per litter, or upon sex ratio (DMSO: 49 ± 3%; EB: 40 ± 3%; A1221: 48 ± 3%; PCB: 48 ± 
7%). Likewise, there was no main effect of treatment upon body weight in either sex, 
although we did observe a trend for increased body weight in females treated with EB or 
A1221 (Fig. 4.1A, p = 0.062). A sex-dependent effect of treatment on AGD was noted, 
with EB-, A1221-, and PCB-treated females having reduced AGD  (p<0.001) and EB- 
and A1221-treated males having increased AGD (p<0.05) compared to their vehicle 
counterparts (Fig. 4.1B).
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A. Body Weight at Postnatal Day 1
B. Anogenital Distance at Postnatal Day 1
 
Figure 4.1: Data for body weight (A) and anogenital distance (B) on P1 are shown for 
female and male rats (mean ± S.E.M). Treatment with estradiol benzoate (EB) or Aroclor 
1221 (A1221) caused a non-significant trend for increased body weight in females 
(ap=0.06). For AGD, treatment with EB, A1221, or PCB Mix caused a decrease in female 
AGD (**p<0.001), while EB- or A1221-treatment increased male AGD (*p<0.05). 
Treatment with PCB Mix caused a non-significant trend for increased AGD in males 
(ap=0.06).  AGD index is the ratio of AGD (mm) to the cube root of body weight. PCB 
on the x-axis of this and other figures refers to the PCB Mix group. 
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Serum hormones 
We observed a significant effect of treatment upon serum estradiol in EB-treated 
females (Fig. 4.2A, p<0.005), a group with higher estradiol levels than all other groups. 
A significant main effect of treatment upon serum progesterone was noted in females 
(Fig. 4.2B) but not in males, with A1221- and PCB Mix-treated females having reduced 
progesterone compared to EB- (p<0.05) but not DMSO-treated females. However, no 
group differed from control in progesterone concentrations. There was a main effect of 
treatment upon serum testosterone in males (Fig. 4.2C, p<0.001), but not females, with a 

















































































Figure 4.2: Serum levels of estradiol (A), progesterone (B), and testosterone (C) in neonatal F1 
animals. For estradiol, EB-treatment caused an increase in estradiol levels in females (*p<0.005), 
while males were unaffected by any treatment. No effect of treatment upon progesterone was 
observed in males or females. For testosterone, EB- and PCB Mix-treated males had lower serum 
testosterone compared to DMSO- and A1221-treated males (p<0.001 vs. both). N=8 pooled 
samples per sex per assay. The bars represent the mean ± S.E.M.  
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Apoptosis in AVPV and MPN 
Cells undergoing apoptotic cell death display distinct morphological changes, 
characterized by cellular shrinkage, nuclear pyknosis, chromatin condensation and 
membrane blebbing. To ascertain whether prenatal EDC exposure disrupts developmental 
apoptosis in the neonatal hypothalamus, we used a TUNEL assay and DAPI labeling to 
visualize apoptotic nuclei in the AVPV and MPN. A representative photomicrograph of 
TUNEL labeling with DAPI counterstaining is shown for the MPN (Fig. 4.3A).  In the 
female AVPV, EB- and A1221-treatment increased the number of apoptotic nuclei (Fig. 
4.3B, p<0.001), while no effect of treatment was observed in males. In contrast, no effect 
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Figure 4.3: A representative photomicrograph shows TUNEL labeling results for early, middle, 
and late phase apoptosis the MPN (A). TUNEL-positive cells appear bright green (arrows) and 
DAPI counterstained nuclei appear blue. Scale bar = 25 µm. Also shown are quantification of 
apoptotic nuclei in the AVPV (B) and MPN (C). In females, EB- and A1221-treated females have 
a higher incidence of apoptotic nuclei compared to DMSO control (*p<0.01), while males were 
unaffected by treatment. No effect of treatment upon MPN apoptosis was observed in either sex. 
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ER alpha expression in the AVPV and MPN 
In the AVPV, ERα labeling was sparse and highly variable; thus, stereological 
analysis for this region was not possible. However, qualitative observations suggest that 
ERα immunoreactivity (ir) in the AVPV is greater in control females compared to control 
males, and that neither males or females were affected by treatment with EB, A1221, or 
PCB Mix.    
Representative photomicrographs of ERα-ir in the MPN are shown in P1 male 
and female rats for the four treatments (Fig. 4.4, A-H). Stereological cell counting 
showed a significant main effect of treatment on ERα-ir cell numbers, with EB-treated 
males and females having significantly more cells than DMSO-, A1221-, and PCB Mix-
treated counterparts (p<0.05; Fig. 13A). No effect of treatment upon MPN regional 
volume was observed in males or females (Fig. 13B). Density of ERα was increased by 
EB-treatment in MPN of F1 males and females (p<0.05; Fig. 13C). 
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Figure 4.4: EDC Effect on ERα  Expression in the P1 MPN 
 
Figure 4.4: Photomicrographs of estrogen receptor alpha (ERα) immunoreactivity in the 
medial preoptic nucleus (MPN; A-H) of P1 female and male rats prenatally exposed to 
DMSO vehicle (A,E), EB (B,F), A1221 (C,G), or PCB Mix (D,H). The third ventricle 
can be seen at the left of each micrograph. Although the images presented here were 
photographed at low magnification (10X), quantification and analysis of ERα-
immunoreactivity was performed at high-power magnification (40X). ERα nuclei are 
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Figure 4.5:  Stereologic analysis results for ERα-immunoreactive cell numbers in the MPN (A), 
regional volume of the MPN (B) and cell density (C) are shown for neonatal P1 rats (n = 6-8 rats 
per treatment group). Data are the mean ± S.E.M. ERα cell number was significantly increased in 
EB-treated males and females compared to DMSO control. MPN volume was unaffected by EDC 
treatment in either sex. Cell density was increased by EB treatment in both sexes. *p < 0.05.  
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Effects of developmental PCB exposure on POA neuroendocrine gene 
expression 
Forty-seven of the candidate genes on the neuroendocrine TLDA were detectable 
following real-time PCR reactions (Table 4; not shown are 18S, glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) “housekeeping” control genes and the non-detected 
3ß-hydroxysteroid dehydrogenase (HSD3b)). As described previously (Walker et al., 
2009), POA genes were normalized to GAPDH for analyses, as this gene did not vary by 
treatment. Of the remaining detectable genes, relative gene expression of nine genes was 
significantly affected by developmental EDC exposure in P1 males or females following 
the Bonferroni correction (Fig. 4.6): brain-derived neurotrophic factor (BDNF), GABAB 
receptors 1 and 2, IGF-1, kisspeptin receptor (GPR54), NMDA receptor subtypes NR2b 
and NR2c, prodynorphin, and TGFα.  
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Table 4. PCB Effects on P1 POA Gene Expression 
 Males Females 
Gene EB A1221 PCB EB A1221 PCB 
Aryl hydrocarbon receptor 0.01 ↓ -- 0.05 ↓  -- -- 0.009 ↑  
Androgen receptor -- -- -- -- -- -- 
Aryl hydrocarbon nuclear 
translocator  -- -- 0.06 ↓  0.004 ↑ 0.022 ↑ 0.026 ↑ 
Brain-derived neurotrophic 
factor <0.001 ↓   0.01 ↓  0.01 ↓   -- --  --  
Cytochrome P450, 17a1 (17-
alpha hydroxylase)  --  --  --  --  --  -- 
Cytochrome P450, 19a1 
(aromatase)  --  --  --  0.037 ↑  -- 0.026 ↑ 
Cytochrome P450, 1b1 -- -- --  0.04 ↑   0.075 ↓  0.062 ↓  0.078 ↑  
Estrogen receptor alpha  --  --  -- 0.067 ↑ --  0.079 ↑  
Estrogen receptor beta  --  --  --  --  --  -- 
GABA-B receptor 1 0.07  ↓ --   0.028 ↓ <0.001 ↑  <0.001 ↑  <0.004 ↑ 
GABA-B receptor 2  0.011 ↓  -- <0.001 ↑  --   -- --  
Galanin  --  --  --  --  --  -- 
Gonadotropin-releasing 
hormone 1  --  --  --  --  --  -- 
Gonadotropin-releasing 
hormone receptor  0.037 ↓  --  --  --  --  -- 
G-protein coupled receptor 30  --  --  --  --  --  -- 
GluR1  --  --  --  --  --  -- 
GluR2  0.072 ↓  -- 0.042 ↓   --  --  -- 
GluR3  --  --  --  --  --  -- 
Kainate 2 receptor  0.01 ↓  --  0.07 ↓  --  --  -- 
Hydroxysteroid 17-beta 
dehydrogenase 1  --  --  --  --  --  -- 
Hydroxysteroid 17-beta 
dehydrogenase 2  --  --  --  --  --  -- 
Hydroxysteroid 17-beta 
dehydrogenase 3  --  --  --  --  --  -- 
Hydroxysteroid 17-beta 
dehydrogenase 8  --  --  --  --  --  -- 
Insulin-like growth factor 1  --  <0.001 ↑   --  --  --  -- 
Insulin-like growth factor 1 
receptor 0.03 ↓  --  0.04 ↓  --  --  -- 
Kisspeptin  --  --  --  --  --  -- 
Kisspeptin receptor (GPR54) <0.001 ↓     0.01 ↓  <0.001 ↓    0.009 ↑ 0.047 ↑ 0.05 ↑ 
Membrane progesterone 
receptor  --  --  --  --  --  -- 
N-methyl-D-aspartate receptor 
(NMDAR) subunit 1 (NR1)  --  --  --  --  --  -- 
NMDAR subunit 2a 0.066 ↓  --  0.033 ↓  --  --  -- 
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NMDAR subunit 2b  --  --  -- <0.001 ↑   <0.001↑   -- 
NMDAR subunit 2c   <0.001↑    --  --  --  -- 0.03 ↑ 
NMDAR subunit 2d  --  --  --  --  --  -- 
Prodynorphin  --  --  --  0.008 ↓   --   0.01 ↓ 
Progesterone receptor  --  --  --  --  --  -- 
Vesicular glutamate 
transporter 1  --  --  0.006 ↓  --  --  -- 
Vesicular glutamate 
transporter 2  --  --  --  --  --  -- 
Steroid 5-alpha reductase 1  --  --  --  --  --  -- 
Signal transducer and activator 
of transcription 5B  --  --  --  --  --  -- 
Steroid sulfatase  --  --  --  --  --  -- 
Neurokinin B  --  --  --  --  --  -- 
Transforming growth factor 
alpha  --  -- < 0.001 ↑   --  --  -- 
Transforming growth factor 
beta-1  --  --  --  --  --  -- 
Uncoupling protein 2  --  --  --  --  --  -- 
Vitamin D receptor  --  --  --   --  0.005 ↑  0.016 ↑ 
 
Low-density PCR arrays were used to measure expression of 45 genes in whole POAs of 
P1 F1 female and male rats treated prenatally with EDCs. Statistical results are shown for 
significant effects and for trends in data. Because of the Bonferroni correction, the cut-off 
for a significant effect was set at p < 0.001. Not shown are results for internal controls 
18S, glyceraldehyde-3-phosphate dehydrogenase (GAPDH). In addition, one gene was 
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Figure 4.6: Gene expression data are shown for the nine neuroendocrine genes that were 
significantly affected in the POA of neonatal P1 male or female rats. Data shown are 





Neonatal exposure of developing organisms to EDCs such as PCBs is a global 
public health and environmental concern, as the body burdens of humans and wildlife, 
even in areas remote from industrialization, have appreciable levels of these compounds. 
PCBs readily cross the placenta and are passed to the suckling young in laboratory 
animals as well as humans (Masuda et al., 1978a; Masuda et al., 1978b; Ando et al., 
1985; Lackmann et al., 1999; Covaci et al., 2002; Park et al., 2008). Moreover, due to 
their size and lipophilicity, PCBs cross the blood-brain-barrier, and accumulate in human 
fetal brain tissue at an average concentration of 50 ppb (Lanting et al., 1998). This is 
important, because exposure to environmental EDCs during critical developmental 
windows can cause permanent neuroendocrine deficits by disrupting hormonally 
regulated developmental processes, including brain sexual differentiation. We recently 
reported that prenatal PCB exposure impairs gene and protein expression in the adult 
female hypothalamus (Dickerson et al., 2011), and alters paced mating behavior 
(Steinberg et al., 2007). As sexual differentiation begins during this time period, our 
hypothesis is that PCB exposure at E16 and E18 causes immediate effects on developing 
sexually dimorphic regions of the neonatal brain. In support of our hypothesis, we found 
that low doses of PCBs, relevant for human exposures (Lackmann, 2002; Lackmann et 
al., 2004) had sex-dependent effects on developmental apoptosis in the P1 hypothalamus, 
as well as neuroendocrine gene and protein expression.   
 
 104 
Effects on litter composition, AGD and body weight 
In the current study, we selected doses of A1221 and PCB Mix to approximate 
human and environmental exposures (Lackmann, 2002; Lackmann et al., 2004), 
anticipating that these sub-toxic levels would not cause any gross morphological effects. 
Rather, our aim was to assess the early postnatal neuroendocrine outcomes of PCB 
treatment in the neonatal animal. This would enable us to establish just how early the 
brain is altered and the relationship between these early life outcomes to those we have 
reported for animals later in life (Steinberg et al., 2007; Steinberg et al., 2008; Dickerson 
et al., 2011). As predicted, EB, A1221, and PCB Mix had no significant effects on total 
or live births in the exposed F1 generation, nor did they affect sex ratio. In addition, we 
recorded body weights and measured the AGD of male and female pups on P1. Neonatal 
body weight is a reliable index of general pup health, as well as maternal nursing 
behavior and lactational capacity. A number of previous studies using PCBs have 
reported decreased birth weight in exposed laboratory animals (Turk and Hietman, 1976; 
Hany et al., 1999; Bowers et al., 2004; Shirota et al., 2006) and humans (Taylor et al., 
1984; Murphy et al., 2010). However, we found no effect of treatment on birth weight 
with the current experimental parameters, although we did observe a trend toward 
increased body weight in females treated with either EB or A1221. The discrepancy in 
findings are likely due to experimental differences, including PCB dosage and congener 
composition, and timing, route, and duration of exposure. Littermates of the animals used 
for the current study were allowed to mature for a related study (Dickerson et al., 2011), 
and, similar to the trend we observed in neonatal females, we found a modest increase in 
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adult body weight in females prenatally exposed to either EB or A1221, but not in those 
exposed to the PCB Mix. Male body weight at adulthood was unaffected by treatment, as 
in the P1 animals described in this study. 
In most mammalian species the AGD is sexually dimorphic, with males having a 
longer AGD than females. Neonatal anogenital distance is largely determined by the 
action of androgens (Marois, 1968), and thus can be an external indicator of 
masculinization and endocrine disruption (Gray et al., 1994). In the current study, we 
found a sex-dependent effect upon neonatal AGD, although not in the direction that we 
predicted: EB-, A1221-, and PCB Mix-treatment decreased (hyperfeminized) female 
AGD, while EB- and A1221-exposure increased (hypermasculinized) male AGD. We are 
not certain how to interpret this result. One possibility for the observed reduction in 
female AGD may be related to direct or indirect PCB effects on the androgen receptor 
(AR), although it is important to note that their relative binding affinity for the receptor is 
several orders of magnitude lower than endogenous androgens (Portigal et al., 2002; 
Fang et al., 2003). However, this cannot explain the larger AGD in EB-treated males. In 
the context of reduced serum testosterone observed in EB- and PCB Mix-treated males, 
the increase in male AGD may seem counterintuitive, but it is consistent with reports by 
our lab and others of increased AGD following developmental PCB exposure throughout 
postnatal development (Kuriyama and Chahoud, 2004; Dickerson et al., 2011).  
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Effects on serum hormones 
Serum hormones were measured for the F1 generation. In females, none of the 
hormones measured were significantly affected by treatment with A1221 or PCB Mix, 
although EB treatment increased serum estradiol. However, it should be noted that 
variability in hormones was very high between the P1 pooled samples. In males, serum 
testosterone was reduced by EB and PCB Mix treatment at P1, while serum estradiol and 
progesterone were not affected by any treatment. Our results are consistent with previous 
studies that have reported a reduction in neonatal testosterone in male rats prenatally 
exposed to estrogenic chemicals or to PCBs. For instance, Takagi et al. (2004) found a 
reduction in testosterone at P3 in male rats exposed to ethinyl estradiol (Takagi et al., 
2004), while Kaya et al. (2002) and Yamamoto et al. (2005) reported decreased serum 
testosterone in weanling male rats exposed to PCBs throughout the period of gestation 
and lactation (Kaya et al., 2002; Yamamoto et al., 2005a). Nevertheless, although the 
postnatal testosterone surge on the day of birth (Weisz and Ward, 1980) is critical for 
masculinization of the rodent brain, we observed male-typical neuroendocrine gene and 
protein expression in adult male littermates of these animals in a related study. It is 
possible that because we assayed testosterone on P1, the day following birth, we had poor 
temporal resolution for the testosterone surge that peaks the day of birth (Baum et al., 
1988). Alternatively, it is possible that the reduction in testosterone observed in EB- or 
PCB-treated males reflected an increase in the metabolic breakdown of or sex steroid 
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hormone binding of free testosterone. Collectively, the results from the present and our 
related studies indicate that although postnatal testosterone may be transiently reduced by 
PCB treatment, exposed males nonetheless develop an appropriately masculinized AVPV 
during adulthood. 
 
Effects on developmental apoptosis and ERα  protein expression in the 
neonatal POA 
In the current study, we investigated the effects of gestational PCB exposure on 
sexual differentiation and developmental apoptosis in the neonatal hypothalamus of 
males and females. In the female AVPV, treatment with EB or A1221, but not the PCB 
mix, increased the number of apoptotic nuclei, while no effect of treatment was observed 
in the male AVPV. In addition, no effect of treatment was detected in the MPN of either 
sex. The similar results for EB and A1221 suggest that these effects are exerted through 
an estrogenic mechanism to masculinize the female AVPV via increased apoptosis. In 
addition, the differences between A1221 and the PCB mix may be attributable to their 
difference in relative estrogenicity at the ER. While A1221 has been consistently shown 
to have estrogenic properties, the di-ortho substituted non-coplar congeners that comprise 
the reconstituted PCB mixture have demonstrated anti-estrogenic properties in several in 
vitro studies (Oh et al., 2007). The lack of treatment effect in males may be attributable 
to the higher baseline exposure of their developing hypothalamus to steroid hormones. 
The consequences of altering developmental apoptosis in the female AVPV may alter the 
AVPV’s ability to generate the estrogen-induced GnRH/LH surge and ovulation in 
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adulthood (Wiegand et al., 1978; Wiegand and Terasawa, 1982; Gu and Simerly, 1997; 
Le et al., 2001). In our related study (Dickerson et al., 2011), we found that EB- and 
A1221-treatment reduced AVPV volume in female littermates of the animals used herein 
who had been allowed to mature to early adulthood and were studied at P60. Together, 
these results suggest that increased AVPV cell loss at P1 may be a contributing factor to 
the reduction of the regional AVPV volume observed in adult (P60) females.  
 There are also developmental sex differences in the number of cells in the AVPV 
that are immunopositive for ERα (Davis et al., 1996b; Orikasa and Sakuma, 2003). Thus, 
we also ascertained the effect of prenatal EDC exposure on this endpoint in the neonatal 
AVPV and MPN. In both regions, qualitative observations suggested no clear sex 
difference in ERα-ir at P1, consistent with reports from other labs (Yokosuka et al., 
1997). Although we could not quantify ERα-ir in the AVPV due to low cell numbers, in 
the MPN, stereological analysis showed that treatment with EB, but not PCBs, increased 
the number of cells immunopositive for ERα in both male and female P1 pups. These 
results were unexpected, as estradiol has been shown to down-regulate ERα at the level 
of gene expression (Lauber et al., 1991; Simerly and Young, 1991) as well as 
immunoreactivity in the adult (Koch, 1990) and neonatal (P10) (Orikasa et al., 1994; 
Orikasa et al., 1995; Orikasa et al., 1996) rodent brain. Other studies investigating the 
effects of PCBs upon hypothalamic estrogen receptor expression are quite limited. In one, 
Lichtensteiger et al. (2003) found that gestational exposure to A1254 increased ERα gene 
expression in the ventromedial nucleus of the hypothalamus (VMN), a region important 
for feminine sexual behavior, in female rat embryos (Lichtensteiger et al., 2003). Because 
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sex differences in ERα in the AVPV and MPN regions do not appear until postnatal day 
10, it is likely that future studies evaluating later developmental time points will provide 
temporal resolution to the endocrine disrupting effects of PCBs upon hypothalamic ERα. 
Although the experimental design did not enable us to collect tissues from rats at ages 
other than P1 (this study) and P60 (Dickerson et al., 2011), ongoing work includes a 
more systematic analysis of developmental postnatal profiling of the POAs of male and 
female rats prenatally exposed to PCBs.  
 
EDCs affect neuroendocrine gene expression in the neonatal POA 
Using a custom-designed 48-gene PCR array, we identified nine genes whose 
expression changed significantly with neonatal PCB exposure: brain-derived 
neurotrophic factor (BDNF), GABAB receptors 1 and 2, IGF-1, kisspeptin receptor, 
NMDA receptor subunits NR2b and NR2c, prodynorphin, and TGFα. Each of these 
identified genes is an important contributing factor to hypothalamic development, 
differentiation and function (Gore, 2001b; Daftary and Gore, 2004; Walker et al., 2009). 
For instance, BDNF stimulates migration of neurons during development, is highly 
expressed in discrete regions of the hypothalamus during postnatal development, and its 
release from certain cell types is regulated by gonadal steroid hormones [reviewed in 
(Tobet et al., 2009)]. In our study, expression of BDNF was reduced 50% by EB 
treatment in males, while females were not affected by treatment. Similarly, several 
neurotransmitters, including GABA, are thought to act as neurotrophic factors in 
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hypothalamus (McClellan et al., 2008). The GABAB receptor subunits B1 and B2 guide 
cell migration and positioning in the ventromedial nucleus (VMN). In females prenatally 
exposed to either EB or A1221, we observed an increase in the expression GABAB1, 
while a decrease in the expression of GABAB2 was observed in males treated with the 
PCB mix. This observation could have implications for proper establishment of sexually 
dimorphic circuitry and connections within this region.  
Other significantly affected genes are involved in brain sexual differentiation by 
modulating cell survival and developmental apoptosis. For example, the growth hormone 
IGF-1 plays a crucial role in somatic growth, as well as proliferation and inhibition of 
apoptosis [reviewed in (D'Ercole and Ye, 2008)]. Similarly, NR2b and NR2c are each 
subunits of the ionotropic NMDA receptor, whose activation not only has actions on 
GnRH neurons and the reproductive axis (Gore, 2001b; Maffucci et al., 2008), but also 
play an important role in sexually dimorphic apoptosis (Hsu et al., 2000; Hsu et al., 
2001).   
Kisspeptin signaling is important for many aspects of reproductive maturation and 
function, including a recently discovered role in the guidance of GnRH neurites to the 
median eminence at the base of the hypothalamus (Fiorini and Jasoni, 2010). In males 
treated with either EB or PCB Mix, we observed a decrease in POA kisspeptin receptor 
expression. Interestingly, in littermates of these animals used for a related study, we 
observed a delay in male pubertal onset (Dickerson et al., 2011) that may reflect 
improper targeting of kisspeptin fibers. The neuropeptide dynorphin is co-expressed in 
kisspeptin neurons, and also acts to modulate GnRH secretion (Navarro et al., 2009a). In 
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females treated with EB or PCB Mix, we observed a decrease in prodynorphin gene 
expression, and a non-significant trend (p=0.006) in A1221-treated females. This 
observation is consistent with results of our related study, where we observed decreased 
kisspeptin protein expression and impaired GnRH neuron activation in adult female 
littermates in the EB, A1221, and PCB treatment groups (Dickerson et al., 2011). It is 
possible that disruption of this neuronal circuitry begins during neonatal development. 
Finally, TGFα, expression of which was increased in male-A1221 rats, is a cytokine 
involved in a number of cellular functions such as cell growth, proliferation, 
differentiation, and apoptosis (Galbiati et al., 2003). Moreover, this growth factor is 
released by hypothalamic glial cells, and plays a role in regulation of GnRH release. As a 
whole, these gene expression data identify a group of candidates for further study as early 
developmental targets of EDCs.  
 
SUMMARY AND CONCLUSIONS 
Collectively, these data show that endocrine disruption by gestational PCBs 
causes changes to the hypothalamic neural circuitry controlling reproduction, a process 
that is detectable as early as the day after birth. We found that PCBs cause changes in 
sexually dimorphic brain regions underlying sex-specific reproductive physiology and 
behavior through the perturbation of normal developmental apoptosis, and by altering 
gene expression of neurotransmitters and receptors known to play important roles in 
differentiation and migration of hypothalamic neurons. Although there may not be an 
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easy or obvious interpretation of the nine genes affected by prenatal PCB exposure, the 
gene expression data add to the story of the effects of developmental EDC exposure on 
reproductive neuroendocrine function. In fact, the sex differences in gene expression 
profiles and differential regulation by the various EDCs suggest that subtle mechanistic 
differences underlie the physiological phenotypic differences such as hormonal 
regulation, reproductive development, and adult reproductive function. Because proper 
neuronal migration and development requires that expression of downstream signal 
transduction components occur in temporal- and spatial-specific patterns, these changes 






CHAPTER 5: DEVELOPMENTAL PCB EXPOSURE DISRUPTS 
SEXUAL DIFFERENTIATION OF THE RAT HYPOTHALAMUS 
The text in this section is modified from the article “Endocrine disruption of brain 
sexual differentiation by developmental PCB exposure,” Dickerson SM, Cunningham SL, 
Patisaul, HB, Woller, MJ, and Gore AC, (Endocrinology, 2011; in press). 
 
ABSTRACT 
In mammals, sexual differentiation of the hypothalamus occurs during prenatal 
and early postnatal development due in large part to sex differences in hormones. These 
early organizational processes are critically important for the attainment and maintenance 
of adult reproductive functions. We tested the hypothesis that perinatal exposure to 
polychlorinated biphenyls (PCBs) that disrupt hormonal pathways would perturb 
reproductive maturation and the sexually dimorphic development of neuroendocrine 
systems in the preoptic area (POA). Pregnant Sprague-Dawley rats were injected on 
gestational days 16 and 18 with vehicle (DMSO), Aroclor 1221 (A1221, an estrogenic 
PCB mix), a PCB mixture representing those highest in human body burden (PCBs 138, 
153, 180) or estradiol benzoate (EB), an estrogenic control. Male and female pups were 
monitored for somatic and reproductive development. In adulthood, some rats were 
perfused and used for immunohistochemistry of estrogen receptor α (ERα), kisspeptin 
and co-expression of Fos in GnRH neurons. Other rats were used to obtain fresh-frozen 
POA dissections for use in a PCR-based 48-gene expression array. Pubertal onset was 
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advanced and estrous cyclicity irregular in endocrine-disrupted females. Furthermore, 
sexual differentiation of female neuroendocrine systems was masculinized/defeminized.  
Specifically, in the adult female anteroventral periventricular nucleus (AVPV), ERα cell 
numbers and kisspeptin fiber density were significantly decreased, as was GnRH-Fos co-
expression. PCR analysis identified androgen receptor, IGF-1, NMDA receptor subunit 
NR2b, and TGFβ1 mRNAs as significantly down-regulated in endocrine-disrupted 
female POAs. These data suggest that developmental PCBs profoundly impair the sexual 
differentiation of the female hypothalamus. 
 
INTRODUCTION  
Exposure to environmental endocrine disrupting chemicals (EDCs) during 
susceptible periods of development, particularly embryogenesis and early postnatal life, 
has been shown across a wide range of species to cause neurological and reproductive 
deficits (reviewed in (Dickerson and Gore, 2007)). In humans, there is growing concern 
that exposure to low levels of EDCs may contribute to advanced pubertal onset in 
females and an overall decline in fertility in both sexes (Patisaul and Adewale, 2009). 
Polychlorinated biphenyls (PCBs) are a prototypical class of EDCs that are detectable in 
nearly all humans, and have been linked to a broad range of reproductive impairments. 
PCBs are of particular concern for developing offspring of exposed females, because a 
portion of the maternal body burden is transferred to the neonate through the placenta and 
mother’s milk (Ando et al., 1985). The specific mechanisms underlying the observed 
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reproductive effects are not well understood, but many EDCs, including PCBs are 
thought to act through steroid hormone receptors, particularly the estrogen receptors 
(ERs) (Dickerson and Gore, 2007), to target neural and reproductive tissues.   
In vertebrates, reproduction is coordinated by the hypothalamic-pituitary-gonadal 
(HPG) axis. At the neuroendocrine level, specific regions within the hypothalamus are 
sexually dimorphic, and function to coordinate sex-appropriate reproductive physiology 
and sexual behavior. In rodents, these sex differences in hypothalamic morphology and 
neurochemistry become organized during critical developmental windows, particularly 
the late embryonic and early postnatal periods, when sex differences in levels of gonadal 
hormones are large. While the female rodent brain develops in the relative absence of sex 
steroid hormones (Bakker and Brock, 2010), the brain of the neonatal mammalian male is 
exposed to higher levels of testosterone, along with the product of its aromatization, 
estradiol (McCarthy, 2008). Not only are cell numbers and brain regional volumes 
dimorphic, but the phenotype of cells is also sexually differentiated due to hormonal 
exposures. In rodents, one such region is the anteroventral periventricular nucleus 
(AVPV), which differs between males and females in regional volume, estrogen receptor 
α (ERα) and kisspeptin expression.  This sexual dimorphism appears to underlie 
differences in positive feedback effects of estradiol, via AVPV ERα and kisspeptin-
expressing neurons, on the hypothalamic GnRH neurons that control preovulatory LH 
release, which occurs in females but not in males. Furthermore, kisspeptin neurons 
located in the AVPV are important for pubertal initiation (Navarro et al., 2004; Kauffman 
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et al., 2007b) and such neurons are potential targets for the actions of EDCs (Bateman 
and Patisaul, 2008), although this latter question has not yet been addressed for PCBs.    
In the current study, we evaluated the effects of perinatal exposure to low levels 
of PCBs on somatic and reproductive neuroendocrine development, including sexual 
differentiation of the AVPV.  The PCB mixtures used in this study differ based on degree 
of chlorination, half-lives, and chemical properties. A1221 is a lightly chlorinated 
mixture of estrogenic PCBs that was once used commercially and has a half-life on the 
order of days (Matthews and Anderson, 1975). We also utilized a reconstituted mixture 
of more heavily chlorinated PCBs: PCB138, PCB153, and PCB180, which comprise the 
three most prevalent congeners detected in human and wildlife samples (Gladen et al., 
2003). The congeners in this PCB mixture have been reported to be estrogenic, anti-
estrogenic or anti-androgenic (Bonefeld-Jorgensen et al., 2001), and have a half-life on 
the order of years. At low doses, these compounds have been reported to shown to 
interact with steroid hormone receptors (Bonefeld-Jorgensen et al., 2001). Here, we 
performed immunohistochemical assessments of ERα, kisspeptin and GnRH, and we 
used a 48-gene PCR-based array (Walker et al., 2009) to identify novel hypothalamic 
gene expression targets of developmental PCB exposure, as manifested in the adult male 
and female rats.  
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MATERIALS AND METHODS 
Animals and perinatal treatment 
All experimental procedures were carried out in accordance with the National 
Institute of Health Guide for Care and Use of Laboratory Animals, and performed 
following protocols approved by the Institutional Animal Care and Use Committee at the 
University of Texas at Austin. Three-month old Sprague-Dawley rats were purchased 
from Harlan Sprague–Dawley Inc. (Houston, Texas; Stock/Strain: Hsd:Sprague–
Dawley®™ SD®™) and were housed individually in a humidity- and temperature- 
controlled room with a 12:12 partially reversed light cycled (lights on 2300 h, lights off 
1100 h) at 21 – 23 °C. Because standard soy-based rat chows contain phytoestrogens, 
which may affect the neuroendocrine endpoints studied herein, animals were switched to 
low-phytoestrogen Harlan-Teklad 2019 Global Diet ad libitum for the duration of the 
experiments. Although this diet is not phytoestrogen-free, previous work from our lab has 
shown that rats of this strain and on this diet are sensitive to the endocrine disruptor 
treatments (Steinberg et al., 2007; Steinberg et al., 2008). Animals were handled daily to 
minimize stress and acclimatized to the new diet for at least three weeks before mating to 
generate F1 generations.  
Female rats were mated with sexually experienced male rats (mated in a random 
rotation with females assigned to different treatments to avoid any paternal bias), and the 
day of sperm positive vaginal smears was termed embryonic day (E) 1. Dams (n=8 per 
treatment group) were randomly assigned to one of four treatment groups and injected 
 118 
i.p. on E16 and E18 with one of four treatments (the same treatment given on E16 and 
E18): 0.1 ml of vehicle (DMSO 99.5%, Sigma, #D4540, Lot# 037K07663); 50 µg/kg 
estradiol benzoate (Sigma, #E8515, Lot# 125K1029, serving as an estrogenic positive 
control); 1 mg/kg Aroclor 1221 (AccuStandard, #C-221N, Lot# 083-166; dose based on 
our published work showing effects on reproductive function in female rats (Steinberg et 
al., 2007; Steinberg et al., 2008); or 1 mg/kg reconstituted PCB mixture (referred to as 
PCB Mix). The PCB Mix was composed of the three most prevalent PCB congeners 
found in mammalian tissue samples (Gladen et al., 2003; Bentzen et al., 2008): PCB138 
(2,2',3,4,4',5'-Hexachlorobiphenyl; AccuStandard, #C138N, Lot# 082704MS-AC), 
PCB153 (2,2',4,4',5,5'-Hexachlorobiphenyl; AccuStandard, #C153N, Lot# 111804AG-
AC), and PCB180 (2,2',3,4,4',5,5'- Heptachlorobiphenyl; AccuStandard, #C180N, Lot# 
013004MT-AC), each present at the same concentration. These three congeners are 
nonplanar and do not bind the arylhydrocarbon receptor (AhR) with appreciable affinity 
(Van den Berg et al., 1998) The dose of PCB used was selected to approximate the 
typical body burden of newborn humans (Lanting et al., 1998; Lackmann, 2002).  The 
timing of administration was selected to coincide with the period just prior to brain sexual 
differentiation during late gestation (Murakami and Arai, 1989; Rhees et al., 1990a). We 
chose intraperitoneal injection for continuity with previous reports, including our own, 
showing that this route of PCBs affects neuroendocrine endpoints (Chung and Clemens, 
1999; Chung et al., 2001; Gore et al., 2002; Salama et al., 2003; Woodhouse and Cooke, 
2004; Steinberg et al., 2008). Because individual pups are exposed to approximately 
500X less than the maternal dose (Takagi et al., 1986; Steinberg et al., 2007; Steinberg et 
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al., 2008), we estimate that each pup was exposed to approximately 2 µg/kg total PCBs 
for both the A1221 treatment group and the PCB Mix treatment group. Although we did 
not quantify body burden of experimental animals following dosage of the pregnant dam, 
other laboratories have confirmed the transfer of injected PCB138, PCB153, and PCB180 
from the dam to individual pups, as well as accumulation in the dam and pup brains 
(Cocchi et al., 2009). During pregnancy, dams were provided with nesting materials on 
E20, and were left undisturbed until the day after birth, termed postnatal day (P) 1, to 
minimize stress from handling that might interfere with parturition, maternal behavior, or 
add a confounding factor to the experiment. 
Developmental measures 
For each dam, weights during gestation and gestational duration were recorded, 
and these did not vary between treatment groups. All dams delivered spontaneously and 
the day of parturition, determined by the birth of at least one pup before lights out at 1100 
h, was termed postnatal day (P) 0. On P1, the numbers of live and dead offspring, 
referred to as the F1 generation, were counted, sex ratio was determined, and the litter 
was standardized to 6 pups (three males and three females). Experimental animals for this 
study were selected based on anogenital distance (AGD); those three individuals with 
AGD closest to the litter median AGD per sex were retained, while the remaining 
animals were euthanized. AGD was measured using a digital caliper (Marois, 1968; 
Steinberg et al., 2008), and the ratio of AGD to the cube root of body weight (AGD 
index) was calculated to evaluate AGD (Marois, 1968; Gallavan et al., 1999). Tissues 
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from the culled P1 pups were banked for separate reproductive and neuroendocrine 
studies (not reported here).  
After culling, the remaining F1 pups’ AGD was measured on P7, P14, and P21. 
Body weight was measured on P7, P14, P21, P28, P35, P49, and P60. The day of eye 
opening was recorded. On P21, pups were weaned and housed 3 same-sex littermates per 
cage, and animals were checked daily for pubertal onset starting on P28. The timing of 
puberty was quantified as age of vaginal opening (VO), first estrus (FE), and first diestrus 
(FD) (Salama et al., 2003; Steinberg et al., 2008) for females, and age at preputial 
separation for males (Korenbrot et al., 1977). In females, daily vaginal lavage was 
conducted from the day of vaginal opening until euthanasia. Intact females were 
euthanized on the closest age following P58 at which proestrus occurred. 
Tissue collection 
At approximately P60, one male and female F1 rat per litter was euthanized for 
protein studies (N=8 per sex, each from different litters), and 1 male and female per litter 
was utilized for gene expression studies (N=6 per sex, each from different litters). For 
gene expression analyses, animals were rapidly euthanized by decapitation between 0900 
– 1000 h (males), or on the first proestrus following P58 between 1500 – 1700 h 
(females). Brains were quickly removed and the preoptic area-anterior hypothalamus 
(POA), which contains the AVPV and GnRH cell bodies, was dissected on ice, snap 
frozen (Dickerson et al., 2008) and stored at -80 C until processing. Trunk blood was 
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collected, allowed to clot, centrifuged for 5 min at 5000 X g, and stored at -80 C until 
use.  
For immunohistochemistry studies, F1 animals were deeply anesthetized with 0.4 
ml ketamine (100 mg/ml) and 0.4 ml of xylazine (20 mg/ml), and trans-cardially perfused 
initially with 0.9% saline (50 ml) at a rate of 50 ml/min, followed by 4% 
paraformaldehyde (500 ml). Following perfusion, the brains were carefully removed and 
postfixed overnight in 4% paraformaldehyde, and then transferred into PBSA with 0.2% 
sodium azide for storage at 4 °C. A vibrating microtome (Leica VT 1000S, Leica 
Microsystems, Nussloch, Germany) was used to cut brain into sections (40 μm-thick) that 
were stored in PBS with 0.2% sodium azide at 4 °C until use within a 6-month period. At 
the time of perfusion, a cardiac puncture was performed on the anesthetized rats to collect 
a terminal blood sample, and after perfusion the uteri, ovaries, and testes were removed 
and wet weights were recorded. We note that during perfusion the descending aorta is 
clamped such that while the head and brain are fixed, the trunk (including organs) are 
unfixed to enable wet weight measurements and tissue collection. One ovary or one testis 
from each animal was post-fixed in Bouin’s solution for morphological analysis. Blood 
samples were centrifuged at 5000 x g for five minutes to separate serum, and serum was 
stored at -80 C until steroid hormone analysis. Males were euthanized between 0900 – 
1000 h, and females were euthanized on the first proestrus following P58 between 1500 – 
1700 h. For either method of euthanasia, all carcasses were examined for any gross 
abnormalities, and none were found. 
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Gonadal morphology 
Ovaries and testes of F1 animals were coded at collection, and processed at the 
NIEHS Center for Research on Environmental Disease (CRED) Histology and Tissue 
Processing Facility Core. For each animal, the ovary or testis was paraffin embedded, 
microtome sectioned at 6 µm, and mounted onto slides (Superfrost Plus, Fisher 
Scientific). Sections were then deparaffinized, stained with hematoxylin and eosin and 
coverslipped. For males, random testis sections (2 per male) were qualitatively examined 
for histological abnormalities, and for presence of mature sperm. For females, ovary 
sections (2 per female) were qualitatively examined for histological abnormalities, and 
for the number of corpora lutea.  
Serum hormone assays  
LH concentrations in serum samples of F1 adults was measured in the laboratory 
of Dr. Michael Woller, University of Wisconsin-Whitewater, by double antibody 
competitive binding RIA as previously described (Vella et al., 2001; Maffucci et al., 
2008), using reagents provided by Dr. A. F. Parlow of the National Hormone and 
Pituitary Program at NIDDK. The reference standard used was rat LH-RP-3. Duplicate 
volumes of 100 µl serum were used for each sample, and a single assay was performed. 
The assay sensitivity was 0.2 ng/ml, and the intra-assay coefficient of variability (CV) 
based on duplicate samples was 4.33%. 
Total serum testosterone was determined in a single assay using the Active® 
Testosterone coated well EIA kit (Catalog # DSL-10-4000, Lot # 08035-B, Diagnostic 
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Systems Laboratories, Inc., Webster, TX, USA), according to the manufacturer’s 
instructions. Duplicate volumes of 50 µl serum were used for each sample. The assay 
limit of detection was 0.04 ng/ml, and the intra-assay CV based on duplicate samples for 
the assay was 2.97%.  
Progesterone concentrations were determined in a single assay using the 
ACTIVE®¨ Progesterone Coated-Tube Radioimmunoassay Kit (Catalog # DSL-3900, Lot 
# 07076, Diagnostic Systems Laboratories, Inc., Webster, TX, USA), according to the 
manufacturer’s instructions. Duplicate volumes of 25 µl serum were used for each 
sample. The sensitivity of the assay was 0.12 ng/ml, and the intra-assay CV was 3.26%.  
Estradiol concentrations were determined in a single assay using an ultrasensitive 
double-antibody RIA kit (Catalog # DSL-4800, Lot # 07076, Diagnostic Systems 
Laboratories, Inc., Webster, TX, USA), according to the manufacturer’s instructions. 
Duplicate volumes of 200µL serum were used for each sample. The assay limit of 
detection was 2.2 pg/mL, and the intra-assay coefficient of variability based on duplicate 
samples was 7.97%. For all assays, a few samples for which the CV between duplicates 
was 10% or greater were excluded from analysis. 
Immunohistochemistry of ERα, kisspeptin, and GnRH-Fos double 
labeling 
All analyses were performed on coded sections by investigators blind to 
treatment. For ERα immunohistochemistry, sections were selected in a 1:2 series through 
the AVPV of adult male and female F1 rats, and were processed in four runs using the 
purified rabbit polyclonal antibody C1355 (1:20,000, Upstate Biotechnology, Waltham, 
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MA) as previously described in detail (Chakraborty et al., 2003; Wu et al., 2009a). The 
antibody is well characterized and has no cross-reactivity with ERβ (Wu et al., 2009a). 
For each run, animals from each sex and treatment group were equally represented. In 
order to make the experimenter blind to sex and treatment group, section IDs were 
recoded. All steps, unless noted, occurred at room temperature (22 °C) on a shaking 
platform. Procedures of immunohistochemistry, tissue handling and Nissl staining were 
done identically to our previously published work (Wu et al., 2009a). In brief, sections 
were incubated in the primary antibody for 48 hours, incubated with 5% normal goat 
serum and secondary antibody (biotinylated goat anti-rabbit immunoglobulin (Ig)G, 
1:600; BA-1000; Vector Laboratories) for one hour, then subjected to peroxidase reaction 
with nickel-enhanced DAB. Sections were mounted on gelatin-subbed slide, dried, 
dehydrated in a graded alcohol series, counterstained with methyl green, and 
coverslipped with DPX (44581; Fluka, Steinheim, Germany). 
For each adult F1 animal, three AVPV tissues per rat were immunolabeled for 
kisspeptin using immunofluorescence methods described in detail elsewhere (Bateman 
and Patisaul, 2008). In brief, tissues were incubated with the rabbit polyclonal kisspeptin-
10 antibody (1:6000; generous gift of Dr. Alain Caraty, Institut National de la Recherche 
Agronomique/Centre National de la Recherche Scientifique, Université de Tours) for 48 
hours.  The antibody is well characterized for use in neural tissue and has been 
extensively validated for specificity by other labs (Gottsch et al., 2004; Smith et al., 
2005; Clarkson and Herbison, 2006; Franceschini et al., 2006).  The secondary antibody 
was the Alexa-Fluor goat anti-rabbit 488 (1:200, 2 hours). Tissues were mounted onto 
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slides (Superfrost Plus, Fisher, Pittsburgh, PA), and cover-slipped using VectaShield 
(Vector Labs).   
Female adult F1 rats were perfused 3 hours after lights out on proestrus, when 
GnRH-Fos double-labeling is high (Finn et al., 1998). GnRH and Fos coexpression were 
detected using a cocktail of primary antibodies directed against GnRH (raised in mouse, 
1:1,000, Santa Cruz, SC-32292) and Fos (raised in rabbit, 1:250, Santa Cruz, SC-52) 
followed by the secondary antibodies biotinylated horse-anti-mouse and biotinlyated 
goat-anti-rabbit, each at 1:600. After secondary antibody incubation, sections were 
processed with the Universal Elite ABC kit (Vector Laboratories, Burlingame, CA) and 
labeled with diaminobenzidine (brown) for GnRH and nickel-enhanced diaminobenzidine 
(black) for Fos. Sections were then rinsed, mounted onto slides (Superfrost Plus, Fisher, 
Pittsburgh, PA), and coverslipped using DPX mountant. Preliminary IHC showed that 
GnRH and Fos immunoreactivity was evenly distributed laterally and dorsally throughout 
the rostral to caudal extent of the organum vasculosum of the lamina terminalis (OVLT) 
(Wray and Hoffman, 1986; Adewale et al., 2009). Therefore, for each female two 
midlevel sections containing the OVLT through the caudal border of the AVPV were 
selected for immunolabeling and analysis of GnRH and Fos. Cells immunostained for 
GnRH only, and cells immunolabeled for both GnRH and Fos were counted by an 
individual blind to the treatment groups and verified by a second independent observer. 
GnRH neuron activation is expressed as percentage dual-labeled GnRH neurons out of 
the total number GnRH neurons counted.  
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Quantification of ER alpha cell numbers, kisspeptin fiber density, and 
GnRH-Fos double labeling 
Quantification of ERα in the AVPV was performed using unbiased stereological 
analysis according to methods described in detail previously (Chakraborty et al., 2003; 
Chakraborty et al., 2005). A wet-mount of fresh tissue showed that average tissue 
thickness was 39.8 μm. The sections were carefully matched for rostral–caudal 
landmarks among all the animals, and the regions were identified in Nissl-stained 
sections by comparing anatomical landmarks to an atlas of the rat brain (Swanson, 1998). 
Contours were drawn around the AVPV at low magnification (10× objective) using an 
Olympus BX-61 microscope. A buffer zone at the top and bottom of sections was set at 
3 μm for all experimental stereology. For each rat, the regional volume of the AVPV was 
extrapolated based on the contours and tissue thickness (Volume = regional 
area × thickness). The Stereo Investigator® software (MicroBrightField, Williston, VT) 
randomly placed 60 μm × 125 μm grids (“disector frames”) within the AVPV contour. 
Within these disector frames, the DAB-stained ERα-labeled nuclei were counted within a 
45 μm × 45 μm counting frame (“optical disectors”). Based on these parameters, the 
number and density (# immunoreactive cells/volume of each nucleus) of ERα-
immunoreactive (ERα-ir) nuclei falling within the regions was quantified. The 
coefficients of error (Cruz-Orive/Geiser) and variation of the estimates were calculated as 
described by Schmitz and Hof (Schmitz and Hof, 2000). Photomicrographs were taken to 
produce the figures, and images were subjected to only minor adjustments of contrast 
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using Adobe Photoshop CS4 (Adobe, San Jose, CA). In order to avoid any bias, any 
adjustments were applied equally to tissues from rats of different treatment groups. 
For quantification of kisspeptin fiber density, three AVPV sections were analyzed 
for kisspeptin immunofluorescence on a Leica TCS SPE confocal microscope fitted with 
a 63× oil corrective objective lens. For each scan, a set of serial image planes (z-step 
distance = 1 μm) was collected through the entire thickness of each section, producing a 
set of confocal stacks ranging in size from 26 to 36 image planes. Image stacks were 
analyzed using the Image J software package (National Institutes of Health (NIH), 
Bethesda, MD) as previously described (Bateman and Patisaul, 2008). To control for 
variations in tissue thickness that would result in unequal numbers of image planes, 
substacks of consecutive image planes that excluded the rostral and caudal edges of the 
tissue sections were created for each set of scans. Substacks consisted of 24 sequential 
image planes for the AVPV. Only data from sections with consistent staining throughout 
the entire thickness were included in the analysis. Individual images contained within 
each substack were first binarized and depixelated to minimize the inclusion of 
background fluorescence. Fibers were then skeletonized to a thickness of one pixel to 
compensate for differences in individual fiber thickness and brightness. The number of 
resulting bright pixels in each image plane was then quantified using the Image J Voxel 
Counter plug-in (NIH). The voxel counts were averaged within the substack to obtain a 
single measure for each section that was then used as a quantitative representation of 
average kisspeptin fiber density within the volume sampled (Bateman and Patisaul, 
2008). 
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For quantification of GnRH neuron activation, GnRH/Fos double-labeled slides 
were visualized and evaluated with an Olympus BX-61 microscope. Each GnRH cell was 
scored as Fos-positive or negative based on the presence or absence of nickel-DAB 
product in the GnRH nucleus. 
RNA extraction and Taqman low-density arrays (TLDA) 
In brief, RNA from frozen POA dissections was extracted using an in-house 
double detergent lysis buffer system as described previously (Dickerson et al., 2008; 
Walker et al., 2009). Samples were homogenized and the cytoplasmic RNA was treated 
with proteinase K, followed by extraction with phenol chloroform and precipitation in 
isopropanol. Genomic DNA contamination was removed using the TURBO DNA-free kit 
(Applied Biosystems Inc, Foster City, CA) according to the manufacturer’s protocol. The 
concentration of resulting cytoplasmic RNA was determined using a Nanodrop (ND-
1000, Nanodrop Technologies, Inc., Wilmington, DE).  
Samples were run on a custom-designed rat neuroendocrine TLDA (Applied 
Biosystems Inc., Foster City, CA), a panel of 48 candidate neuroendocrine genes chosen 
by our laboratory to identify putative genes in the POA affected by developmental EDC 
exposure. Cytoplasmic RNA (2 µg) was converted to cDNA using the High-Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems). The resulting cDNA was stored 
at -20 C until use, at which time samples were diluted 1:5 before PCR reactions were 
performed using Applied Biosystems’ Taqman reagents, and run on an ABI 7900 real-
time PCR machine using the following parameters: 50 C for 2 min, 94.5 C for 10 min, 45 
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cycles of 97 C for 30 sec, and 59.7 C for 1 min. Relative expression for each gene was 
determined using the comparative Ct method (Pfaffl, 2001). Each sample was normalized 
to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression, a “control” gene 
chosen because it is unaffected by sex/treatment in the POA in this and another study 
(Walker et al., 2009), and the data were calibrated to the average change in Ct for the 
treatment group with the lowest expression.  
Statistical analysis 
SPSS statistical software (17.0 for Macintosh, SPSS Inc., Chicago, IL) was used 
to evaluate the effects of treatment on somatic and reproductive development, serum 
hormones, AVPV volume, AVPV ERα immunoreactivity and kisspeptin fiber density. 
Repeated-measures ANOVA was used to assess significant differences between 
treatment groups for serially recorded anogenital distances and body weights. Because 
previous research has already demonstrated sex differences in many of the 
neuroendocrine endpoints evaluated herein and we had independent a priori hypotheses 
for each sex, statistics were performed separately for each sex. Each dataset was tested 
for homogeneity of variance and normality. For datasets that met these criteria, 
comparisons were made by one-way ANOVA (factor: treatment) followed by Fisher’s 
LSD post-hoc analysis when indicated by a significant main effect. Datasets for which 
variance between treatment groups was unequal were compared using the nonparametric 
Kruskal-Wallis test. For analysis of estrous cyclicity, statistical significance was 
determined using the nonparametric Fisher’s exact test (Wu and Gore, 2010). For GnRH 
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neuron activation in females, percentage of GnRH and Fos co-labeled cells were 
compared across treatment groups by χ2 analysis. The number of GnRH neurons counted 
did not differ between treatment groups (data not shown). In all these cases p-values < 
0.05 were considered statistically significant. For the gene expression data, statistics were 
conducted using the normalized Ct (δ-Ct) for each sample (before transformation to fold 
change). Because the TLDA measures expression of 48 genes, a Bonferroni correction 
was used to adjust the alpha for significance to p < 0.001. The Grubb’s test was used to 
detect a few outliers, which were excluded from statistical analysis. 
 
RESULTS 
Somatic and reproductive development 
After animals were culled on P1, anogenital distance (AGD) for the remaining 
experimental animals was measured from the day after birth until weaning, and body 
weight was measured throughout postnatal development until P60. As shown in Figure 
5.1, a slight but significant main effect of treatment (p<0.01) on postnatal body weight 
gain was detected in females, but not males, throughout postnatal development. Post-hoc 
analysis showed that females treated with EB (p = 0.001) or A1221 (p=0.01) were 
heavier than control animals. Moreover, neonatal EDC exposure resulted in a significant 
main effect of treatment (p<0.01) on male, but not female, AGD (p<0.001). Post-hoc 
analysis revealed an increase in AGD in EB-, A1221-, and PCB Mix-treated males 
throughout postnatal development (p<0.01; Figure 5.1).  
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As shown in Table 5, a significant main effect of treatment was observed on the 
developmental landmark of eye opening (p < 0.05) in females. Post-hoc analysis showed 
a modest but significant advancement in eye opening in females from the A1221 
(p<0.001) and PCB Mix (p<0.05) groups compared to controls. We observed a 
significant interaction of treatment on pubertal onset (p < 0.001), with females prenatally 
exposed to EB (p<0.005), A1221 (p<0.005), or PCB Mix (p<0.01) having earlier vaginal 
opening compared to control females. Males treated with these same agents had a delay 
in preputial separation compared to control males (Table 5; p<0.005). The age of vaginal 
opening occurred an average of 1.4 days earlier in EDC-treated females than the control 
rats, while the age of preputial separation was 1.7 days later in EDC-treated males 
compared to control rats (Table 5).  
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Figure 5.1: Postnatal Developmental landmarks. Data for anogenital distance (A) and 
body weight (B) shown are in postnatal days, mean ± S.E.M. Repeated-measures 
ANOVA showed that treatment with estradiol benzoate (EB), Aroclor 1221 (A1221), or 
the reconstituted PCB mixture (PCB Mix) caused a modest but significant increase in 
male AGD (**p<0.001), while female AGD was unaffected by treatment. For body 
weight, a slight but significant increase in body weight in EB- and A1221-treated females 
was detected. AGD index is the ratio of AGD (mm) to the cube root of body weight. The 
legend in the upper left panel applies to the other three panels. 
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Aroclor 1221 PCB Mix 
Eye Opening 
(days) 
15.07 ± 0.13 15.00 ± 0.15 14.36 ± 0.14 ** 14.69 ± 0.14  
Vaginal Opening 
(days) 
34.14 ± 0.39 32.71 ± 0.30 ** 32.64 ± 0.28 ** 32.77 ± 0.38 * 
First Estrus (days) 34.21 ± 0.41 33.29 ± 0.33 33.07 ± 0.30 34.54 ± 0.71 
First Diestrus 
(days) 
35.14 ± 0.37 34.29 ± 0.28 33.93 ± 0.41 35.00 ± 0.63 













0.77 ± 0.06 0.72 ± 0.05 0.66 ± 0.07 0.78 ± 0.07 
Ovary Wet 
Weight (g) 
0.127 ± 0.004 0.129 ± 0.004 0.123 ± 0.003 0.147 ± 0.005 ** 
Gonadosomatic 
Index 






Aroclor 1221 PCB Mix 
Eye Opening 
(days) 
15.07 ± 0.17 15.07 ± 0.16 14.79 ± 0.12 14.83 ± 0.12 
Preputial 
Separation (days) 
40.93 ± 0.23 42.67 ± 0.33 ** 42.79 ± 0.41 ** 42.33 ± 0.45 * 
Paired Testes Wet 
Weight (g) 
3.77 ± 0.004 3.68 ± 0.004 3.58 ± 0.003 3.68 ± 0.005 
Gonadosomatic 
Index  
1.23 ± 0.02 1.18 ± 0.02 1.15 ± 0.01 1.16 ± 0.03 
 
Data shown are mean + SEM. *p < 0.05, **p < 0.005 vs. DMSO vehicle. 
Gonadosomatic index = gonad wet weight/body weight 
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Estrous cyclicity in females 
Upon vaginal opening, regularity of the estrous cycle was assessed by daily 
vaginal lavage. An abnormal estrous cycle was defined as 3 or more consecutive days in 
estrus, or 4 or more consecutive days of diestrus in a cycle (Delclos et al., 2009). The 
nonparametric Fisher’s exact test showed a treatment effect of EDCs on estrous cyclicity, 
with all groups of EDC-treated females having a significantly higher percentage of 
individuals having at least one irregular estrous cycle (Table 5; χ2 = 17.1, df = 3, 
p<0.001). 
 
Gonadal weight and morphology 
Gonadal weights and gonadosomatic index (calculated as [gonadal weight/body 
weight] * 100) were also affected in a sex-dependent manner by EDCs (Table 5). 
Ovarian weight (p<0.01) and gonadosomatic index (p<0.05) showed a slight but 
significant increase in PCB Mix-treated females, but gonadal weight was unaffected by 
treatment in males. There was a nonsignificant trend for male gonadosomatic index to be 
decreased by either PCB treatment (p=0.051). Gonadal morphology was not significantly 
different between treatment groups in adult males or females (Figure 5.2). Qualitative 
histological comparison between groups showed consistently healthy-appearing ovaries 
characterized by all stages of follicular development and the presence of healthy corpora 
lutea (CLs). None of the treatment groups displayed any degree of abnormalities such as 
hemorrhagic follicles, large antral-like follicles, multioocyte follicles, or ovarian cysts. In 
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females, the number of corpora lutea (CL) were counted to determine whether females 
had ovulated. Although there was a non-significant trend for a reduction in the number of 
CLs present in the A1221 and PCB Mix groups, this did not reach significance (DMSO= 
13.75 ± 0.86, EB= 12.5 ± 2.3, A1221= 11.25 ± 3.1, PCB= 10.5 ± 1.7). In males, 
qualitative observations of testes showed no histological abnormalities in any of the 
treatment groups, nor any apparent differences in the presence of mature sperm (Fig. 
5.2). 
 
Effects of PCBs on serum hormones  
 Serum LH levels varied considerably among rats, an observation likely due to the 
pulsatile nature of LH release (Maffucci et al., 2008). Kruskal-Wallis analysis showed no 
effect of treatment upon LH levels in males or females (Fig. 5.3A). For estradiol, no main 
effects of treatment were observed in males or females (Fig. 5.3B). A significant main 
effect treatment on serum testosterone was detected (p<0.05) attributable to males treated 
with PCB Mix having lower levels of testosterone than A1221-treated male rats 
(p=0.013; Fig. 5.3C). However, no EDC groups differed from the DMSO control group. 
Serum progesterone levels were significantly reduced in males treated with either A1221 
(p=0.01) or PCB-treated (p=0.002) animals (Fig. 5.3D). 
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Figure 5.2: EDC Effect on Gonadal Morphology 
 
Figure 5.2: Representative photomicrographs of gonadal morphology from females (top 
row; scale bar = 500 µm) and males (bottom row; scale bar = 250 µm). Ovarian 
morphology did not differ significantly across treatment groups, and markers of active 
oogenesis and ovulation were observed in all samples. Testicular morphology was similar 
across treatment groups, with mature sperm observed in all samples. 
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Figure 5.3: Serum hormone levels of luteinizing hormone (A), estradiol (B), testosterone 
(C), and progesterone (D) in adult F1 animals. For both LH and estradiol, no significant 
main effect of treatment upon either hormone was observed in males or females. For 
testosterone, A1221-treated males had higher serum testosterone compared to PCB Mix-
treated males (p<0.05). For progesterone, A1221- and PCB Mix-treated males had lower 
levels than DMSO males.  The bars represent the mean ± S.E.M.  a, p<0.05 vs. A1221 
males; b, p<0.05 vs. DMSO males. PCB on the x-axis refers to the PCB Mix group. 
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ER alpha and kisspeptin expression in the AVPV 
Representative photomicrographs of ERα immunoreactivity in the AVPV are 
shown in male and female rats for the four treatments. (Fig. 5.4, A-H). Stereological cell 
counting showed a significant main effect of treatment on ERα-ir cell numbers in 
females, with EB- and A1221-treated females having significantly fewer cells than 
DMSO- and PCB Mix-treated females (p<0.01; Fig. 5.5). In addition, we observed a 
significant main effect of treatment upon AVPV volume in both males (p=0.019) and 
females (p=0.01). In females, treatment with EB (p<0.01), A1221 (p<0.01), or PCB Mix 
(p=0.049) resulted in reduced volume compared to DMSO females. PCB Mix-treated 
males had increased AVPV volume compared to DMSO males (p<0.005). Density of 
ERα was unaffected by treatment in AVPV of F1 males or females (Fig. 5.5). 
Representative photomicrographs of kisspeptin immunoreactivity in the AVPV 
are shown in male and female rats (Fig. 5.4, I-P). We detected a significant effect of 
treatment on kisspeptin-ir density in females, but not males, with all EDC-treated F1 
females having lower kisspeptin expression compared to control counterparts (Fig. 5.6; 
p<0.001).   
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Figure 5.4:Representative AVPV ERα  and Kisspeptin Labeling  
 
Figure 5.4: Upper Panel. Photomicrographs of estrogen receptor alpha (ERα) immunoreactivity 
in the anteroventral periventricular nucleus (AVPV) of P60 female and male rats developmentally 
exposed to DMSO vehicle (A, E), estradiol benzoate (B, F), A1221 (C, G), or PCB Mix (D, H). 
The third ventricle can be seen at the right of each micrograph. Although the images presented 
here were photographed at low magnification (10X), quantification and analysis of ERα-
immunoreactivity was performed at high-power magnification (40X). ERα nuclei are labeled 
with dark brown nickel-enhanced diaminobenzidine product. Scale bar = 250µm. Lower Panel. 
Confocal images (5 merged consecutive optical planes) of kisspeptin fiber immunofluorescence 
in the AVPV of representative female and male rats. The third ventricle is at the right of each 
micrograph. Data are shown for a representative female and male treated prenatally with DMSO 
vehicle (I, M), EB (J, N), A1221 (K, O) and PCB Mix (L, P). Scale bar = 100µm. 
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Figure 5.5:  Stereologic analysis results for ERα-immunoreactive cell numbers in the 
AVPV (A), regional volume of the AVPV (B) and cell density (C) are shown for adult F1 
rats in the AVPV (n = 8 to 10 rats per treatment group). Data are the mean ± S.E.M. ERα 
cell number was significantly reduced in EB- and A1221-treated females compared to 
DMSO control. Female AVPV volume was reduced by EDC treatment, while the AVPV 
volume of PCB Mix-treated males was higher than their control counterparts. Cell 
density was unaffected by treatment in either sex. *, p < 0.05 vs. DMSO control;  **, p 
<0.005 vs. DMSO control. PCB on the x-axis refers to the PCB Mix group. 
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Figure 5.6: Quantification of kisspeptin immunofluorescence density in the AVPV. Data 
are shown for total (A) and average (B) kisspeptin immunoreactivity. By both measures, 
kisspeptin immunoreactivity was significantly reduced in females perinatally exposed to 
EB, A1221 or PCB Mix compared to DMSO controls. Male AVPV kisspeptin was 
unaffected by any perinatal EDC treatment.  ** p < 0.001 vs. DMSO control. PCB on the 




For GnRH co-expression of Fos, a significant effect of treatment was observed 
(Fig. 5.7; χ2 = 19.07, df = 3, p<0.001). Fos immunoreactivity was observed in 62% of 
GnRH neurons of the DMSO treated control females. Only 15% of GnRH neurons in EB 
treated, 6% in A1221 treated, and 8% in PCB-treated females, co-expressed Fos.  
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Figure 5.7: GnRH-Fos co-expression in the POA was measured in P60 female rats on the 
afternoon of proestrus. Examples of immunohistochemical labeling of GnRH (light brown) and 
Fos (dark brown nuclei) in the female OVLT are shown. Tissues are counterstained with methyl 
green to enable detection of cell nuclei. A) Several single-labeled GnRH neurons are seen with 
blue (Nissl) nuclei (arrows). Some Fos-positive nuclei (arrowheads) are seen. In this panel, none 
of the GnRH neurons co-expresses Fos. B) Single- and double-labeled GnRH neurons are seen. 
Those GnRH neurons that are immunopositive for Fos are indicated (asterisks). Single-labeled 
GnRH cell bodies (arrow) and single-labeled Fos nuclei (arrowhead) are also seen in that section. 
Scale bar A and B = 50 µm. C) The percentage of GnRH neurons of proestrous F1 females that 
co-expressed Fos was quantified. About 60% of GnRH neurons were double-labeled with Fos in 
the DMSO control group. This was significantly lower in all three neonatally EDC treated groups. 
Data shown are mean ± S.E.M. **p<0.001 vs. DMSO control. PCB on the x-axis refers to the 
PCB Mix group. 
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Effects of developmental PCB exposure on POA neuroendocrine gene 
expression 
Forty-seven of the candidate neuroendocrine genes on the Rat Custom Taqman® 
Low Density Array (TLDA) were detectable following real-time PCR reactions (Table 
6). Of the three potential internal controls for normalization on the TLDA card: GAPDH 
(glyceraldehyde-3-phosphate dehydrogenase), 18S and β-actin, our analyses showed that 
GAPDH did not vary across sex and treatment group. Thus POA genes were normalized 
to GAPDH for analyses. Of the remaining detectable genes, relative gene expression of 
four genes was significantly affected by developmental PCB exposure following the 
Bonferroni correction (Fig. 5.8, Table 6): androgen receptor, IGF-1, the N-methyl-D-
aspartate (NMDA) receptor subunit NR2b, and TGFβ1. For these genes, the EDC 
animals had significantly decreased mRNA levels compared to vehicle in the females, but 
there were no significant effects in the males. 
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Figure 5.8: Gene expression data are shown for the four neuroendocrine genes that were 
significantly affected in the POA of P60 F1 male and female rats. Androgen receptor and 
TGFβ1 gene expression were reduced by A1221- or PCB Mix-treatment in females, 
compared to control. IGF-1 and NR2b gene expression were reduced in females 
prenatally exposed to EB or PCB Mix, compared to DMSO. Gene expression in males 
was unaffected by treatment. Data shown are mean ± S.E.M. N = 6 rats per group; 
*p<0.0001 vs. DMSO control of the same sex. PCB on the x-axis refers to the PCB Mix 
group. 
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Table 6: Low-density PCR Array Gene Expression Results for P60 Animals 
 
  Males Females 
Gene  
Name 





receptor -- -- -- -- -- --  
AR Androgen receptor -- -- -- 0.002 *<0.001 *<0.001 Decreased 
Arnt 
Aryl hydrocarbon 
















19a1 (aromatase) -- -- -- -- -- --  
Cyp1b1 
Cytochrome P450, 





alpha 0.011 -- -- -- -- --  
Esr2 
Estrogen receptor 
beta -- -- -- -- -- --  
Gabbr1 
GABA-B receptor 1 
-- -- -- 0.088 0.021 0.024 
Decrease 
(trend) 
Gabbr2 GABA-B receptor 2 -- -- -- -- -- --  
Gal Galanin -- -- -- -- -- --  
Gnrh1 
Gonadotropin-




receptor -- -- -- -- -- --  
Gper 
G-protein coupled 
receptor 30 -- -- -- -- -- --  
Gria1 GluR1 -- -- -- -- -- --  
Gria2 GluR2 -- -- -- -- -- --  
Gria3 GluR3 -- -- -- -- -- --  
Grik2 Kainate 2 receptor -- -- -- -- -- --  
Hsd17b1 
Hydroxysteroid 17-
beta dehydrogenase 1 -- -- -- -- -- --  
Hsd17b2 
Hydroxysteroid 17-
beta dehydrogenase 2 -- -- -- -- -- --  
Hsd17b3 
Hydroxysteroid 17-
beta dehydrogenase 3 -- -- -- -- -- --  
Hsd17b8 
Hydroxysteroid 17-
beta dehydrogenase 8 -- -- -- -- -- --  
Igf1 
Insulin-like growth 




factor 1 receptor -- -- -- -- -- --  
Kiss1 Kisspeptin -- -- -- -- -- --  
Kiss1r 
Kisspeptin receptor 
(GPR54) -- -- -- -- -- --  
Pgrmc1 
Membrane 




subunit 1 (NR1) -- -- -- -- -- --  
Grin2a NMDAR subunit 2a -- -- -- -- -- --  
Grin2b NMDAR subunit 2b -- -- -- *<0.001 0.005 *<0.001 Decreased 
Grin2c NMDAR subunit 2c -- -- -- -- -- --  
Grin2d NMDAR subunit 2d -- -- -- -- -- --  
Pdyn Prodynorphin -- -- -- -- -- --  
Pgr Progesterone receptor -- -- -- -- -- --  
Slc17a1 
Vesicular glutamate 
transporter 1 -- -- -- -- -- --  
Slc17a6 
Vesicular glutamate 
transporter 2 -- -- -- -- -- --  
Srd5a1 
Steroid 5-alpha 
reductase 1 -- -- -- -- -- --  
Stat5b 
Signal transducer and 
activator of 
transcription 5B -- -- -- -- -- --  
Sts Steroid sulfatase -- -- -- -- -- --  
Tac2 Neurokinin B -- -- -- -- -- --  
Tgfa 
Transforming growth 
factor alpha -- -- -- -- -- --  
Tgfb1 
Transforming growth 
factor beta-1 -- -- -- 0.003 *<0.001 *<0.001 Decreased 
Ucp2 Uncoupling protein 2 -- -- -- -- -- --  
Vdr Vitamin D receptor -- -- -- -- -- --  
 
Table 6: Low-density PCR arrays were used to measure expression of 48 genes in whole 
POAs of P60 F1 female and male rats treated prenatally with EDCs. The full list of 
detected neuroendocrine genes is shown. Statistical results are shown for significant 
effects and for trends in data. Because of the Bonferroni correction, the cut-off for a 
significant effect was set at p < 0.001.  
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DISCUSSION 
Developmental exposure to environmental EDCs can cause permanent deficits in 
reproductive physiology by interfering with hormone-dependent developmental 
processes, including brain sexual differentiation and reproductive maturation. We 
hypothesized that prenatal exposure to PCBs, which act in part via steroid hormone 
receptors, would have lasting effects on developing sexually dimorphic regions of the 
brain. In support of our hypothesis, we found that sub-toxic levels of PCBs administered 
at doses relevant for human exposures (Lackmann, 2002; Lackmann et al., 2004) had 
sex-dependent effects on reproductive neuroendocrine maturation, sexual differentiation 
of the hypothalamus, and neuroendocrine gene and protein expression in adulthood.  
 
Effects on eye opening, postnatal AGD and body weight gain  
A number of external markers of development were monitored in our F1 males 
and females. Eye opening was modestly but significantly advanced in females prenatally 
exposed to PCBs, but unaffected in males. As thyroid hormone signaling plays a crucial 
role in the onset of eye opening in rodents (Goldey et al., 1995), we believe that this 
effect may be due to effects of PCBs on the thyroid system as shown in some (Goldey et 
al., 1995; Goldey and Crofton, 1998) but not all studies (Sitarek and Gralewicz, 2009).  
In this study, we also observed a slight but significant increase in postnatal body 
weight gain in females neonatally exposed to either EB or A1221, but not in those 
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exposed to the PCB Mix. Males were unaffected. Emerging evidence suggests that 
developmental EDCs may alter adipogenesis, energy balance and body weight (reviewed 
in (Hany et al., 1999; Bowers et al., 2004; Grun and Blumberg, 2005). Further work is 
merited to determine the mechanism for the body weight effect in our F1 females. 
Other somatic and reproductive landmarks were modestly affected, including 
postnatal AGD in males but not females. In rodents and many other mammals, the AGD 
is a sexually dimorphic external marker of masculinization, with males having a longer 
AGD than females due largely to differences in perinatal exposures to androgens 
(Marois, 1968). The increase in AGD in males may seem counterintuitive, but it is 
consistent with a report by Kuriyama and Chahoud (Kuriyama and Chahoud, 2004) who 
showed that male rats exposed to the dioxin-like coplanar congener PCB118 throughout 
early postnatal development had hypermasculinized AGD. Other studies have shown 
effects of PCBs on AGD in a manner that varied by sex, congener, and timing of 
treatment (Wang et al., 2002; Lilienthal et al., 2006). While it is not a neuroendocrine 
marker per se, changes in postnatal AGD may be a biomarker for exposure to EDCs 
during early postnatal development in laboratory rodents, and is beginning to be used in 
human studies (Swan et al., 2005). 
 
Sexually dimorphic effect of PCBs on pubertal onset 
Pubertal onset was affected by perinatal PCB exposure in a sex-dependent 
manner, with an advancement observed in females, and a delay in males. Our results are 
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consistent with the results of other studies, which have found that developmental 
exposure to estrogenic chemicals hastens the onset of puberty in females (Delclos et al., 
2009; Ryan et al., 2010) and delays puberty in males (Masutomi et al., 2003). The 
reported effects of PCBs on pubertal onset vary depending upon the dose and timing of 
administration, and the three-dimensional structure and half-life of the PCBs. In addition, 
these properties of PCBs and their metabolites also determine their interaction with 
steroid hormone receptors, and whether they behave as agonists or antagonists (Bonefeld-
Jorgensen et al., 2001). For our study, two PCB mixtures were selected based on their 
degree of chlorination and expected half-lives. Lightly chlorinated PCBs such as those in 
Aroclor 1221, are believed to exert mostly estrogenic activity via either direct binding of 
the parent compound to estrogen receptor alpha or through interactions of its catechol or 
hydroxylated metabolites with ERs (Korach et al., 1988; Conner et al., 1997; Kramer et 
al., 1997; Layton et al., 2002; Kitamura et al., 2005). A1221 has a short half-life on the 
order of several days. In contrast, the reconstituted PCB mixture is comprised of heavily 
chlorinated PCB congeners that are known to accumulate and remain in biological tissues 
for years in humans, and have pleiotropic effects on the estrogen receptor (estrogenic or 
anti-estrogenic) and androgen receptor (anti-androgenic), depending upon dose 
(Bonefeld-Jorgensen et al., 2001). Our finding that the three EDCs all stimulated timing 
of puberty in females is probably due to the estrogenic component of these compounds. 
In males, androgens play an important role in the timing of pubertal onset 
(Korenbrot et al., 1977), and anti-androgens have been shown to delay puberty (Goto et 
al., 2004). Because A1221 and one of the congeners used in our study, PCB138, has been 
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shown to act as an anti-androgen at low doses (Bonefeld-Jorgensen et al., 2001; Portigal 
et al., 2002), the delay in preputial separation observed in males prenatally exposed to the 
PCB Mix may be caused by an antagonistic effect on the androgen receptor. In addition, 
since EB also delayed puberty in males, the estrogenic properties of the three EDCs may 
cause an imbalance of the androgen:estrogen systems. Although not reported here, 
littermates of these males were utilized for a separate study, and we observed a decrease 
of testosterone in males at P1. Unfortunately, we did collect blood to measure 
testosterone at puberty, but our observation of a slight reduction in serum testosterone at 
P60 suggests a possible interference in the achievement of a normal secretory pattern of 
testosterone during pubertal maturation. 
 
EDCs do not affect gonadal morphology but alter estrous cyclicity 
EDCs such as PCBs can target all levels of the HPG axis. Previous studies have 
shown that reduced fertility in rats exposed to EDCs during early postnatal development 
is associated with abnormal gonadal morphology and abnormal estrous cyclicity in 
females (Adewale et al., 2009; Jefferson et al., 2009). However, very little is known 
about how PCB exposure during the critical neonatal window, at doses relevant for the 
typical human body burden, can affect gonadal development and function. Here, we 
found that although gonadal morphology was qualitatively unaffected by PCBs 
administered during the critical period, estrous cyclicity in females was disrupted. While 
females from the vehicle group displayed normal estrous cycles following vaginal 
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opening, those treated with either EB or PCBs displayed abnormal cycles characterized 
by 3 or more consecutive days of estrus or 4 or more days of consecutive diestrus. 
Because the ovarian morphology in these animals was within normal range, we suspect 
the abnormal estrous cycles were related to the effects of PCBs on the hypothalamic 
regulation of ovulation, which would be consistent with the disrupting effects of prenatal 
PCBs on neuroendocrine circuits described below. In addition, the male gonad showed 
normal seminiferous tubules and presence of sperm in all groups. 
 
PCBs affect the hypothalamic circuits controlling reproduction in 
females but not males 
By investigating effects of prenatal PCBs on neuroendocrine systems of males 
and females, we were able to test the hypothesis that females would be more vulnerable 
since their baseline neonatal steroid exposure is lower than that of males. In rodents, 
estradiol aromatized from testosterone is particularly important in brain sexual 
differentiation (Bakker and Brock, 2010), and PCBs can disrupt estrogenic processes. 
Perinatal hormone exposures of the AVPV are necessary for female rodents to develop 
the ability to generate the estrogen-induced GnRH/LH surge and ovulation in adulthood 
(Wiegand et al., 1978; Wiegand and Terasawa, 1982; Gu and Simerly, 1997; Le et al., 
2001). These processes involve developmental sex differences in the number of cells in 
the AVPV that are immunopositive for ERα (Davis et al., 1996b; Orikasa and Sakuma, 
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2003) and kisspeptin (Clarkson and Herbison, 2006), among other sex differences 
(Simerly and Swanson, 1987; Simerly, 1989).   
We examined the effects of prenatal PCBs on an important part of the neural 
circuitry controlling these processes through immunohistochemical measurements of 
kisspeptin immunofluorescent density and ERα immunoreactive cell numbers in the 
AVPV, and the activation of GnRH neurons as indicated by Fos co-localization in the 
POA. In the adult female F1 rats, kisspeptin- and ERα-immunoreactivity (ir) in the 
AVPV were significantly reduced by perinatal exposure to EB or A1221. Thus, the 
AVPV of these females was more male-like in its kisspeptin and ERα expression through 
defeminization, masculinization, or both. Moreover, GnRH-Fos co-expression on the 
afternoon of proestrus was substantially down-regulated in the EDC-treated female rats. 
The PCB Mix females, while having lower kisspeptin fiber density and GnRH-Fos co-
expression, did not differ from the control group in ERα cell number, possibly due to the 
PCB mixture being much less estrogenic than either EB or A1221, and having more 
diverse molecular targets. We interpret our findings of decreased GnRH neuron 
activation as reflecting a disruption in the developmental programming of estrogen 
responsive afferents to GnRH neurons, such that AVPV ERα and kisspeptin-ir neurons 
do not respond robustly to estrogen positive feedback to stimulate a GnRH surge. Taken 
together, the observations reported here suggest that PCBs may mimic the masculinizing 
effects of endogenous estrogen in the developing AVPV. The effects of EB and A1221, 
and to a lesser extent the PCB Mix, are consistent with estrogenic exposures of the 
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perinatal female brain. The relative lack of effect in males is likely due to the already 
high exposures of the developing male brain to gonadal steroid hormones. 
The results of the present study are consistent with earlier reports by our lab and 
others, which provide evidence that developmental exposure to PCBs and other EDCs 
interferes with the organization of the hypothalamus, particularly the AVPV. For 
instance, we have previously shown that developmental A1221 exposure down-regulates 
ERβ-ir in the female AVPV (Salama et al., 2003). Studies of developmental exposures to 
phytoestrogens or bisphenol A (BPA) suggest that both males and females are sensitive 
to the disrupting effects of these compounds on sexual differentiation of the 
hypothalamus. For example, developmental exposure to the phytoestrogen genistein, but 
not BPA (Patisaul et al., 2007), demasculinized male AVPV volume in adult rats, while 
neither of the compounds affected masculine patterns of GnRH activation or AVPV 
kisspeptin-ir (Patisaul et al., 2009). Moreover, genistein and BPA also demasculinized 
AVPV tyrosine hydroxylase (the rate limiting enzyme for dopamine synthesis; TH)-ir in 
males and defeminized the population of neurons that co-express TH and ERα in females 
(Patisaul et al., 2006). In addition, genistein, and high doses of BPA (Navarro et al., 
2009b), defeminized AVPV kisspeptin-ir and GnRH neuron activation (Bateman and 
Patisaul, 2008). Collectively, these studied highlight the sensitivity of the developing 
hypothalamic reproductive neuroendocrine circuits to disruption by EDCs. 
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EDCs affect neuroendocrine gene expression in the female POA 
The Taqman low-density PCR array was used to test hypotheses about a panel of 
neuroendocrine genes involved in hypothalamic development/function, many of which 
are sexually dimorphic in expression. We acknowledge that this approach is more limited 
in its number of molecular targets than the whole-genome microarray approach. 
Nevertheless, this method is powerful, as it enables us to target a subset of genes for 
which we had hypotheses. Furthermore, because it is PCR-based, it does not require 
laborious follow up as is necessitated by DNA microarrays. By this method, we identified 
four genes whose expression changed significantly with neonatal PCB exposure: 
androgen receptor (AR), IGF-1, NMDA receptor subtype NR2b, and TGFβ1. These 
genes were all significantly down-regulated in the POA of EDC-exposed females, but 
were unaffected in the males. All four of these identified genes play roles in 
hypothalamic development, differentiation and function, including the regulation of 
GnRH neurons (Gore, 2001b; Daftary and Gore, 2004; Walker et al., 2009). Activation of 
AR is critical for both defeminization and masculinization of the developing brain and 
body (Raskin et al., 2009). IGF-1 is a growth hormone that plays a crucial role in somatic 
growth, as well as proliferation and inhibition of apoptosis [reviewed in (Joseph D'Ercole 
and Ye, 2008)]. NR2b is a subunit of the ionotropic NMDA receptor, whose activation 
has both direct and indirect actions on GnRH neurons and the reproductive axis (Gore, 
2001b; Maffucci et al., 2008). TGFβ1 is a cytokine protein involved in a number of 
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cellular functions such as cell growth, proliferation, differentiation, and apoptosis 
(Galbiati et al., 2003).  
Not only have these genes been shown to regulate neuroendocrine systems, but 
they also interact with one another. For example, the activation of AR stimulates IGF-1 
gene expression (Gentile et al., 2010), and interestingly, IGF-1 signaling may also 
stimulate AR gene expression (Fan et al., 2007) in a positive feedback loop. It is 
therefore not surprising that down-regulation of AR would be associated with decreased 
expression of IGF-1, and vice versa. Similarly, the promoter region of TGFβ1 has several 
androgen-response-elements (Qi et al., 2008), and may be positively or negatively 
regulated by AR activation depending upon the experimental model. Finally, there are 
numerous studies showing ineractions of NMDA receptors and IGF-1 (Le Greves et al., 
2005; Zheng and Quirion, 2009). These gene expression data add to the story of the 
effects of developmental EDC exposure on reproductive neuroendocrine function, as 
each gene (and presumably its protein products) may directly or indirectly interact with 
other players in this circuitry such as kisspeptin, ERα, and GnRH whose neuroanatomy 
and functionality are impaired by early life endocrine disruptors. 
It is informative to compare the results of protein and gene expression for the 
three molecules studied for both endpoints – GnRH, kisspeptin and ERα. There are 
clearly differences between how protein and gene expression are regulated, so some 
apparent discrepancies may be attributable to regulatory mechanisms such as differential 
effects of EDCs on gene transcription vs. post-transcriptional or post-translational levels. 
In addition, protein immunohistochemistry studies were done in AVPV (ERα, kisspeptin) 
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whereas gene expression analyses were done in the entire POA. Thus, for ERα, protein 
immunohistochemistry showed decreased cell numbers in the AVPV of the EB and 
A1221 females, whereas ERα gene expression in POA was unchanged. For kisspeptin, 
immunofluorescence in the AVPV was decreased in all EDC groups in females, while 
Kiss1 gene expression was similarly unchanged. Finally, for GnRH, gene expression was 
not affected by EDCs, but GnRH-Fos co-expression was decreased in the EDC females. 
 
SUMMARY AND CONCLUSIONS 
Our results show that perinatal exposure to PCBs affected the organization of the 
AVPV, by masculinizing or de-feminizing (or both) the female hypothalamic neurons 
that control reproduction. The observed effects of PCBs on AVPV development were 
similar to those caused by the estradiol benzoate positive control, suggesting that PCBs 
may act in large part through an estrogenic mechanism to target the developing 
neuroendocrine system. Although the link between developmental PCB exposure and 
human brain sexual differentiation is impossible to infer, as human sexuality is far more 
complicated than that of rats, and links between early life exposures and adult outcomes 
cannot be attributable to a single early life event. Nevertheless, PCB exposure is 
correlated with reduced testosterone in men (Goncharov et al., 2009), and reduced 
gonadal steroid hormones in newborns (Cao et al., 2008).  
In addition, developmental PCB exposure affects many other neurobiological 
endpoints in rodents, and PCBs are correlated with behavioral and cognitive traits in 
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humans. In rats, behavioral development, motor function, cognitive function, and social 
behaviors (Cromwell et al., 2007; Jolous-Jamshidi et al., 2010). In humans, prospective 
longitudinal birth cohorts consistently observe impairments in executive functioning 
related to increased prenatal PCB exposure, including deficits in processing speed, verbal 
abilities, and visual recognition memory (Boucher et al., 2010). 
In the context of environmental risk assessment, it is important to identify and 
characterize the neuroendocrine endpoints most sensitive to disruption, as developing 
humans and wildlife are likely to be exposed to PCBs and other EDCs. This research may 
also inform our understanding of other estrogenic EDCs in common usage in household 
products, food containers, plastics, and even plant products, as we are exposed to a 
spectrum of such compounds, both individually and in combination, at a range of dosages 
(vom Saal and Hughes, 2005).  
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CHAPTER 6: GENERAL DISCUSSION 
Recent scientific evidence has advanced our understanding of how exogenous 
environmental chemicals influence organisms. The field of endocrine disruption has been 
the focus of increasing attention from scientists and the general public as concerns mount 
that such chemicals may be contributing to an overall decline in human reproductive 
health. The structural properties of some of these compounds, known as endocrine 
disrupting chemicals (EDCs), allow for potential interactions with the endocrine systems 
of wildlife and humans. Their documented effects include actions on the reproductive, 
growth, metabolic, stress, and lactotrophic endocrine axes. Because the developing brain 
and reproductive organs are sculpted during perinatal life in part via hormonally-
mediated processes, organisms are particularly vulnerable to the actions of EDCs in late 
gestation and early infancy. 
The central focus of this chapter is the impact of environmental EDCs on the 
developing reproductive neuroendocrine axis. Endogenous hormones including estradiol 
and testosterone regulate critical periods of neuroendocrine development, the disruption 
of which manifests as permanent deficits in adult reproductive function. Exposure to 
environmental EDCs during the organization and/or activation of hypothalamic 
neuroendocrine circuitry can have lasting effects on reproductive physiology and sexual 
behavior. Importantly, exposure to EDCs is unavoidable, as a complex cocktail of such 
compounds is present in our daily environment. For instance, they contaminate our food 
and water supply, pollute our air, and are contained in products we come into contact 
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with on a daily basis, such as upholstery, fabrics, houseware, cookware, plastics, and 
even house dust. Moreover, transfer of the maternal body burden results in fetal exposure 
to EDCs.  
EDCs are categorized into several groups, including plant phytoestrogens, 
industrial organohalogens, pesticides, bisphenol A, and phthalates. Our lab has been 
using a class of industrial organohalogen known as polychlorinated biphenyls (PCBs) as 
a model to investigate EDC effects on the developing neuroendocrine axis. PCBs are a 
family of structurally stable synthetic compounds that were globally used for industrial 
applications since the 1930s. Although banned in the US in 1977, PCBs continue to 
constitute a human health risk. Significant quantities of persistent congeners are still 
detectable in both the environment and in the food chain, due to bioaccumulation and 
biomagnification. PCBs are classified as coplanar, dioxin-like coplanar, or non-coplanar, 
based upon the arrangement of chlorine atoms around the biphenyl core. The structural 
differences between the classes of PCBs influence the binding affinity to hormone and 
neurotransmitter receptors, and their ability to act as an agonist or antagonist. The effects 
of PCBs on the developing brain are not fully understood, and a rapidly expanding 
literature continues to reveal previously unknown neuroendocrine targets of PCB action.  
This dissertation has concentrated on understanding the cellular and molecular 
targets of PCBs on the developing rat neuroendocrine axis. The general hypothesis is that 
the PCBs tested cause changes in specific sexually dimorphic brain regions and their 
underlying sex-specific reproductive physiology, and neuroendocrine gene and protein 
expression. I also tested the hypothesis that perturbation of normal developmental 
 161 
apoptosis has long-term consequences for reproductive physiology. Toward this end, the 
immediate and latent effects of low-dose PCB exposure during the critical period of brain 
organization on neuroendocrine reproductive maturation were examined. Specifically, the 
effect of PCBs on sexually dimorphic developmental apoptosis in the AVPV and MPN, 
ERα protein expression, and expression of 48 candidate neuroendocrine genes was 
assessed in neonatal rats at postnatal day (P) 1. Somatic and reproductive maturation was 
monitored until early adulthood. At P60, the volumes of the AVPV and MPN, which are 
shaped in part by developmental apoptosis, were measured. In addition, ERα protein 
expression in the AVPV and MPN, as well as kisspeptin expression in the AVPV were 
assessed. Neurons expressing ERα and kisspeptin send inputs to the population of 
hypothalamic neurons that are the central driving force for the reproductive axis: the 
gonadotropin-releasing hormone (GnRH) neurons. Stimulatory signals from 
ERα/kisspeptin neurons trigger the preovulatory GnRH surge in female rats; therefore, 
activation of GnRH neurons on proestrus was evaluated in females. Finally, expression of 
48 candidate neuroendocrine genes was also assessed in adult rats at P60. These 
endpoints were selected to provide a broad assessment of how PCBs alter maturation and 
function of the neuroendocrine systems underlying sex-typical reproductive physiology. 
The results provide novel insight into the mechanisms through which exposure during 
late gestation to representative mixtures containing either non-coplanar or both non-
coplanar and coplanar PCBs disturb neuroendocrine function in adult mammals.     
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In Vitro Effects of PCB Exposure on a Model Hypothalamic Cell Line 
 Due to their small population and sparse distribution, GnRH neurons are 
technically difficult to study in vivo. The GT1-7 cells, an immortalized mouse 
hypothalamic GnRH line, has provided an in vitro model for studying the effects of 
EDCs on a pure population of GnRH cells (Mellon et al., 1990). Aim I of this dissertation 
project investigated the mechanisms by which PCBs cause neurotoxicity in GT1-7 cells 
(Dickerson et al., 2009).  In that study, the effects of individual PCB compounds 
representing different classes: PCB74 (coplanar), PCB118 (dioxin-like coplanar), 
PCB153 (non-coplanar), or their combination were tested. I found effects of each PCB on 
loss of GT1-7 cell viability, attributable to both increased necrosis and apoptosis. In 
general, the individual PCBs caused necrosis at the highest dosages and times of 
incubation, whereas apoptosis occurred at lower doses and shorter time points. 
Surprisingly, no additivity or synergism of the combined PCBs was observed. This may 
be attributable to only studying one combination that did not fully explore the range of 
dosages needed for such phenomena to be observed. 
Cultured GT1-7 cells synthesize and release GnRH, a decapeptide that regulates 
vertebrate reproductive function, in a pulsatile manner. GnRH peptide levels were 
measured, and I demonstrate generally stimulatory effects of individual and combined 
PCBs at lower dosages/shorter time points, and inhibitory effects at longer time points 
and higher dosages. The co-administration of an ER antagonist showed that PCB-induced 
suppression of GnRH peptide is modulated, at least in part, by the ER. Similar results 
were seen for individual congeners and their combination. Collectively, the in vitro 
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results demonstrate action of specific PCBs on GnRH neurons. These results complement 
earlier work from our laboratory showing that the PCB mixtures A1221 and A1254 cause 
changes in GT1-7 cell morphology, and GnRH gene expression and peptide release (Gore 
et al., 2002). 
 
In vivo effects 
Aims II and III of this dissertation were in vivo studies that sought to determine 
whether exposure to PCBs during a critical period of brain organization would disrupt 
brain sexual differentiation. Two mixtures of PCBs were used, each with unique chemical 
properties. A1221 is a lightly chlorinated mixture of estrogenic coplanar and non-
coplanar PCBs with a short half-life. The reconstituted mixture comprised of the more 
heavily chlorinated non-coplanar congeners PCB138, PCB153, and PCB180, has a long 
half-life. The individual congeners contained in this mixture have been reported to be 
estrogenic, anti-estrogenic or anti-androgenic (Bonefeld-Jorgensen et al., 2001). I found 
that exposure of female rats to these PCBs at environmentally relevant doses during late 
gestation had both immediate (P1) as well as long-lasting effects on neuroendocrine 
reproductive physiology observed during the pubertal transition and early adulthood 
(P60).   
In female rodents it is believed that the attainment of adult reproductive capacity 
requires the organization of a hypothalamic neural network of GnRH cells, together with 
their regulatory inputs, that facilitate steroid hormone feedback effects on pulsatile GnRH 
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release, and the preovulatory GnRH/LH surge in females. The morphological and 
neurochemical organization of this steroid-responsive neural network begins during late 
gestation and infancy, is regulated by hormones, and can be manipulated by gonadectomy 
or administration of exogenous hormones (Piacsek and Meites, 1966; Gross, 1980; Jean-
Faucher et al., 1985). In male rats, androgens released by the fetal/neonatal testes, and 
their subsequent aromatization to estradiol within the nervous system, masculinizes and 
defeminizes the male brain, in part via stimulation or inhibition of programmed cell death 
(apoptosis). Conversely, the female rat brain is exposed to levels of estradiol several 
orders of magnitude lower than the male brain, and is demasculinized and feminized 
during development.  
My experiments show that A1221 or EB increased the extent of AVPV apoptosis 
in P1 females, but not males. However, the reconstituted PCB mixture had no effect on 
developmental apoptosis. The discrepancy between the effects of these two PCB mixtures 
on AVPV apoptosis may be related to differences in their interaction with the estrogen 
receptor, although the current experimental design did not allow for that determination.  
I found that the ERα-ir cell number was increased in the P1 MPN by EB 
treatment in both males and females, while both PCB mixtures had no effect. Thus the 
PCB mixtures studied do not have the same effects as an exogenous estrogen for all 
endpoints. Finally, I found altered gene expression of nine factors involved in neuronal 
migration and anatomical establishment of hypothalamic brain nuclei in P1 pups of both 
sexes, including brain-derived neurotrophic factor (BDNF), GABAB receptors 1 and 2, 
IGF-1, kisspeptin receptor (GPR54), NMDA receptor subtypes NR2b and NR2c, 
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prodynorphin, and TGFα. Specifically, in females, EB and A1221 increased expression 
of both GABAB receptor 2 and NMDA2b. Although there was a trend for PCB-induced 
gene expression changes by the reconstituted mixture, these did not reach statistical 
significance following Bonferroni correction. In males, EB treatment reduced gene 
expression of BDNF and KISSR, while increasing NMDA2c. A1221 increased IGF-1. 
The reconstituted PCB mix increased gene expression of both GABAB receptor 2 and 
TGFα, while decreasing KISSR. As a whole, these results show that a network of genes 
and proteins is altered in the hypothalamus as early as the day after birth, with results 
dependent upon the specific EDC administered. 
The initiating event in the pubertal transition to adult reproductive capacity is 
activation of GnRH release from the hypothalamus, which stimulates the release of 
gonadotropins from the pituitary, which, in turn, activates the gonads. Development of 
secondary sex characteristics results from increased levels of circulating sex steroid 
hormones. Sex steroids activate the sex-specific brain morphology and neurochemistry 
that had previously been organized during early postnatal life. Because puberty is 
sensitive to endogenous hormones, it is not surprising that this postnatal developmental 
transition is also sensitive to EDCs. Moreover, puberty itself may be associated with 
further organizational or reorganizational changes in the nervous system and is beginning 
to be considered a second critical period for brain sexual differentiation (Sisk and Foster, 
2004). In my dissertation research, PCB exposures during early life hastened puberty in 
females, and delayed it in males.  
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A key regulatory region in the control of the hypothalamic GnRH neuronal 
network is the AVPV, a preoptic brain region that expresses nuclear hormone receptors 
such as ERα (Simerly et al., 1990), ERβ (Orikasa et al., 2002), and PR (Quadros et al., 
2002), as well as other neuromodulators such as kisspeptin (Clarkson and Herbison, 
2006) in a sexually dimorphic manner. The adult female rat AVPV is larger than in male 
rats (Sumida et al., 1993), resulting from a sex difference in developmental apoptosis in 
this region, which is normally greater in males than females. A subset of neurons within 
the AVPV directly innervates GnRH neurons (Hahn and Coen, 2006; Polston and 
Simerly, 2006), enabling the positive feedback effects of steroids upon the preovulatory 
GnRH/LH surge (Wiegand et al., 1978; Wiegand and Terasawa, 1982; Gu and Simerly, 
1997; Le et al., 2001), a phenomenon that is latent in males. This population of neurons 
modulates GnRH release in part via expression of ERα (Couse et al., 2003; Wintermantel 
et al., 2006) and kisspeptin (Clarkson et al., 2008). I examined the effects of prenatal 
PCBs on this neural circuitry in adults. The results of this study suggest that these 
processes may be impaired by the prenatal masculinization or defeminization (or both) of 
the female’s AVPV.  
In female rodents, rising levels of estradiol released from ovarian granulosa cells 
during the follicular phase of the estrous cycle trigger a shift from negative to positive 
steroid feedback onto the hypothalamus. Estradiol then stimulates a surge in GnRH 
release from neuroterminals in the median eminence in part via stimulatory inputs from a 
sexually dimorphic population of neurons in the AVPV that co-express ERα and 
kisspeptin (Franceschini et al., 2006; Adachi et al., 2007; Clarkson et al., 2008). The 
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response of GnRH neurons to estradiol positive feedback can be detected through their 
activation, as evident by Fos co-expression. I found that EB- and A1221-treatment 
reduced AVPV volume in adult females, a result consistent with the increased AVPV cell 
loss measured at P1. Interestingly, serum levels of estradiol and progesterone in F1 
offspring at adulthood were not affected by their prenatal PCB exposure, suggesting that 
steroid hypothalamic feedback is potentially unaffected. Moreover, ovarian samples from 
all treatment groups showed corpora lutea, a reliable indicator that ovulation occurred in 
all females.  Nevertheless, the GnRH neurons of the prenatally exposed females did not 
respond normally to ovarian steroid feedback, implicating a central mechanism for PCB 
effects on female reproductive physiology. That is, on the afternoon of proestrus, the 
expression of both ERα and kisspeptin was reduced by prenatal EB or PCB exposure in 
the adult female AVPV. The co-expression of Fos in GnRH neurons of these animals was 
concomitantly and dramatically reduced. The finding of disrupted estrous cyclicity in the 
context of reduced AVPV ERα-ir, reduced AVPV kisspeptin-ir and an inhibition of 
GnRH activation on the afternoon of proestrus suggests that prenatal PCBs interrupt 
developmental programming of the hypothalamic circuits controlling the preovulatory 
GnRH/LH surge in adult females.   
In adult males AVPV ERα-ir cell number and kisspeptin-ir were not affected by 
treatment. The reconstituted PCB mix increased male AVPV volume, while the other 
treatments had no effect. This relative lack of effect in males may be related to the 
already high exposure of their developing brain to gonadal steroid hormones. 
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In addition to the changes in protein expression, I also found that gene expression 
of the following four neuroendocrine genes was affected by developmental EDC 
exposure: androgen receptor (AR), IGF-1, the N-methyl-D-aspartate (NMDA) receptor 
subunit NR2b, and TGFβ1. In females, both A1221 and the reconstituted PCB mix 
decreased AR and TGFβ1 mRNA levels compared to vehicle, while EB and A1221 
decreased expression of IGF-1 and NR2b. There were no significant effects in the males. 
Based on these data, I propose a model for PCB disruption of hypothalamic 
programming, below. 
 
A Comprehensive Model for PCB Disruption of Hypothalamic 
Developmental Programming 
Taken together, these data suggest a model whereby PCBs disrupt developmental 
programming of the female hypothalamus, a process that begins in the neonatal animal, 
continues throughout pubertal development, and is manifested as neuroendocrine 
reproductive deficits in early adulthood. Therefore, the proposed model begins with PCB 
disruption of hypothalamic organization through interference with the anatomical 
establishment of AVPV neural circuitry via aberrant neuronal cell death and migration 
(Fig. 6.1). In the developing hypothalamus, PCBs can interfere with proper anatomical 
and neurochemical establishment of the AVPV via direct or indirect interactions with 
estrogen receptors, stimulation of aberrant apoptosis, and/or interference with expression 
of neurotrophic and migration factors.  
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Figure 6.1: Perinatal Programming of the AVPV 
 
Figure 6.1: Model for the normal organizational effect of sex steroid hormones on the developing 
hypothalamus. In male rats, estradiol, aromatized in the brain from androgens secreted by the 
perinatal testes defeminizes (reduces) the number of AVPV kisspeptin and ERα neurons. In 
contrast, female brains are exposed to estradiol and androgens at several orders of magnitude 
lower than males during the perinatal developmental period. Therefore, the female brain is 
feminized and demasculinized, developing an AVPV with much higher numbers of kisspeptin 
and ERα neurons. In the neonatal EB- or A1221-disrupted female, PCBs increase developmental 
apoptosis, thereby defeminizing and masculinizing this system. Thus, the AVPV develops in a 
male-typical fashion, with a smaller volume, and reduced numbers of neurons that express 
kisspeptin and ERα. 
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The next step in the proposed model is PCB disruption in the activation of hypothalamic 
GnRH release at puberty (Figure 6.2).   
 
Figure 6.2: PCB Disruption of Pubertal Activation of GnRH Release 
 
Figure 6.2: Model for PCB-induced disruption of normal activation of GnRH release at puberty. 
GnRH nerve terminals in the median eminence are shown in green; small circles represent 
secretory vesicles that are released from the GnRH neurons in a pulsatile pattern of about once 
every 30-90 minutes, depending upon age and sex. 
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The final step in the proposed model is a disruption in the integration of steroid 
feedback with stimulatory signals from AVPV ERα/Kisspeptin neurons onto GnRH 
neurons, leading to diminished or delayed activation of the GnRH/LH surge on the 
afternoon of proestrus (Figure 6.3). The male hypothalamus also undergoes maturation at 
puberty, although the response to positive steroid hormone feedback is latent in males.  
The lack of treatment effect upon male AVPV ERα and Kisspeptin protein expression 




Figure 6.3: PCB Disruption of Neural Circuitry Controlling GnRH Surge 
 
Figure 6.3: Prenatal PCBs disrupt the neural circuitry regulating the preovulatory GnRH 
surge. In the female AVPV, neurons expressing kisspeptin and ERα extend projections to 
GnRH neurons in the organum vasculosum of the lamina terminalis (OVLT) and preoptic 
area (POA). In response to the positive feedback triggered by rising levels of estradiol 
(E2) released by the ovary during the follicular phase of the estrous cycle, AVPV 
kisspeptin/ERα neurons send stimulatory inputs to GnRH neurons, which express 
GPR54, the kisspeptin receptor. Activation of GnRH neurons is evident by co-expression 
of FOS, and is followed by the preovulatory GnRH/LH surge. In females prenatally 
exposed to estradiol benzoate or PCBs, positive feedback from reduced numbers of 
kisspeptin/ERα neurons is not completely abolished, but is insufficient to activate GnRH 






In this series of experiments, developing male and female rats were exposed to 
ecologically relevant low doses of PCBs during the period of brain sexual differentiation. 
The exposed F1 generation displayed no gross morphological abnormalities, and litter 
size and sex ratio were not affected. However, treated males and females exhibited 
disruptions in reproductive neuroendocrine development, with females being more 
susceptible to this type of impairment. Developmental profiles of apoptosis, gene and 
protein expression in the POA revealed effects of PCBs as early as the day after birth, 
while results from the pubertal and early adult endpoints highlighted the latent and long-
lasting impact of PCB action on the developing hypothalamus. Collectively, the in vivo 
results point to a comprehensive model for PCB disruption of developmental AVPV 
programming in the female rat, whereby increased AVPV apoptosis and altered POA 
gene expression of neurotrophic and cell migration factors lead to defeminization/ 
masculinization of the AVPV, followed by early activation of GnRH release in the 
peripubertal period, and finally manifesting as a dysregulation of steroid hormone 
positive feedback integration with AVPV stimulation of GnRH activation at proestrus. 
These data contribute important new information to the growing body of literature whose 
aim is to better understand the fetal basis of adult diseases. 
The results of this dissertation research have relevance for human public health 
and disease, as increased trends for reproductive decline (Chandra et al., 2005) have led 
researchers to hypothesize that environmental endocrine disruptors are adversely 
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affecting human health and reproduction. Indeed, the human evidence for endocrine 
disruption by environmental EDCs is mounting [reviewed in (Diamanti-Kandarakis et al., 
2009)], and highlights the importance of linking basic mechanistic research with 
epidemiological observations of obesity, reproductive cancers, sperm counts, diabetes, 
and precocious puberty in humans. As humans are rarely exposed to a single EDC, and 
there are limited data on the interactions between compounds that comprise the typical 
environmental mixture of different classes of EDCs, future research must clarify the 
effects of simultaneous exposure to compounds which may have additive, synergistic, or 
antagonistic effects (Kortenkamp, 2008). 
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